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ABSTRACT
A comprehensive investigation of the optimal conditions for reconstitution of 
bovine heart pyruvate dehydrogenase complex activity (PDC) from dissociated E2/X 
core and E1/E3 fractions is presented, and was employed in the elucidation of the 
disputed involvement of the lipoyl domains of protein X in overall complex 
catalysis.
Selective proteolysis of the lipoyl and linker regions of protein X by Arg C, 
in isolated E2/X core or intact PDC, resulted in a dramatic reduction in E3 binding 
potential and hence, complex activity (with the former, following reconstitution with 
dissociated components, E l and E3), when compared to control complex activities. 
It is proposed that owing to the proximity of the cleavage site to the E3 binding 
domain of protein X, loss of E3 binding affinity arises from conformational changes 
in the aforementioned domain and/or, the specific binding site within. Partial 
recovery of reconstitution was achieved in the presence of excess porcine E3, and 
increased with increasing protein X degradation suggestive of an additional, non­
specific and hence, low affinity E3 binding site -- presumably the subunit binding 
domain of E2.
Following removal of the lipoyl and linker regions of either component E2 or 
X, N-ethyl[2,3-14C]maleimide labelling studies confirmed previous observations of 
a residual (i.e., approx. 10%) complex activity, indicating the ability of either 
component to substitute for the lipoyl domains of the other. The physiological 
implications of this are discussed in relation to the unique diacetylation properties of 
mammalian PDC. However, as attempts to isolate and sequence the extreme C-
x v iii
terminal portion of protein X following the recent discovery of a dihydrolipoamide 
acetyltransferase active site-like motif by J.C. Neagle (University of Glasgow, 
unpublished observations), remained in the initial stages, it is unclear whether 
deacetylation of the lipoyl domains of protein X services an acetyltransferase active 
site on E2 or X.
Precise stoichiometric determinations employing: comparisons of 14C- 
acetylation in E2 and X; and, densitometric scan analysis of highly purified protein 
X, E2 and bovine heart PDC samples resolved by SDS-PAGE and silver stained, 
indicated the presence of 12mol protein X/mol PDC, and of 60mol E2/mol PDC, 
respectively. Structural studies involving covalent N,N’-l,2-phenylene-dimaleimide 
(PDM), crosslinking of the lipoyl domains of protein X in E2-lipoyl domain 
depleted complex, revealed dimeric organisation. Presented together, this evidence 
is in close agreement with the 1:1 (E3:E1) binding relationship of bovine heart 
OGDC, and is strongly suggestive of the involvement of six protein X dimers in the 
binding of six dimers of E3 to the E2/X core in bovine heart PDC. Furthermore, the 
presence of 60 E2 subunits supports previous proposals for a non-integrated, 
external protein X core positioning.
X i X
CHAPTER 1: INTRODUCTION
1
1.0 INTRODUCTION
1.1 The 2-oxoacid dehydrogenase complex family
1.1.1 A role in metabolism
The pyruvate dehydrogenase complex (PDC) is a member of the thiamine 
pyrophosphate-requiring 2-oxoacid dehydrogenase complex family which also 
comprises the 2-oxoglutarate dehydrogenase complex (OGDC), and the branched 
chain 2-oxoacid dehydrogenase complex (B CO ADC). Together, these self­
assembling multienzyme complexes with calculated Mr values in the range of 4-10 x 
106 (Bates etal., 1977; Reed, 1974), represent classic examples of macromolecular 
structure and organisation. As such, they have been the subject of considerable 
interest since the initial purification and characterisation of PDC from Escherichia 
coli (Nawa et al., 1960; Koike et al., 1963; Reed & Oliver, 1968; Reed & 
Mukherjee, 1969) and later, eukaryotic sources (Linn et al., 1969,1972; Wieland & 
von Jagow-Westermann, 1969) began in the late 1950s with the work of Lester J. 
Reed and others.
Located in the mitochondrial matrix in eukaryotes and probably associated 
with the inner mitochondrial membrane (Yeaman, 1986), all three complexes occupy 
key positions in metabolism and are instrumental in the regulation of substrate flux 
to, from and within the TCA cycle.
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Each is composed of multiple copies of three individual enzyme components 
known as E l, E2 and E3, which catalyse the sequential partial reactions in the 
oxidative decarboxylation of 2-oxoacids to their acyl CoA derivatives with the 
concomitant production of CO2 . Thus, whilst PDC controls the committed step in 
carbohydrate metabolism with the conversion of pyruvate to acetyl CoA for 
subsequent oxidation by the TCA cycle or, utilisation in fatty acid or ketone body 
synthesis, OGDC catalyses the oxidative decarboxylation of 2-oxoglutarate to 
succinyl CoA and thereby regulates flow through the TCA cycle itself. 
Furthermore, B CO ADC is responsible for the irreversible oxidation of the 2- 
oxoacids derived from the essential branched chain amino acids, leucine, isoleucine 
and valine and, of 2-oxobutyrate and 4-methylthio-2-oxobutyrate (the products of 
threonine and methionine metabolism) which, following further oxidation may enter 
the TCA cycle as acetyl- or succinyl CoA.
Reflected in the characteristically narrow (PDC & OGDC), or broad 
(B CO ADC), substrate-specificities of the complexes are the corresponding catalytic 
preferences of the complex-specific E l and E2 components known as: pyruvate 
dehydrogenase (El, EC 1.2.4.1) and dihydrolipoamide acetyltransferase (E2, EC 
2.3.1.12) of PDC; 2-oxoglutarate dehydrogenase (E l, EC 1.2.4.2) and 
dihydrolipoamide succinyltransferase (E2, EC 2.3.1.61) of OGDC; and the 
branched chain a-ketoacid decarboxylase (El, EC 1.2.4.4) and dihydrolipoamide 
acyltransferase of BCOADC. In contrast, the highly conserved lipoamide 
dehydrogenase (E3, EC 1.8.1.4) or LDH, is common to all three complexes and 
also appears as the "L" protein of the glycine decarboxylase system of bacteria and 
mammals (Sokatch & Bums, 1984). Notably, structural similarities also exist 
between the E2 component and the lipoic acid-containing "H" protein of the glycine 
decarboxylase complex (GDC) -- see Fujiwara et al. (1986,1991).
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In addition, LDH is also a member of the disulphide oxidoreductase family 
which comprises trypanothione, mercuric and glutathione reductases -- to the latter 
of which Azotobacter vinelandii E3 has been shown recently, through high 
resolution X-ray crystallography, to share common structural features although, 
amino acid homologies between the different members of this group range from only 
20-30% identity (Mattevi et al., 1991). Whilst apparently the product of a single 
LDH gene in mammalian and (possibly) plant mitochondrial 2-oxoacid 
dehydrogenase complexes (Bourguignon et al., 1992; Turner et al., 1992; and 
references within), the situation is complicated by the characterisation of complex- 
specific LDH genes in Pseudomonas putida (Palmer et al., 1991 a,b), Pseudomonas 
aeruginosa (McCullet et al., 1986), E. coli (Richarme, 1989) and, by the discovery 
of several isoforms in rat liver and potato mitochondria (Carothers et al., 1987; R.E. 
Millar, University of Glasgow, unpublished observations).
In Pseudomonas, two genetically distinct forms designated, LDH-Val and 
LDH-Glc, have been characterised -  the former specific for BCOADC (Bums et al., 
1989a), and the latter, for OGDC, GDC and possibly, PDC (Palmer et al., 1991a). 
Furthermore, a third lipoamide dehydrogenase of unknown function, LDH-3, 
isolated from P. putida (Bums et al., 1989b), appears capable of substituting, at 
least in part, for LDH-Glc in OGDC and PDC. Notably, the close similarity of the 
LDH-3 encoding gene to that of eukaryotic LDH (Palmer et al., 1991b) may provide 
further insight into the origins of E3. In parallel, two forms of E3 exist in E. coli, 
one encoded by the Ipd gene and specific for PDC and OGDC; and, a second 
exhibiting similarities to LDH-Val of P. putida but of unknown function. However, 
the identification of lipoamide dehydrogenases from Trypanosoma brucei, 
Clostidium sporogens and archaebacterium, Halobacterium halobium, which lack 
the 2-oxoacid dehydrogenase complexes (Danson et al., 1987) coupled, with 
evidence for the involvement of E3 in galactose and maltose transport in E. coli
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(Richarme & Heine, 1986), has led to proposals for an additional role in sugar 
transport, for E3 from bacteria .
1.1.2 General reaction scheme
As summarised in the reaction scheme in Fig. 1.1.2.1, E l catalyses the 
initial steps in the rate-limiting and irreversible decarboxylation of the appropriate 2- 
oxoacid substrate to an hydroxyacyl-TPP intermediate via the transient ionisation of 
the thiazole ring of co-factor, TPP, to which the negatively charged carboxyl group 
of the 2-oxoacid binds and is stabilised prior to the extraction of CO2 . The oxidation 
to an acyl group and corresponding reductive acylation of the S8-thiol of the E2- 
linked lipoic acid co-factor, also catalysed by E l, results in the regeneration of the 
carbanion of TPP. Transfer of the acyl group to a reduced CoA molecule is then 
facilitated by E2, leaving the lipoic acid S6,S8-thiols in a reduced state — ready for 
reoxidation and regeneration of the disulphide by E3 following the successive 
reduction and oxidation of co-factors FAD and NAD+.
1.1.3 Macromolecular structure and organisation
Central to the structure and function of the 2-oxoacid dehydrogenase 
complexes are the dihydrolipoamide acyltransferase (E2) subunits. Forming the 
structural core about which all other components arrange, non-covalent aggregates 
of E2 polypeptides provide a framework for the coordination of the partial reactions 
involved in complex catalysis. In mammalian OGDC, BCOADC and PDC from
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F ig .1.1.2.1 Reaction scheme for the oxidative decarboxylation of 2-
oxoacids to acyl CoA derivatives.
Fig. 1.1.3.1 Interpretive models of E2 quaternary structure.
Model A: 24 E2 molecules arranged with octahedral symmetry. 
Model B: 60 E2 molecules arranged with icosahedral symmetry.
Gram negative bacteria such as E. coli and A. vinelandii, the core consists of 24 
identical copies arranged with octahedral (432) symmetry which gives a cubic 
appearance when viewed by electron microscopy (Oliver & Reed, 1982). In 
contrast, PDC from Gram positive bacteria, Bacillus stearothermophilus, Bacillus 
subtilis and Streptococcus faecalis, and from mammalian, avian and fungal sources, 
exhibit dodecahedral cores comprising 60 E2 components arranged with icosahedral 
(532) symmetry (see Perham, 1991 for review; see Fig. 1.1.3.1). Thus, the 2- 
oxoacid dehydrogenase complexes appear species-specific and furthermore, 
growing evidence from plant sources suggests organelle-specificity in some species 
(Taylor et al., 1992).
Information from negative stain electron microscopy images of PDC (Oliver 
& Reed, 1982), and low resolution X-ray crystallography of E2/E3 subcomplexes 
(Fuller et al., 1979), led to a model where dimers of E l and E3 are thought to 
associate along the edges and faces of the E2 core, respectively. Whilst six E3 
homodimers of total Mr 110000 appear common to all 2-oxoacid dehydrogenase 
complexes, the number, Mr values and subunit configuration of E l varies from the 
12 homodimers of Mr 220000 in E. coli to the 20-30 split-chain c*2p2 
heterotetramers of icosahedral PDC and mammalian BCOADC which, in bovine 
heart PDC, comprise a total Mr of 154000 with subunit Mr values of 42000 (a) and 
36000 (p). It has been suggested that reactions 1 and 2 of the overall reaction 
scheme (see Fig. 1.1.2.1) are catalysed by E la  and Elp, respectively — although 
this remains somewhat controversial (see Reed & Yeaman, 1987; Reed & Hackert, 
1990 for reviews). In addition, a fourth component known as protein X was 
identified in PDC from mammalian and yeast sources (De Marcucci & Lindsay, 
1985; De Marcucci et al., 1985; Jilka et al., 1986; Behai et al., 1989), and found to 
exhibit close structural/functional identity, tight association and copurification with 
E2, although present at considerably lower levels (i.e., 6-12 molecules/complex).
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Considerable information concerning the 2-oxoacid dehydrogenase 
complexes has come to light from the cloning and sequencing of the genes encoding 
individual components. Initial research involved elucidation of the ace E (El, 
PDC), ace F (E2, PDC), sue A  (E l, OGDC), sue B (E2, OGDC) and, Ipd (E3) 
genes from E. coli, led by the work of J.R. Guest & coworkers (Guest et al.,
1989). However, the genes for E l, E2 and E3 of PDC and BCOADC, from various 
eukaryotic sources including human, and additional prokaryotes, have since been 
isolated and sequenced (reviewed in Yeaman, 1989; Thekkumkara et al., 1989). In 
addition, the full length cDNA sequence for protein X from S. cerevisiae (PDX 1) is 
also known (Behai et al., 1989). Sequence alignments have revealed surprisingly 
little homology between the E l components of PDC and OGDC, suggestive of early 
divergence during evolution. In contrast, both the E2 and E3 components exhibit 
close sequence identity across species and complex type (approx. 40% identity for 
E3) -- the former, also possessing remote similarities to chloramphenicol 
acetyltransferases and the latter component, to related enzymes of the disulphide 
oxidoreductase family.
Furthermore, a small number of the complex-specific regulatory enzymes, 
kinase and phosphatase, have been found tightly and rather more loosely associated 
with the E2 core, respectively, of mammalian, avian and Neurospora crassa PDC 
and of mammalian BCOADC (Linn et al., 1969; Reed & Yeaman 1987 for review). 
PDC kinase and phosphatase are also known to be present at low levels in plant 
mitochondria -- a fact which has precluded a successful purification to date (Randall 
et al., 1990). In contrast, both enzymes have been purified to homogeneity from 
bovine kidney and heart mitochondria (Linn et al., 1972; Stepp et al., 1983; Teague 
et al., 1982), and found to exist as heterodimers of Mr 48000 and 45000 (kinase) 
and, Mr 50000 and 94000 (phosphatase), of which the former appears to be the 
catalytic subunit (as with the 33000-Mr subunit of BCOADC phosphatase — see
7
Yeaman, 1989). An unsubstantiated regulatory role has been proposed for the 
45000-Mr (Kb) subunit of PDC kinase (Stepp et al., 1983), supported by the recent 
findings of enhanced kinase activity following its removal by Arg C (Rahmatullah et 
al., 1989a) whereas, the 48000-Mr (Kc) subunit is thought to be involved in the 
binding of the kinase heterodimer to E2 (Radke et al., 1993). In contrast, both the 
catalytic involvement of the 94000-Mr FAD-containing subunit of PDC phosphatase 
and, the subunit composition of the 460000-Mr BCOADC phosphatase, remain to be 
established. In addition, due to problems encountered with tight core association, 
which in the isolation of PDC kinase required the employment of denaturing and 
chaotrophic conditions such as high salt, alkaline pH and p-hydroxymercuriphenyl 
sulphonate to effect release (Stepp et al., 1983), little is known of the structure of 
BCOADC kinase.
Recent sizing of both mammalian (Roche et al., 1993) and E. coli PDC 
(Wagenknecht et a l, 1992), employing quasielastic light scattering and cryoelectron 
microscopy, respectively, have resulted in estimations for complex diameters of 
approximately 50nm — far exceeding that previously determined by Oliver & Reed 
(1982). However, as the later studies employed frozen-hydrated complex, in 
contrast to the earlier methods using dehydrated and fixed samples, it is likely that 
these lower determinations reflect the collapse of flexible, extended regions.
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1.1.4 Regulation
In all 2-oxoacid dehydrogenase complexes, regulation is facilitated by end- 
product inhibition, imparted by the increasing concentrations of products, NADH 
and acyl CoA in relation to the levels of substrates. In addition, changes in the 
actual amounts of each enzyme complex are facilitated through altered gene 
expression. However, in PDC from mammals, birds and N. crassa, and BCOADC 
from mammals, a further control mechanism exists involving the regulatory 
enzymes, kinase and phosphatase. These enzymes, in response to the levels of 
hormones and other effector molecules, regulate both acute and long-term changes in 
the active state of the aforementioned complexes via the reversible phosphorylation 
of the E l component; in the latter case, also involving the indirect)effects of altered 
kinase/phosphatase gene expression. Notably, this additional regulation is only 
apparent with complexes exhibiting an ot2p2 E l configuration although, previous 
unsuccessful attempts to isolate PDC kinase from S. cerevisiae indicated one 
exception to this rule (Kresze & Ronft, 1981 a,b). Nevertheless, S. cerevisiae 
retains the potential for in vitro regulation by bovine kidney PDC kinase and 
phosphatase (Uhlinger et al., 1986). Furthermore, recent research from this 
laboratory has demonstrated significant levels of kinase activity in vivo, which were 
subsequently lost upon complex purification and may therefore, reflect the presence 
of inactivated or unusually labile forms of the regulatory enzymes (James & 
Lindsay, 1994).
Inactivation follows the primary phosphorylation of one of three (PDC) or 2 
(BCOADC) specific serine residues located within highly homologous sites on the 
El a  subunits and is accompanied by lowered Vmax and insensitivity to all allosteric 
activators, with further phosphorylation of the remaining sites possibly inhibiting
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dephosphorylation by phosphatase (Sudgen et al., 1978; Yeaman etal., 1978; Cook 
et al., 1983). Notably, the site of phosphorylation in S. cerevisiae E l closely 
resembles the primary phosphorylation sites of E l from bovine heart and kidney 
PDC and OGDC (Uhlinger et al., 1986). In PDC, this "on/off switch is subject to 
complex catalytic regulation in which both kinase and phosphatase exhibit a 
Mg2+/Mn2+ requirement -- the former enzyme, inhibited by substrates CoA, NAD+, 
pyruvate, TPP and activated by products acetyl CoA, NADH; and the latter enzyme, 
inactivated by NADH, and activated by Ca2+ which binds at two sites, one involved 
in catalysis and the second, in promoting binding to the E2 core (see Reed & 
Yeaman, 1987; see Fig. 1.1.4.1).
In light of the observed enhancement in E l phosphorylation following the 
binding of kinase to the E2 core, Roche and others (Kerbey et al., 1976; 
Rahmatullah & Roche, 1987; Rahmatullah et al., 1989a), proposed a mechanism for 
kinase modulation involving the reductive acetylation of the lipoic acid moieties of 
both components, E2 and X, in response to the relative levels of substrates and 
products. Although disputed by the findings of Reed et al. (1980) which suggested 
direct allosteric control of the kinase, Roche and co-workers subsequently reported 
the loss of this core-bound increase in kinase activity, following acetylation of the 
lipoyls of E2 from bovine kidney PDC, and proposed a critical involvement of one 
of the latter two moieties in kinase binding (Radke et al., 1993).
PDC is also found in plant mitochondria and chloroplasts, providing in the 
latter organelle, acetyl CoA for fatty acid and isoprenoid biosynthesis and the only 
known source of NADH (Camp & Randall, 1985). These two spatially-separated 
complexes exhibit characteristic substrate specificities, pH optima and Mg2+ 
requirements (Miemyk & Randall, 1987), and are both subject to end-product 
inhibition. However, whereas plant mitochondrial PDC is additionally regulated by
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Fig. 1.1.4.1 Schematic representation of PDC regulation via covalent  
modification and the control elicited by effector molecules.
reversible phosphorylation, chloroplast PDC is controlled by the indirect effects of 
the light-dark transitions which include, changes in pH and metal ion concentrations 
(Randall et al., 1990). However, as PDC has only been successfully purified once 
from broccoli mitochondria (Rubin & Randall, 1977), characterisation of structure, 
organisation and regulation is still in the initial stages.
1.1.4.1 Acute control
Acute control of BCOADC kinase, unaffected by Ca2+, NAD+/NADH or 
CoA/acetyl CoA levels, is facilitated by substrate dependent activation involving all 
five 2-oxoacid substrates with complex kinetics (see Yeaman, 1989 for review). In 
contrast, no evidence has come to light for such regulation in either prokaryotic 
complexes or the octahedral OGDCs. The latter complexes have been shown to 
exhibit an antagonistic allosteric activation/inactivation by Ca2+/ATP (due to 
decreasing/increasing Km values for 2-oxoglutarate), in response to the levels of 
hormones, adrenaline and vasopressin (Yeaman, 1989).
Acute hormonal Ca2+-mediated control has also been demonstrated for PDC 
from heart and liver tissue with adrenaline, although clearly not an effect of direct 
allosteric activation but of PDC phosphatase activation (Denton & McCormack,
1985). However, the classic example of acute hormonal regulation, involving the 
insulin-directed dephosphorylation of PDC from adipose tissue, also occurs via 
phosphatase activation and although the mechanism of this activation remains 
unresolved, it is known not to involve increases in Ca2+ ions (Marshall et al., 
1984). Less information is available concerning the affects of acute hormonal 
control on BCOADC, nevertheless rapid inactivation has been observed following
1 1
increased levels of glucagon or adrenaline in diaphragm muscle (Palmer et al., 
1983).
1.1.4.2 Long term regulation
Owing to the phosphorylated state of heart and muscle tissue BCOADC, 
almost all active complex resides in the liver, the major site of branched-chain 2 - 
oxoacid oxidation, where an activity state of 90% or higher exists following 
implementation of a protein-rich diet. Restriction of this diet would then result in the 
conservation of essential amino acids by a gradual reduction in BCOADC activity 
over several days in agreement with observed increases in kinase activity. Yet, with 
another example of long-term control such as, during starvation or alloxan-induced 
diabetes, BCOADC remains dephosphorylated (Randle et al., 1981). In contrast, 
the levels of inactive PDC in heart, liver and kidney tissue increase, promoted by 
enhanced lipid metabolism, resulting in high acetyl CoA/CoA and NADH/NAD+ 
ratios and consequent acute kinase activation, coupled with increased kinase 
production via altered gene expression. This can, however, be accounted for by the 
necessary utilization of branched-chain amino and 2 -oxoacids in glucogenesis and 
ketogenesis, required for the continual supply of glucose to the brain (see Yeaman, 
1989 for review).
12
1.1.5 Physiological disorders
The regulatory importance of the 2-oxoacid dehydrogenase complexes is also 
reflected in the severity of related disorders, which include various forms of 
metabolic acidosis such as, the widely recognised Maple Syrup Urine Disease 
(MSUD). Arising from a variety of structural aberrations in the branched chain 
complex and resulting in the accumulation of branched chain amino acids in the urine 
of sufferers, this autosomal recessive inborn error of metabolism was first described 
over 30 years ago, characterised by its high prevalence (i.e., 1 in 176 live births), in 
the Mennonite populations of Philadelphia (Marshall & DiGeorge, 1981). Various 
phenotypes have been described, ranging from the classic form, characterised by 
severe mental and physical impairment and early death, to a number of milder 
conditions with late onset classified as intermediate, intermittent and thiamine- 
responsive.
A second inborn error of metabolism first documented in 1970 (Blass et al., 
1970), involves deficiences of the pyruvate dehydrogenase complex and is 
associated with a broad spectrum of conditions characterised by low complex 
activity (typically 10-30% of normal), and accompanied by the presence of primary 
lactic acidosis and neurological disabilities of varying severity including Leigh’s 
disease — an autosomal recessive condition affecting normal brain function 
(Johnston et al., 1984).
Until recently, little was known of the genetic mutations associated with 
either condition. Since complex activity depends upon the correct translation of 3(- 
5) components -- E l, E2, E3, (in PDC, E la , E lp  and X); and the regulatory 
enzymes, phosphatase and kinase, aberrations could arise through mutations in one
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or more of 3(-9) gene loci. However, through measurement of individual 
component activities and immunological screening with component-specific antisera 
in cultured skin fibroblast samples, together with assessment at the mRNA level 
employing cDNA clones encoding individual components, recent research has 
identified several types of specific genetic mutations.
Located predominantly in E l -- specifically E l a, but also associated with 
E2, E3, PDC phosphatase and protein X, the situation is clearly one of wide genetic 
heterogeneity varying from single base pair transitions (Zhang et al., 1989; Fisher et 
a l 1993), to large sequence deletions resulting in impaired transcription, 
translation, nuclear processing or catalytic function (Fisher et al., 1991,1993; Ho et 
al., 1989; see Robinson e ta l., 1988 for mini-review; 1990; Marsac e ta l., 1993). In 
MSUD, the heterogeneity of E l related defects is also reflected in the multiple 
patterns of inheritance, although location of the E l a  gene to the X chromosome 
(Brown et al., 1989) has explained X-linked inheritance in some patients (Bindoff et 
al., 1989), since E l is composed of a  and p subunits encoded by two separate 
genes, the mode of inheritance is likely to be more complex. Notably, the rarity of 
E3-linked deficiencies reflects the severity of the associated condition in which all 
three 2 -oxoacid complex activities are reduced resulting in the accumulation of lactic, 
2 -oxo- and branched chain, amino acids and their derivatives, in the plasma and 
urine of sufferers (Liu et al., 1993).
Deficiencies in OGDC activity have been linked to Alzheimer's disease. 
Here, lowered 2-oxoglutarate/glutamate interconversion, caused by impaired 2- 
oxoglutarate oxidation, is thought to result in the accumulation of the neurotoxin, 
glutamate, the potency of which increases where energy metabolism appears 
suppressed (Beal, 1992). Previous reports of both impaired PDC and OGDC 
activities in autopsied brain tissue were unable to distinguish between cause and
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effect (Butterworth & Bernard, 1990), but a recent study of cultured skin fibroblasts 
from familial Alzheimer patients revealed both defective OGDC activity and 
abnormalities of the E2 component, whereas, all other mitochondrial proteins 
including PDC were normal. The cause remains unclear, although mutations in the 
gene encoding E2 have been implicated (Sheu et al., 1994).
More recently, six components of the 2-oxoacid dehydrogenase complexes 
have been identified as autoantigens of the autoimmune condition, primary biliary 
cirrhosis (PBC). This disease affects the intra-hepatic biliary ductular cells of the 
liver resulting in end-organ damage, and was first characterised by Walker et al. 
(1965), by the presence of non-organ, non-species specific autoantibodies directed 
against a group of mitochondrial antigens, later classed as M2 antigens (Berg et al., 
1986). Cloning and sequencing of the M2 antigens from Xgtl 1 expression libraries, 
together with immunological analysis of purified bovine PDC employing patients' 
sera, initially identified E2 and X of PDC (Yeaman et al., 1988), as the major 
autoantigens — characterised by high autoantibody frequency and titre (in greater 
than 90% of all PBC patients, Palmer et al., 1993); and subsequently, E2 of OGDC, 
BCOADC, and E l of PDC (Fussey et al., 1988; 1989).
Considerable research has located the major site of immunoreactivity to the 
inner lipoyl domain of E2, specifically the lipoate attachment site where the presence 
of a lipoic acid moiety appears crucial for autoimmunity (Surh et al., 1989; Quinn et 
al., 1993b), although weak immune responses are also elicited from the outer 
lipoyl, and peripheral subunit binding domains. Further, the recent generation of 
human monoclonal antibodies from an Epstein-Barr virus transformed PBC B 
lymphocyte cell line suggests the involvement of both an E2-specific and a cross­
reactive epitope on protein X (Matsui et al., 1993).
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The role of M2 autoantigens in the pathogenesis of PBC include proposals 
for the involvement o f : tissue-specific E2 isoforms; bacterial aetiology; or, somatic 
cell presentation. Prompted by the recent discovery of E2, and a second cross- 
reactive antigen, on the external surface of affected biliary cells (Joplin et al., 1990; 
Cha et al.y 1993), Van de Water et al. (1993) proposed two scenarios for the onset 
of the disease. The first involves tissue-specific overexpression of the cross-reactive 
molecule, leading to cell surface presentation by MHC proteins, cell lysis and the 
resultant release of the 2 -oxoacid dehydrogenase complexes arising in the production 
of autoantigens by the cross-reactive species-primed lymphocytes. Alternatively, 
the specialised transport of IgA to the lumen of human bile duct epithelial cells may 
allow contact with E2 during translation or transport to the mitochondrion, thus 
preventing uptake into the mitochondrion, leading to eventual metabolic disfunction 
and cell death.
Clearly, further research is necessaiy to elucidate the mechanism(s) by which 
intramitochondrially located proteins, distributed throughout the body, can elicite an 
autoimmune response specific to biliary tissue and prior to cell damage.
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1.2 The multidomain structure of E2
In 2-oxoacid dehydrogenase complexes, E2 functions not only as an 
acyltransferase but also as the structural/functional framework upon which complex 
assembly and catalysis are dependent. Possessing highly segmented structures 
consisting of independently folding domains joined by short, flexible regions of 
polypeptide chain, E2 was first characterised in E. coli PDC where limited tryptic 
degradation resulted in the release of a reductively acetylatable lipoic acid-bearing 
fragment (Mr 32000 from SDS-PAGE), from a truncated E2 aggregate (composed 
of Mr 30000 peptides), which continued to exhibit E1/E3 binding potential and E2 
activity (Bleile et al., 1979). Extension of the proteolytic studies to mammalian PDC 
obtained similar results, where electron microscopy and velocity sedimentation 
revealed maintenance of an apparently native icosahedral core symmetry following 
release of the lipoyl-bearing domains (Bleile et al., 1981; Kresze etal., 1980).
The discovery of well-aligned sequence homologies between genes encoding 
E2 from different species and complexes (Thekkumkara et al., 1988; Russell & 
Guest, 1991), led to the prediction of a multi-domain structure common to all E2 
molecules, comprising 1-3 lipoyl domains; a subunit binding domain, involved in 
E l and/or E3 binding; and, an inner catalytic domain in which resides the E2 active 
site, E2 self-assembly sequences and, in some complexes, additional E l binding 
sites. Each domain is then separated by conformationally mobile linker regions of 
variable length and composition (see Fig. 1.2.1). Sequence alignments were also 
used to plot phylogenetic trees for E2 which suggested early divergence of the three 
E2 enzymes and therefore, complex types — apparently prior to mitochondrial 
symbiosis (Russell & Guest, 1991; Matuda et al., 1992), and the possible
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Fig. 1.2.1 Schematic representation of E2 domain structure.
Lipoate indicates lipoyl domains, E3 the peripheral subunit binding domains, 
and CAT the catalytic, core domain. Linkers are represented by zigzag lines, and 
active sites by diamonds.
emergence of various types of E2 from an ancestral form possessing one lipoyl 
domain.
Thus, assembled as an oligomeric core to which E l and E3 bind, E2 
facilitates increased catalytic efficiency through enhanced substrate channelling and 
stability, via the intimate coupling of the individual active sites by the flexible, so 
called "swinging arm" of the lipoic acid-lipoyl domain (Reed, 1974).
1.2.1 The lipoyl domains of E2 -  redundancy and active site 
coupling
Located at the N-terminus of E2 and comprising approximately 80 amino 
acids in length, lipoyl domains vary in number independently of species, complex or 
core symmetry type -- in some species, seemingly superfluous to requirement. For 
example, whilst the octahedral cores of E. coli and A. vinelandii PDC contain three 
lipoyl domains per E2 chain, the same core symmmetry in OGDC and BCOADC is 
associated with only one lipoyl domain. In contrast, the icosahedral core-containing 
PDH complexes of mammals, and Gram negative bacterium, Streptococcus faecalis 
possess two, whereas PDC of S. cerevisiae and both PDC and BCOADC of 
prokaryotes, B. subtilus and B. stearothermophilus, have only a single lipoyl 
domain per E2 subunit (reviewed in Perham, 1991). In addition, recent sizing via 
immunological screening of SDS-PAGE resolved plant extracts, suggests E2 from 
pea mitochondria and chloroplasts may only possess one lipoyl domain (Taylor et 
al., 1992).
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Maintenance of complex activity following selective proteolysis/modification 
of 1-2 of the lipoyl domains of E2 from E. coli PDC (Ambrose-Griffin et al., 1980; 
Stepp et al., 1981), or substitution of the essential lysine with glutamate residues 
(Graham et al., 1986), revealed the ability of each lipoyl domain to fold 
independently and support overall complex catalysis. Furthermore, complex activity 
clearly could not rely upon the serial transfer of acetyl groups between outer and 
inner domains. These results confirmed previous predictions of a catalytic 
mechanism, known as active site coupling (Bates etal., 1977; Stanley etal., 1981). 
This proposed that, through the rapid intramolecular transfer of acyl groups between 
lipoic acid moieties on different E2 components within an E2 core and, the ability of 
more than one lipoyl domain to service any given E l active site, efficient catalysis of 
a multistep reaction could be facilitated in a complex deviating from a simple 1:1 
subunit stoichiometric ratio.
However, as maximum acetylation determinations in E. coli PDC have 
repeatedly reported sub-stoichiometric incorporations of 1.7-2 acetyl groups/E2 
chain (Perham, 1991), it remains unclear whether all lipoyl domains are fully 
lipoylated and therefore, functional, or as proposed recently by Packman et al.
(1991), upon observing full lipoylation, that previous estimations were subject to 
systematic eiTor.
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1.2.2 Protein-protein interactions of lipoylation and substrate 
channelling
Little is known of the mechanisms of lipoic acid biosynthesis, and 
lipoylation which involves the attachment of a lipoic acid moiety to the e-amino 
group of conserved lysine residues located within specific cofactor attachment sites 
on each lipoyl domain (residue 40 in E. coli PDC; see Fig. 1.2.2.1). However, 
two genes, lip A and B, have been identified in E. coli, and the former gene product 
characterised and found to be responsible for the insertion of a suphur atom into the 
backbone of lipoic acid precursor, octanoate (Hayden et al., 1992; Reed & Cronan,
1993). Further, the inability of this latter enzyme to convert bound octanoyl to 
bound lipoyl indicates that lipoic acid synthesis precedes that of covalent attachment, 
discounting the involvement of octanoyl-E2 as a synthetic intermediate (Guest et al., 
1991). Comparison of amino acid sequences revealed similarities to a sulphur- 
insertion enzyme, biotin synthase, suggesting the presence of a common sulphur- 
donor involved in both biotin and lipoic acid synthesis. Whilst the role of the lip B 
gene product remains uncertain, findings from lip B gene mutants in E. coli point to 
a possible regulatory function or, following isolation of two lipoyl domain-specific 
ligases in E. coli (Brookfield et al., 1991) and one in S. faecalis (Reed et al., 
1958), a role in lipoic acid attachment itself (see Fig. 1.2.2.2).
Recent construction and overexpression of a plasmid containing the sub-gene 
encoding the single lipoyl domain from E2 of B. stearothermophilus PDC, in 
E. coli, resulted in the limited production of lipoylated domains compared to the 
overwhelming production of octanoylated domain (Dardel et al, 1990). This result 
revealed the ability of the relevant ligases in E. coli to recognise the lipoyl domains 
of B. stearothermophilus PDC, and to utilise octanoate in the absence of lipoyl
2 0
groups, highlighting the potential for mis-modification under conditions of 
saturation or stress. Similar results were obtained following the first case of in vivo 
lipoylation of a eukaryotic lipoyl domain in E. coli (Quinn et al., 1993a). In 
contrast, expression of the E2 gene from bovine heart BCOADC in E. coli resulted 
in the production of unlipoylated domain, subsequently lipoylated following 
exposure to bovine heart mitochondrial extracts — demonstrating some degree of 
differentiation between ligases of different species/complexes (Griffin & Chuang,
1990). Notably, lipoyl domains exhibit considerable specificity for the E l 
component of the same complex and whilst free lipoic acid or lipoamide are 
substrates for E2 and E3 of E. coli PDC (Reed et al., 1958), the lipoic acid cofactor 
can only be efficiently reductively acetylated by E l when attached to its protein 
domain (Graham et al., 1988). Clearly, additional protein recognition processes are 
involved, conferring specificity on the reductive acetylation of the dithiolane ring by 
E l, and thereby facilitating a simple but highly effective mechanism for substrate- 
channelling.
1.2.3 Elucidation of the 3-D structure of lipoyl domains
Owing to the involvement of the lipoyl domains in the specific 
protein/protein interactions of the lipoylating enzymes and of E l, considerable 
interest surrounded the elucidation of the 3-D structure. iH-NMR spectroscopy of 
both the lipoylated and unlipoylated domains, produced through the overexpression 
of the the sub-gene encoding the lipoyl domain of E2 from B. strearothermophilus 
PDC, revealed little conformational change associated with such post-translational 
modification (Dardel et al., 1991). Further analysis then led to the discovery of a 
flattened eight stranded p-barrel structure, folded around a hydrophobic core with
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closely positioned N- and C-termini, and the lipoic acid attachment site, lysine42 , 
prominently displayed on an exposed p-tum — presumably for presentation to El 
(Dardel et al., 1993). Two areas of conservation were located to the hydrophobic 
core (believed responsible for stabilisation), and to the highly charged, solvent 
exposed residues presumed to be involved in the specific recognition processes (see 
Fig. 1.2.3.1).
Sequence alignment and the identification of significant homology between 
the lipoyl domains from bacterial and eukaroytic sources (Russell & Guest, 1991; 
Dardel et al.y 1993), led to proposals for the existence of a common 3-D fold. This 
proposal was subsequently extended to include the domain responsible for biotinyl 
attachment in such biotin containing enzymes as pyruvate carboxylase where, a 
requirement for lysine and conservation of amino acids at the biotinyl attachment site 
mirrors that seen in the lipoyl domains of E2. However, research employing 
mutated forms of the B. stearothermophilus lipoyl domain-encoding subgene has 
very recently discounted a role for the conserved aspartate and alanine residues 
flanking the lipoyl attachment site in ligase-recognition, pinpointing an important but 
non-essential participation in El recognition (Wallis & Perham, 1994).
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1.2.4 The linker regions of E2 -- involvement in active site 
coupling
In contrast to the compact and folded nature of the functional domains of E2, 
the linker regions are thought to possess an extended, flexible conformation, central 
for the formation of the so called “swinging arm” of the lipoyl/lysine moieties on E2.
Early spin-label experiments in E. coli PDC demonstrated total rotational 
freedom of the dithiolane ring of lipoic acid where effectively, this cofactor is in free 
solution on the surface of the E2 core (Ambrose & Perham, 1976). However, 
fluorescence energy transfer measurements indicated that the distances between the 
catalytic sites were too large (i.e., 4.5nm) to be encompassed by the rotation of a 
single lipoyl/lysine moiety (Shepherd & Hammes, 1977), even though attachment 
via the e-amino group of lysine provided a flexible arm of 1.4nm in length. Electron 
microscopic images revealed a fuzz of low resolution surrounding the E2 core 
indicating the external positioning of the lipoyl domains of E2, interdigitating 
between the El and E3 components (Bleile etal., 1979; Oliver & Reed, 1982). This 
provided an explanation for their proteolytic sensitivity and led to the proposal of a 
"super-arm" in which, additional mobility contributed by the lipoyl domain and 
linker regions, provides a rotational span wide enough to facilitate active site 
coupling.
The conformational flexibility of these regions was first demonstrated by *H- 
NMR spectroscopy of native PDC from E. coli (Perham et al., 1981), and 
subsequently, with genetically engineered mutants and synthetic peptides 
representing the amino acid composition of linkers (Radford et al., 1989). Owing to 
the paucity of aromatic residues, replacement of GIU291 by a histidine facilitated
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mobility measurements via the detection of two peak resonances generated by the C2 
and C4 protons, indicative of placement in a region of high flexibility.
1.2.5 Amino acid composition and flexibility of the linker regions
Occupying segments of poor sequence conservation between the folded 
domains, considerable variation in the composition of the linkers exists. Most are 
alanine/proline rich with or without charged amino acids present; fewer, only proline 
rich — again with or without charged residues; and a third set, containing an 
abundance of charged and hydrophilic amino acids. More than one of the above 
sequence types may also reside within a single linker region (Perham, 1991).
Starting from the N-terminus of E2 from E. coli or A. vinelandii PDC, the 
three linkers separating the lipoyl domains from each other and the subunit binding 
domain are designated, apa 1, 2 and 3 which measure approximately 20-30 amino 
acids in length, although the absolute lengths remain unclear owing to ill-defined 
domain boundaries. A shorter fourth linker, separating the subunit binding and 
inner catalytic domains, is known as apa 4. Deletion of more than 13 residues of the 
proposed 32 amino acids of apa 3 in a mutant PDH complex from E. coli where all 
but the innermost lipoyl domain of E2 were removed (see Graham et al., 1986 and 
section 1 .2.1  for previous discussion), resulted in a dramatic reduction in complex 
activity, reductive acetylation and active site coupling, demonstrating the importance 
of linker length (Miles et al., 1987; 1988). Furthermore, antibodies raised to apa 3 
acted like "wedges" preventing active site coupling and complex activity without 
affecting individual component acitivities, and illustrating the requirement for 
flexibility in this region (Perham, 1991). While it remains unclear whether apa 1
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and 2 can maintain activity following removal of apa 3 from intact PDC, 
fluorescence anisotropy of A. vinelartdii PDC has revealed that although apa 1-4 
exhibit internal flexibility, movement of the lipoyl domains pivots at apa 3 which the 
authors proposed as the hinge of the "super arm" (Hanemaaijer et al., 1988). In 
contrast, deletion of apa 4 indicated little involvement in lipoyl arm flexibility 
(Schulze et al., 1993), supported by the evidence of similar studies in E. coli, where 
high mobility in this region only followed removal of the lipoyl domains (Radford et 
al., 1987, 1989; G u e s ts  a/., 1989).
Recent circular dichroism and *11- & 13C-NMR spectroscopic analyses of 
synthetic peptides with amino acid sequences identical to the linker regions in E2 
from E. coli PDC, revealed a preponderance of ala-pro peptide bonds in the trans 
configuration which accounted for the stiff, extended conformation, and the absence 
of a-helical or random coil structure, associated with cis-bonds. As apa 3 was 
found to comprise more than 95% trans-peptide linkages, it is thought to be 
responsible for preventing the lipoyl domains from collapsing into the inner core, 
maintaining the optimal rotational span for catalysis (Green et al., 1992). This is 
supported by observations of enhanced catalytic efficiency in an E. coli PDC mutant 
where apa 3 of E2 was replaced by a polyproline linker exhibiting greater extension 
and inflexibility (Turner et al., 1993), and offers a ready explanation to the presence 
of three lipoyl (and accompanying linker) regions in E. coli and A. vinelandii PDC 
where only one lipoyl/lysine may participate directly in reductive acetylation. 
Indeed, the tandemly repeated lipoyl domains of this complex, encoded for by three 
highly homologous but non-identical lip gene segments, would be good candidates 
for recombinational instability and deletion in the absence of a positive selective 
pressure, such as increased active site coupling attributed to enhanced flexiblity 
(Graham et aL, 1986). In agreement, recent cryoelectron microscopy studies, 
employing hydrated complex, have revealed a maximal reach of 13nm in E. coli
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PDC for the outermost lipoyl moiety (Wagenknecht et al., 1992), and ^ -N M R  
spectroscopy of mutants containing 0 to 9 lipoyl domains per E2 chain in E. coli 
indicated optimal linker mobility and complex catalysis with three lipoyl domains, 
decreasing in the presence of more (Machado et a l, 1992; 1993).
It is also of interest to note that in complexes possessing only one lipoyl 
domain such as OGDC of E. coli, considerable contributions to lipoyl/lysine arm 
flexibility come from the linker region equivalent to apa 4 of E. coli PDC, situated 
between the subunit binding and inner catalytic domain, and not believed to have 
much involvement in the latter complex in the "super-arm" mobility (see Perham, 
1991 for review).
1.2.6 The subunit binding domain of E2 -  a role in E1/E3 binding
The subunit binding domains comprise one of the most highly conserved 
regions of E2, spanning 30-50 amino acids and located between the innermost lipoyl 
and catalytic domains. Common to all E2 components sequenced to date, except 
apparently that of rat OGDC (Nakano et al., 1991), the peripheral subunit binding 
properties of this domain were first recognised following limited proteolysis in 
B. stearothermophilus and E. coli PDC (Behai et al., 1989; Perham & Packman,
1986).
A relationship between core symmetry and subunit binding has emerged for 
this domain where, in octahedral cores such as, E. coli PDC and OGDC, it is 
associated primarily with E3 binding (Perham, 1991) and, in icosahedral cores such 
as, B. stearothermophilus, mammalian and S. cerevisiae PDC, with both El and E3
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binding. The situation is complicated, however, by the additional E l binding 
affinity of E2 from octahedral A. vinelandii PDC (Hanemaaijer et al., 1988), and by 
the presence of protein X in yeast and mammalian PDC (De Marcucci et al., 1985), 
which has led to further differentiation of subunit binding roles where E l associates 
with E2, and E3 with a similar domain in protein X (Lawson et al., 1991a,b).
Site-directed mutagenesis of the subunit binding domain in A. vinelandii 
PDC located the sites of E3 and E l binding to the N- and C- termini, respectively, 
where association of the latter component also involves the N-terminus of the 
catalytic domain but not, surprisingly, of the linker in between (Schulze et al., 
1991c). Furthermore, overexpression of the subgene encoding the catalytic domain 
of either A. vinelandii or E. coli PDC in a bacterial host strain of E. coli, resulted in 
native E2 activity and core assembly but no El binding, indicating a requirement for 
the subunit binding domains in both complexes (Schulze et al., 1991b), and 
contradicting previous observations for E l binding in E. coli (Russell & Guest, 
1991).
Similar overexpression in E. coli of a subgene encoding a di-domain 
comprising the linker, lipoyl and subunit binding domain of B. stearothermophilus 
E2 PDC, was followed by E3 binding studies involving both di-domain and the 
subunit binding domain, proteolytically cleaved from the former (Hipps et al.,
1994). These revealed a subunit stoichiometry of one E3 dimer/subunit binding 
domain suggestive of non-cooperative binding. In agreement, studies in 
A. vinelandii and Pseudomonas faecalis PDC have shown that E3 binds when only 
in a dimeric and therefore, active conformation (Schulze et al., 1991a). Stronger E3 
binding affinity was exhibited by the di-domain compared to that of the isolated 
subunit binding domain which pointed to the involvement of the linker, but not 
lipoyl regions, in E3 binding (Hipps & Perham, 1992). The varying involvement of
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involvement of the linker regions in peripheral subunit binding is subject to growing 
interest following observations from cryoelectron microscopic images of bovine 
heart, bovine kidney and E. coli PDC of variable El and E3 positioning — thought 
to reflect flexible tethering (Wagenknecht et al., 1991; 1992). In addition, l-3nm 
"gaps" corresponding to areas of poor resolution and therefore, high flexibility were 
also noted between the surface of the core and the E l and E3 components. This was 
then offered further support by the evidence of fluorescence anisotrophy in
A. vinelandii PDC, which indicated retention of E3 mobility following binding 
(Schulze et al., 1991a). These results call into question the original face-centred 
model for E3 binding proposed by Oliver & Reed (1982), whereby each monomer 
of an E3 dimer spans one face of the E2 core and is bound relatively inflexibly.
1.2.7 Elucidation of the 3-D structure of the subunit binding 
domain of E2
Recent elucidation of the 3-dimensional solution structure of the subunit 
binding domains from both an octahedral complex, E2 of E. coli OGDC (Robien et 
al., 1992), and from the icosahedral complex of B. stearothermophilus PDC (Kalia 
et al., 1993) have highlighted close similarities, as previously predicted from the 
high degree of sequence conservation between different species (Russell & Guest,
1991); but, also significant differences. Synthetic peptides of 51 and 33 residues, 
representing the amino acid composition of the subunit binding domains of E. coli 
and B. stearothermophilus, respectively, were subjected to iH-NMR spectroscopy, 
revealing structures composed of two parallel a-helices separated, in E. coli, from a 
disordered loop by a short extended strand and helical turn; and from a highly 
structured loop of overlapping p-tums in B. stearothermophilus by a 3io helix. In
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Fig. 1.2.7.2 3D-ribbon drawing of the peripheral subunit binding domain 
from B. stearotherm ophilus  PDC -  reproduced from Kalia et al. (1993).
consideration of the extremely small size of these domains (that of
B. stearothermophilus is the smallest independently folding domain known to date) 
and, in the absence of stabilising ligands or cofactors, stability is thought to derive 
from the tight hydrophobic cores and essential aspartate residues buried deep within 
the loop regions (see Figs. 1.2.7.1-2).
In the absence of X-ray crystallographic images of intact complex, owing to 
the flexibility of the lipoyl domains, little is known of the E1/E3 binding interface on 
E2. However, following examination of sequence homologies, Robien et al. 
(1992) proposed that as binding interactions would necessarily involve electrostatic 
interactions (such as salt bridges, H-bonds) with solvent-accessible residues, the 
contiguous surface of the two a-helices offered a likely location for binding 
interactions. In agreement, Russell & Guest (1991) observed that as E l and E3 
dissociation is easily facilitated with high ionic strength/pH and, in light of the 
highly conserved nature of both E3 and the subunit binding domains, peripheral 
subunit binding presumably involves a limited number of charged residues such as 
the conserved glutamate and aspartates found on the a-helices (see Fig. 1.2.7.1).
A highly conserved nucleotide binding motif “Gly Xaa Gly Xaa Xaa Gly 
(Xaa)n Lys” is also present within this domain from all species excepting E2 from 
rat, yeast and B. subtilis OGDC, where it has been proposed that TPP, NAD+, 
Co A or ATP may bind alongside components El and E3 (Matuda et al., 1992).
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1.2.8 The inner catalytic core domain of E2 and E2 core self- 
assembly
The inner catalytic domain of E2 typically comprises 200-250 amino acid 
residues in which reside : the E2 binding sites involved in the self-assembly of the 
E2 core; the acyltransferase active site including the highly conserved “Asp His Arg 
Xaa Xaa Asp Gly” CoA binding site; and, in some complexes, additional E l binding 
sites (see section 1.2.6).
Early observations of E2 core and complex self-assembly, and of the 
maintenance of acyltransferase activity within the core assembly, following removal 
of a lipoyl-bearing fragment by limited proteolysis in E. coli (Koike et al., 1963; 
Bates et al., 1977; Bleile et al., 1979), were later confirmed via the over-expression 
of sub-genes encoding the inner catalytic domain of E2 from S. cerevisiae PDC 
(Niu et al., 1990), A. vinelandii and E. coli PDC (Schulze et al., 1991b) in E. coli 
hosts. Purification and analysis of the 3-D structure by electron microscopy (Stoops 
et al., 1992), and X-ray crystallography (Mattevi et al., 1992), revealed apparently 
wild type core structures coupled with fully functional E2 active sites. Although 
little information is available concerning the mechanisms of self-assembly nor the 
determining sites involved, high resolution (2.6 A) X-ray analysis of the individual 
E2 subunits of the assembled catalytic domains from A. vinelandii (Mattevi et al.,
1992), resolved a topology identical to that of chloramphenicol acetyltransferases 
(CAT), confirming a prediction of Guest (1987). This was based upon the 
discovery of remote but significant homologies between the amino acid sequences of 
E2 from E. coli PDC and OGDC and, of CAT complexes from various species 
(i.e., 19% identity within the catalytic domains) and followed elucidation of a 
trimeric organisation in CAT (Leslie et al., 1986).
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1.2.9 Structural resemblances between the catalytic domain of 
E2 and CAT
Fig. 1.2.9.1 illustrates a schematic representation of the trimeric organisation 
of CAT and of the proposed ’’building block" of E2 cores (reproduced from Mattevi 
et al., 1992). Differences in the degree of intratrimeric contact are apparent, where 
with E2, the N-terminus of one subunit forms an interconnecting arm to a 
neighbouring subunit within each trimer. In a recent review article, De Rosier
(1992) postulated that the enhanced stability afforded by this additional interaction, 
absent in CAT complexes, may be necessary in the overall process of subunit 
folding and complex assembly or, to counterbalance instabilities wrought by the 
flexibility of the lipoyl domains. Indeed, such a requirement for stability is not 
surprising where the interface between neighbouring subunits forms the catalytic 
channel of the acyltransferase active site in both 2-oxoacid dehydrogenase and CAT 
complexes. Thus, in the former complexes the cubic/dodecahedral vertices form a 
cage-like structure composed of cone-shaped trimers, orientated with flattened bases 
facing outwards and apices pointing inwards towards a large, solvent filled interior. 
Measuring 7.6 x 14nm in a core of 22.6nm diameter in S. cerevisiae PDC, and 
comprising 50% of the total core volume, access to this internal cavity (apparently 
necessary for the internal localisation of the CoA binding cleft), comes from large 
symmetrical openings across the faces of the core.
Fewer inter-trimeric interactions are involved in the assembly of the E2 cores 
from the trimer building blocks, although closer interactions have been observed in 
S. cerevisiae PDC (Stoops et al., 1992), compared to that of A. vinelandii (Mattevi 
et al., 1992). Upon E1/E3 binding, the 24 subunit octahedral core of the latter 
species exhibits a unique dissociation into the smallest known functional PDH
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complex of Mr 860000 (Bosma et al., 1984), comprising a tetramer of E2 to which 
three dimers of E l and one dimer of E3 are bound. Site-directed mutagenesis 
experiments have located the sites involved in this coupled dissociation/activation 
process to the N-terminus of the inner catalytic domain (Schulze et al., 1991c) where 
clearly, dissociation is dependent upon weaker inter-trimer associations.
Following numerous reports of size heterogeneity in preparations of active 
PDC from E. coli and mammalian sources, Sumegi & co-workers (1987) proposed 
the existence of smaller active forms in situ in equilibrium with larger aggregates. 
Whilst this could be conveniently explained by the presence of active trimers 
assembling into cubic then icosahedral cores, no evidence of such a process has 
been provided by the literature to date.
1.2.10 Mechanistic similarities between the active sites of E2 
and CAT
Sequence alignments between the inner catalytic domains of E2 from E. coli 
PDC, OGDC and, that of CAT complexes from various species have pinpointed 
areas of significant homology centred around the conserved “Pro Xaa Xaa Xaa Gin 
His His Xaa Xaa Xaa Asp Gly His” active site motif of CAT (Guest, 1987). 
Mirrored by an “Asp His Arg/Lys Xaa Xaa Asp/Asn Gly” motif located at the 
equivalent position of all dihydrolipoamide acyltransferases sequenced to date, this 
observation led to the prediction of similar mechanisms of catalysis in both E2 and 
CAT. The latter complex catalyses the O-acetylation and inactivation of 
chloramphenicol in antibiotic resistant bacteria and has been the subject of 
considerable characterisation.
3 2
Subunit
core Subunit
core
Subunit
core
CAT
Su b u n i t
core
S u b u n i t  
core /
Su b ia i i t
core
E2
catalytic
domain
Fig. 1.2.9.1 Schematic representation of CAT and E2 trimers from 
A. vinelandii PDC -- reproduced from Mattevi et al. (1992)
E 2 p
Hi* 6 0 2
C o e n z y m e  A A s p  0 0 6
C H  - C - S - C o AE2pi HS
8 - A c e t y l  L i po y l  l y s i n e
Fig. 1.2.10.1 Schematic representation of the mechanism of catalysis at 
the active site of E2.
In CAT, the conserved active site H1S195 residue is absolutely essential for 
catalysis. Acting as a general base, the N-l protons form an hydrogen bond to the 
carboxyl of neighbouring ASP199 conferring tautomeric stabilisation and thereby, 
allowing the electron pair of N-3 to abstract a proton from the 3-hydroxyl of 
substrate, chloramphenicol. This in turn, promotes a nucleophilic attack on the 
thioester of acetyl CoA, facilitating acetylation of chloramphenicol. Hence, Guest 
(1987) proposed an analogous mechanism involving proton abstraction from the 
thiol of CoA and, nucleophilic attack on the 8 -acyl lipoamide thioester (Fig. 
1.2.10.1). However, considerable variation exists between species concerning the 
functional requirements of the various active site residues. For example, whilst site- 
directed mutagenesis in E. coli PDC revealed an absolute requirement for His602 
(reviewed in Russell & Guest, 1991), similar substitutions in S. cerevisiae 
suggested no involvement of the active site histidine residue in acetyltransferase 
activity (Niu et al., 1990). In contrast, substitution of active site Asp43i -- 
equivalent to ASP199 *n CAT; Asp606 in E. coli E2p; and, Asp609 in A. vinelandii 
PDC (Mattevi et al., 1992), and involved in salt-bridge formation essential to 
catalysis, led to loss in complex activity.
Nevertheless, in support, of the proposed involvement of histidine, X-ray 
crystallographic analysis of substrate binding and catalysis in the assembled 
truncated core domain of E2 from A. vinelandii (Mattevi et al., 1993), revealed that 
the reactive thiol of both substrates, CoA and lipoamide, were within hydrogen 
bonding distance to the side chain of active site His6io- Furthermore, in agreement 
with the proposed stabilising function of Ser^g in CAT, Mattevi & co-workers
(1993), characterised an active binding mode for substrate, CoA, involving 
transition state stabilisation of reaction intermediates by residue, Ser 553.
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1.3 The active sites of E1 and E3
A similar active site mechanism to that seen in E2 and CAT complexes 
involving a histidine/glutamate couple, has been proposed for E3 whereby, histidine 
serves as a proton acceptor during the oxidation of enzyme-bound dihydrolipoamide 
-  with E3 shuttling between an oxidised and two electron-reduced state (Guest, 
1987). The importance of all three active site residues, His45o, Pro45i and GIU455 
was later confirmed in A. vinelandii E3 by site directed mutagenesis studies (Benen 
et al., 1991). As a member of the well-characterised flavoprotein disulphide 
oxidoreductase family, elucidation of the structure/function of E3 has followed 
refined crystallographic analyses of E3 from P. putida, P.fluorescens, S. cerevisiae 
and A. vinelandii, and comparative studies on the related enzyme, glutathione 
reductase (Takanaka et al., 1988; Mattevi et al., 1991,1992b). These have revealed 
common features such as the involvement of the reactive disulphide bridge in 
catalysis, and the requirement for dimerisation in the formation of the E3 active site 
(Schulze etal., 1991a).
In contrast, little is known of the active site mechanisms of E l, although the 
general chemistry of TPP-dependent catalysis is known (see Perham, 1991 for 
review). Identification of a proposed TPP binding site motif (Hawkins et al., 
1989), following sequence alignments, has suggested the locality of the active site. 
Spanning 30 residues, this sequence is thought to adopt a pap fold and possess 
essential tryptophan and aspartate residues involved in TPP and possibly, Mg2+ 
binding but not apparently, of pyruvate (Diefenbach et al., 1992). Furthermore, its 
location on the a-subunit of E l from icosahedral complexes, has led to the proposal 
that the active site of this subunit be involved in the formation of the 1- 
hydroxyethylidene-TPP intermediate, and that of Eip involved in the subsequent
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reductive acylation of the lipoic acid moiety of E2 (see Perham, 1991). In addition, 
following the initial rapid formation of S8-acetyldihydrolipoamide, intramolecular 
acetyl transfer between the S8 and S6-thiols of the E2-linked lipoic acid cofactor is 
known to occur in E. coli PDC (Yang & Frey, 1986). However, as the 
isomerisation rate constant (0.045.s*1 at pH 6.5) is considerably lower than the 
turnover number for this complex (1.6 xilO2 .s_1), the significance of this process in 
overall complex catalysis remains unclear.
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1.4 Protein X - structural/functional similarities to E2
1.4.1 Identification of a fourth component in yeast and 
mammalian PDC
Adoption of the neutral Laemmli buffered SDS-PAGE system resulted in 
improved resolution of PDC and led to the discovery of a fourth component from 
mammalian and yeast sources, known as protein or component X (De Marcucci et 
al., 1985).
Previous observations in bovine heart and kidney PDC of an extra band of 
approximately 50000-Mr migrating with the E3 component, had dismissed X as a 
proteolytic fragment of E2 or E3 or, as the yet uncharacterised PDC kinase (Stanley 
& Perham, 1980; Kresze et al., 1980; Bleile et al., 1981). However, immune 
analysis of whole cell and subcellular preparations from bovine, rat and pig cell 
lines, under conditions where proteolytic degradation should not occur, revealed the 
presence of this 50000-Mr band. Further extensive characterisation employing: 
component specific antisera; one and two dimensional peptide mapping of purified 
iodinated E2 and X; various 14C-acetylation/deacetylation studies in bovine heart and 
kidney extracts in this laboratory and elsewhere (De Marcucci & Lindsay, 1985; De 
Marcucci et al., 1986; Jilka et al., 1986; Hodgson et al., 1986); N-terminal amino 
acid sequence analysis of E2 and X isolated from bovine heart PDC (Neagle et al., 
1989); and, the isolation of a separate gene encoding X in S. cerevisiae (Behai et 
al., 1989), subsequently confirmed the existence of a fourth independent species.
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Like E2, protein X possesses a multi-domain structure comprising lipoyl, 
subunit binding and inner domains, separated by flexible linker regions. In 
mammalian PDC, the lipoyl domain of X has been shown to be capable of El- 
dependent acetylation, CoA dependent deacetylation and NEM modification 
(Hodgson et al., 1986). Furthermore, protein X exhibits the unique phenomenon of 
mammalian acetyltransferases of diacetylation whereby, both S6 ,S8-thiols of the 
dithiolane ring on the lipoic acid cofactor incorporate acetyl groups. Following 
rapid, initial S8-acetylation and the exchange of acetyl groups between S8 and 
sulphur atoms, a slow secondary acetylation takes place, leading to an enhanced 
storage potential for acetyl groups. This is thought to be of physiological 
importance during mild starvation or diabetes, facilitating the removal of excess 
levels of NADH and acetyl CoA from the cytosol.
1.4.2 A role for protein X in complex catalysis
In contrast to E l and E3, protein X remains tightly associated with the E2 
core assembly following treatment with high salt or alkaline pH and like the 
intrinsically core-bound kinase, application of chaotrophic reagents such as, p- 
hydroxymercurial sulphonate or 5M urea, are necessary for its removal (De 
Marcucci & Lindsay, 1985; Jilka et al., 1986). This copurification has proved 
problematic in the determination of a precise role for X in overall complex catalysis. 
However, the presence of a functional lipoyl domain on X points to some 
involvement in catalysis.
This is supported by the findings of protein X-mediated activity in both 
S. cerevisiae and bovine kidney PDC following selective gene deletion or,
37
proteolytic cleavage, of the lipoyl domains of E2 (Lawson et al., 1991b; 
Rahmatullah et al., 1990). Indeed, in contrast to the active site coupling properties 
of the lipoyls of E2, proteolytic removal of the protein X lipoyl domains leads to an 
immediate loss in complex activity, which Gopalakrishnan & co-workers (1989), 
attributed to disruption in the flow of reducing equivalents from the lipoyls of E2 to 
E3. Sequence alignment between E2 and X from S. cerevisiae and mammalian 
sources (Behai et al., 1989; Neagle et al., 1989), has revealed 45-50% identity at the 
N-termini suggestive of a common ancestor and a role for X as an isoenzyme of E2. 
However, as direct evidence of acetyltransferase activity in preparations of isolated 
protein X from bovine kidney and yeast sources does not exist (Rahmatullah & 
Roche, 1987; Lawson et al., 1991a) and, in the absence of an active site motif in the 
C-terminal domain of yeast X (Behai et al., 1989), such a suggestion seems 
doubtful. Nevertheless, translation of a 245 base pair cDNA clone encoding the 
extreme C-terminus of protein X from human PDC, has revealed an active site-like 
motif of "His Xaa Xaa Xaa Ser Gly" clearly warranting further investigation (J.C. 
Neagle, University of Glasgow, unpublished observations).
1.4.3 Stoichiometry and organisation of protein X
Little information is available concerning the organisation and subunit 
stoichiometry of X, again owing to its tight core interactions. Estimates of 6-12 
molecules of X per PDH complex have come from : comparisons of 14C-acetylation 
of the lipoyl moieties of components E2 and X (Jilka et al., 1986); sedimentation 
coefficients (Lawson et al., 1991a); and, densitometric scan analysis of X band 
staining in purified complex samples (Jilka et al., 1986).
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How these molecules arrange within the E2 core remains unclear. Evidence 
from covalent crosslinking studies of the lipoyl domains of E2 and X in intact 
bovine heart PDC (Hodgson et al., 1988), and the proteolytic sensitivity of these 
regions, suggest that X is arranged like E2 with the extended lipoic acid bearing 
regions interdigitating between the E l and E3 components. If an isoenzyme of E2, 
X would necessarily exist as an integral core component substituting for molecules 
of E2 and thereby, maintaining icosahedral symmetry. However, E2 core 
assemblies devoid of X yet exhibiting native symmetry and E2 activity, have been 
purified from both yeast (Niu et al., 1990), and bovine sources (Powers- 
Greenwood et al., 1989; Rahmatullah et a l., 1989b). These results could be 
interpreted as an indication of independence from X which could, therefore, exist as 
an accessory protein bound once core assembly is complete. Notably, a limited 
binding capacity appears to exist for X, since transformation of protein X-deficient 
S. cerevisiae cells with either single or multi-copy plasmids containing the protein 
X gene (PDX1), resulted in the same degree of incorporation into the native complex 
(Lawson et al., 1991a). Nevertheless, such findings do not altogether preclude the 
possibility of an integrated protein X when E2 core assembly occurs in its presence.
1.4.4 A role for protein X in E3 binding
Following initial observations in bovine kidney PDC of E3 and El-mediated 
protection of X and E2, respectively, from proteolytic enzymes, Arg C and trypsin 
(Rahmatullah et al., 1989b), an E3 binding function was ascribed to protein X. 
Further examination of peripheral subunit-binding in core preparations of E2, E2/X 
and E2/Xi — where the lipoyls of X are selectively removed with Arg C, (Powers- 
Green wood et al., 1989; Gopalakrishnan et al., 1989); in protein X-deficient
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S. cerevisiae mutants transformed with mutated forms of the PDX1 gene, housing 
specific domain deletions (Lawson et al., 1991a); and, in E2-deficient S. cerevisiae 
strains transformed with similarity mutated E2 (LAT1) genes (Lawson et al., 
1991b), confirmed this prediction. Nevertheless, whilst the latter experiments pin­
pointed the E l binding function to the subunit binding domain of E2, and the E3 
binding function to a similar domain on X, the inability of the E2/Xj core to maintain 
PDC activity following reconstitution with dissociated E l and E3, indicated a 
requirement for the lipoyl domains of X in E3 binding. Yet, complete removal of 
these domains from X has been facilitated in intact bovine heart PDC in the absence 
of complex activity loss, although E3 affinity was lowered (Neagle & Lindsay, 
1991). This result may be explained if, once the complex is assembled and E3 
bound, intact protein X is no longer necessary.
It is of interest to note that in the absence of a subunit binding motif in rat E2 
from OGDC (Nakano et al., 1991), an E3 binding role has been identified recently 
for the lipoyl-like sequences at the N-terminus of E l from bovine heart OGDC (Rice 
et al., 1992). As with protein X, dissociation of E l from the E2 core is difficult 
suggestive of a strong binding interaction, and whilst no lysine-bound lipoic acid 
moiety resides within the lipoyl domain-like sequence, precluding a catalytic 
function, other characteristics such as proteolytic sensitivity and immunoreactivity 
parallel those of functional lipoyl domains. In addition, although protein X has only 
been identified in yeast and mammalian PDC to date, recent reports of a Mr 67000 
and 48000 species from pea mitochondria and chloroplasts, respectively, which 
exhibits cross-reactivity with anti-X sera, may uncover individual X or X-like 
sequences on components from plant sources (Taylor et al., 1992).
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1.5 Aims of research
1) Conflicting evidence of a role in E3 binding for the lipoyl domain of X 
from mammalian PDC exists. Re-examination and extension of the work of Roche 
& coworkers, and of this laboratory, providing a more detailed analysis of 
reconstitution, should offer an explanation to these discrepancies.
2) Following preliminary unpublished observations of an active site-like 
motif in mammalian protein X (J.C. Neagle, University of Glasgow), investigations 
into the nature of the involvement of X in complex catalysis is presented.
3) In light of the scant information available for the subunit stoichiometry 
and organisation of protein X in mammalian PDC, the final area of research is 
directed towards the precise quantification and structural positioning of X within the 
E2 core of bovine heart PDC.
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CHAPTER 2: MATERIALS AND METHODS
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2.1 MATERIALS
2.1.1 Chemicals
The following chemicals were purchased from SIGMA Chemical Company 
Ltd., Dorset, U.K.:-
silver nitrate, 3-[N-Morpholino]-propane-sulphonic acid (MOPS), 
imidazole, salicylic acid (2-hydroxybenzoic acid), Coomassie Brilliant Blue R250, 
Pyronin Y, antifoam A (concentrate), L-cysteine-HCl (anhydrous), p-nicotinamide 
adenine dinucleotide (oxidised form, p-NAD+; reduced form, p-NADH), adenosine- 
5’-triphosphate (ATP; sodium salt), thiamine pyrophosphate chloride (TPP), DL- 
6 ,8 -thioctic acid amide (DL-lipoamide, oxidised form), benzamidine-HCl, 
phenylmethylsulphonyl fluoride (PMSF), N-ethylmaleimide (NEM), coenzyme A 
(lithium salt), acetyl coenzyme A (C2:0) lithium salt, pyruvic acid (sodium salt) and 
2 -oxoglutaric acid (disodium salt).
The majority of commonly used chemicals were purchased from FISONS 
FSA laboratory supplies, Leicestershire, U.K. and were of the highest grade 
available. This included:-
PEG 6000, acrylamide, N,N-methylenebisacrylamide, ammonium 
persulphate, citric acid, glycine, trichloroacetic acid (TCA), sodium lauryl sulphate 
and Folin & Ciocalteu’s phenol reagent.
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Tris (2-amino-2[hydroxymethyl]-l,3 propandiol) base was purchased from 
BOEHRINGER MANNHEIM, U.K. (Diagnostics and Biochemicals) Ltd., Sussex, 
U.K.; dithiothreitol (DTT; Cleland’s reagent) from CALBIOCHEM Novabiochem, 
Nottingham, U.K.; and N, N-1,2 phenylene dimaleimide (PDM) from ALDRICH 
Chemical Company, Dorset, U.K.
2.1.2 Radioisotopes
The following radioactive materials were purchased from AMERSHAM 
International pic., Buckinghamshire, U.K.:-
N-ethyl[2,3-14C]maleimide (9mCi.mmol_1, 100p.Ci.ml*1), [ l-14C]acetyl 
coenzyme A (54mCi.mmol*1, 50pCi.ml-!), 125I-labelled Protein A (>30mCi.mg_1).
[2-14C]pyruvic acid, sodium salt (10.4mCi.mmol*1) was purchased from 
NEN Research Products, DU PONT [U.K.] Ltd., Hertfordshire, U.K.
2.1.3 Enzymes and Proteins
From SIGMA Chemical Company Ltd., Dorset, U.K. the following 
enzymes and proteins were purchased:-
Trypsin, type XIII (TPCK treated) E.C. 3.4.21.4, from bovine pancreas 
(12600 U.mg*1 solid); collagenase, type VII, E.C. 3.4.24.3, chromatographically
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purified from Clostridium histolyticum  (1700 U.mg-1 solid); lipoamide 
dehydrogenase, type VI, E.C. 1.8.1.4, isolated from bovine intestinal mucosa (170 
U.mg-1 protein); endoproteinase, Arg C, E.C. 3.4.21.40, HPLC purified from 
mouse submaxillary gland (sequencing grade); protein A (extracellular), purified 
from Staphylococcus aureus; bovine serum albumin, fraction V of cold alcohol 
precipitation; leupeptin protease inhibitor.
The majority of endoproteinase, Arg C, used was purchased from 
BOEHRINGER MANNHEIM, U.K.(Diagnostics and Biochemicals) Ltd., Sussex, 
U.K. Isolated from mouse submaxillary gland (E.C. 3.4.21.40), the enzyme was 
of analytical grade (220U.mg'1). Low molecular mass electrophoresis marker 
proteins were purchased from PHARMACIA LKB Biotechnology, Milton Keynes, 
U.K.
2.1.4 Photographic materials
LX-24 X-ray developer, FX-40 X-ray liquid fixer and X-OMAT S film were 
purchased from IBI Ltd. (KODAK), Cambridge, U.K.
High performance Hyperfilm-ECL, AMPLIFY fluor and a Sensitize pre­
flash unit were all purchased from AMERSHAM International pic., 
Buckinghamshire, U.K. Autoradiography cassettes and HIGH SPEED-X 
intensifying screens were purchased from GENETIC RESEARCH 
INSTRUMENTATIONS Ltd., Essex, U.K.
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2.1.5 Chromatographic materials
Sephadex G25 and Superose 6  and 12 were purchased from PHARMACIA 
LKB Biotechnology, Milton Keynes, U.K., and the immobilised anhydrotrypsin 
column purchased from PIERCE (& WARRINER) Ltd., Cheshire, U.K.
2.1.6 Biological materials
Bovine hearts were obtained from Paisley Abbatoir, Sandyford Rd., Paisley, 
U.K. shortly after slaughter, transported on ice to the laboratory and diced before 
storage at -80°C.
New Zealand rabbits, used in the production of antibody, were purchased 
from Medical Research Council accredited sources. Freund’s adjuvant (incomplete 
& complete) was purchased from SIGMA Chemical Company Ltd., Dorset, U.K.; 
and heat inactivated donkey serum supplied by the Scottish Antibody Production 
Unit (SAPU), Glasgow & West of Scotland Blood Transfusion Service, Law 
Hospital, Carluke, U.K.
2.1.7 Miscellaneous
The Biotrap BT-1000 electroelution kit was purchased from SCHLEICHER 
& SCHUELL, Dassel, Germany.
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HYBOND-C extra supported nitrocellulose (0.45pm pore size) was 
purchased from AMERSHAM International pic., Buckinghamshire, U.K.; and 
PVDF protein sequencing membrane purchased from BIO-RAD Laboratories Ltd., 
Hertfordshire, U.K.
Centricon 10 microconcentrator tubes were purchased from AMICON, 
Danvers, Ma., U.S.A.
Ecoscint A was purchased from NATIONAL DIAGNOSTICS, Manville, 
N.J., U.S.A.; and DECON from DECON Ltd., Hove, U.K.
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2.2 METHODS
2.2.1 Determination of protein concentration
Protein concentrations were determined using the method of Lowry et al., 
(1951), modified by Markwell et al. (1976). For dilute protein solutions a protein 
assay modified from Bradford, and the Pierce micro BCA assay were used. In all 
cases, standard curves were constructed using bovine serum albumin, and 
absorbances read at 660nm, 750nm or 562nm, respectively.
2.2.2 Concentration of protein samples
Dilute solutions of protein, for subsequent analysis by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), were concentrated by 
TCA precipitation involving the addition of 10% (w/v) TCA followed by 30min at 
4°C, after which protein could be pelleted using a microcentrifuge. Pellets were 
resuspended in Laemmli sample buffer and the pH adjusted to pH 7 using 2M Tris 
base.
Column fractions of E2/X and E1/E3 were concentrated, often after 
overnight dialysis to remove salt, by covering the dialysis tubing with dry 
poly(ethylene glycol) (PEG 6000) flakes, and stored at 4°C until the required 
decrease in volume was achieved. Alternatively, E2/X samples could be 
concentrated by centrifugation at 120000g (rav 9cm), for 16h, with resuspension in
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1% (v/v) Triton X-100 buffer of the resultant pellet (see section 2.2.8). Likewise, 
dilute samples of PDC and OGDC were concentrated by centrifugation at 200000g 
(rav 9cm), for 2.5h, and pellets resuspended as described above.
Centricon TM tubes were also used to concentrate small volumes of dilute 
protein where the removal of salt was also required. This involved 20-40min spins 
at 5000g (rav 8.5cm).
2.2.3 Dialysis of protein samples
Dialysis was carried out at 4°C using Visking Tubing previously boiled for 
lOmin in 2% (w/v) NaHC0 3 , ImM EDTA pH 8 , rinsed and boiled in distilled water 
for a further lOmin.
2 .2 .4  Protein analysis by S D S -po lyacry lam ide gel 
electrophoresis
Proteins were resolved by SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE), using either the discontinuous Tris/glycine buffered system of Laemmli 
(1970) or, the continuous sodium phosphate buffered system of Weber & Osborne 
(1969).
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a) Preparation of protein samples
i) Laemmli system: Prior to electrophoresis, an equal volume of 
Laemmli sample buffer (62.5mM Tris/HCl pH 6.8, containing 2% (w/v) SDS, 10% 
(w/v) sucrose and 0.2% Pyronin Y), and DTT to a final concentration of lOOmM, 
were added to samples which were then boiled for 3-5min.
ii) W eber & Osborne system: Protein samples were diluted in 
sample buffer (5mM sodium phosphate buffer, pH 7 containing 0.5% (w/v) SDS, 
5% (v/v) mercaptoethanol (2-ME), 50% (v/v) glycerol, 0.002% (w/v) Bromophenol 
blue), and boiled for 3-5min.
b) Preparation of analytical SDS-polyacrylamide gels
i) Laemmli system: Gels with the dimensions of 170mm x 145mm x 
1.5mm were polymerised from the following solutions to give resolving gels of
7-15% (w/v) acrylamide (containing 0.375M Tris/HCl buffer pH 8.8, 0.1% (w/v) 
SDS, 0.1% (w/v) ammonium persulphate, and 0.08% (v/v) NNN’N ’- 
tetramethylethylene diamine (TEMED); and stacking gels of 4.4% (w/v) 
acrylamide (containing 0.12M Tris/HCl buffer pH 6.8, 0.1% (w/v) SDS, 0.1% 
(w/v) ammonium persulphate, and 0.08% (v/v) TEMED).
i) Acrylamide solution ill) Resolving gel buffer
29.2% (w/v) acrylamide 0.75M Tris/HCl, pH 8.8
0.8% (w/v) bis-acrylamide 0.2% (w/v) SDS
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ii) Stacking gel buffer
0.17M Tris/HCl, pH 6 .8
iv) Ammonium persulphate
O.lg/ml (NH4)2S20 8
0.14% (w/v) SDS
The above solutions were degassed prior to polymerisation of the 
acrylamide, initiated by the addition of TEMED.
ii) Weber & Osborne system: Gels with the dimensions of 170mm x 
145mm x 1.5mm were polymerised from the following solutions to give slab gels of
8-10% (w/v) acrylamide (containing 0.1M sodium phosphate buffer pH 7, 0.1% 
(w/v) SDS, 0.075% (w/v) ammonium persulphate, 0.002% (v/v) TEMED).
i) Acrylamide solution lii) Ammonium persulphate
22.2% (w/v) acrylamide 15mg/ml (NH4)2S20 8
0 .6 % (w/v) bis-acrylamide
ii) Gel buffer
0.2M sodium phosphate buffer, pH 7 
0.2% (w/v) SDS
c) Conditions for electrophoresis
i) Laemmli system: This employed a constant current of 40-70mA, and 
electrophoresis 24mM Tris/192mM glycine buffer, pH 8.3 containing 0.1% (w/v)
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SDS. Gels were run using vertical gel electrophoresis kits purchased from Bethesda 
Research Laboratories (BRL).
ii) Weber & Osborne system: Gels were run at a constant current of 
100mA, with 1:1 diluted gel buffer as the electrophoresis buffer. Gels were run 
using BRL vertical gel electrophoresis kits.
d) Conditions for staining and scanning of gels
SDS-polyacrylamide gels were stained overnight to visualise protein bands 
using either 0.04% (w/v) Coomassie Brilliant Blue R (in 10% (v/v) acetic acid and 
25% (v/v) methanol), and destained with 20% (v/v) methanol and 10% (v/v) acetic 
acid; or, where greater sensitivity was required, with silver stain — based on the 
method of Wray et al. (1981). This involved overnight pretreatment in 50% (v/v) 
methanol followed by agitation for 2 0 min in freshly prepared 1% (w/v) silver nitrate 
(previously a 20% (w/v) solution added dropwise to 0.34% (w/v) NaOH and 0.9M 
NH4OH in 20ml, and diluted to give final concentrations of 0.08% (w/v) NaOH and 
0.21M NH4OH). Stringent washings with distilled water over lh were followed by 
the addition of freshly prepared developer, containing 0.24mM citric acid and 0.02% 
(v/v) formaldehyde, until bands were seen. The gel was then treated to further 
washings with distilled water to remove traces of developer, before scanning with a 
Shimadzu FDU-3 dual wavelength flying spot scanner at 450nm.
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e) Preparation of SDS-polyacrylamide gels for fluorographic 
analysis
Radiolabelled proteins were resolved following the method described above. 
However, after electrophoresis the gels were immersed, with agitation, for lh in 
fixer (10% (v/v) acetic acid, 25% (v/v) isopropanol), rinsed with distilled water and 
removed to either: fresh 1M salicylate (solid salicylate was dissolved in 5M NaOH 
and the pH adjusted to pH 6  using NaOH), and agitated in the dark for a further 
hour at room temperature; or, to a commercial fluor, AMPLIFY, for 15-30min at 
room temperature, with agitation. Gels were then dried down under vacuum at 60°C 
onto Whatman 3MM chromatography paper and exposed to either X-OMAT S film 
or, high performance Hyperfilm-ECL at -80°C. The film was then developed by 
hand using commercial developer and fixer.
f) Relative molecular mass (M r) determination of SD S- 
polyacrylamide resolved proteins
Using low Mr protein markers to construct a calibration curve relating 
relative mobility, Rf (see equation below), to log(Mr) for each protein standard, the 
relative molecular mass of sample proteins from the same gel could be determined. 
The standards comprised: phosphorylase b (94000); bovine serum albumin (67000); 
ovalbumin (43000); carbonic anhydrase (30000); soybean trypsin inhibitor (20000); 
and a-lactalbumin (14000). Relative mobility was calculated as follows:-
Rf = distance migrated bv protein
distance migrated by tracking dye
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Where protein relative molecular mass determination was required for 
immunoblot analysis, prestained Mr protein standards with extra protein, myosin 
(H-chain; 200000), were used for easy visualisation on nitrocellulose.
2.2.5 Preparation of gels for protein sequence analysis
The following modified Laemmli (1970) discontinuous Tris/glycine buffered 
system was employed in the separation and isolation of protein samples for amino 
acid sequencing.
a) Preparation of protein samples
Samples were diluted into an equal volume of sample preparation buffer 
(0.06M Tris/HCl buffer, pH 6 .8 , containing 10% (v/v) glycerol, 0.5% (v/v) 2- 
mercaptoethanol, 0.4% (w/v) SDS), boiled for 2min and, l-3pl of 0.1% (w/v) 
Bromophenol blue added.
b) Preparation of sequencing SDS-polyacrylamide gels
From the following solutions 10-15% (w/v) resolving gels (containing 
10-15% (w/v) acrylamide, 0.4M Tris/HCl buffer, pH 8 .8 , 0.1% (w/v) SDS, 0.04% 
(w/v) ammonium persulphate, 0.001% (v/v) TEMED); and 5% (w/v) stacking
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gels (containing 5% (w/v) acrylamide, 0.13M Tris/HCl buffer, pH 8 .8 , 0.1% (w/v) 
SDS, 0.08% (w/v) ammonium persulphate, 0.001% (v/v) TEMED) were 
polymerised.
i) Acrylamide solution
29.2% (w/v) FLUKA acrylamide 
0 .8 % (w/v) bis-acrylamide
III) Resolving gel buffer
1.5M Tris/HCl, pH 8 .8  
0.8% (w/v) SDS
ii) Stacking gel buffer
0.5M Tris/HCl, pH 6 .8
Iv) Ammonium persulphate
O.lg/ml (NH4 )2S20 8
4% (w/v) SDS
All solutions were filtered through 0.2pm MILLIPORE filters, and degassed 
before the addition of TEMED.
c) Conditions for electrophoresis
Gels were pre-run in electrode buffer (25mM Tris/0.2M glycine buffer, pH 
8.3, containing 0.1% (w/v) SDS), at 3mA for 2h, with 250pl of lOmM glutathione 
added to the upper reservoir. The pre-run buffer was then decanted, and replaced 
with fresh buffer to which 70pl of lOOmM sodium thioglycolate was added. The 
samples were then run at 60mA for 3h in a BRL vertical electrophoresis kit.
55
d) Preparation for sequencing
The resolved proteins were then transferred overnight at 40mA to pre-soaked 
IMMOBILON (100% (v/v) methanol for 5min, followed by transfer buffer, 25mM 
Tris/0.19M glycine buffer pH 8 , containing 0.02% (w/v) SDS, 20% (v/v) 
methanol), following the method outlined in section 2.2.7. After transfer, the 
IMMOBILON was washed in distilled water for 5min, stained for 5min with 0.1% 
(w/v) Coomassie blue stain (in 50% (v/v) methanol), destained with 50% (v/v) 
methanol for lOmin, then rinsed in distilled water before drying. Protein bands 
were cut out using a scalpel and stored at 4°C in sealed plastic bags before being sent 
to the SERC Protein Sequencing Facility at Aberdeen University.
2.2.6 Electroelution of proteins from SDS-polyacrylamide gels
The following method of electroelution was used in the preparation of 
isolated E2 and component X for the quantification of X and for the production of 
component specific antibodies.
a) Separation and visualisation of proteins
In the preparation of isolated components, E2 or X. 2-5mg of highly purified 
PDC or E2/X core were run on a single-well 8 % (w/v) SDS-PAGE gel to give 
maximum separation of E3 from component X. The gel was then treated with a
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non-fixative C11CI2 stain. This involved several washes with distilled water, 
followed by agitation in 0.3M C11CI2 for 5min after which bands could be visualised 
against a dark background and excised from the gel before destaining with several 
changes of 0.25M EDTA in 0.25M Tris/HCl buffer pH 9, followed by re­
equilibration in elution buffer (see section 2 .2 .6b).
b) Electroelution of proteins
Samples of electrolytically resolved proteins (see section 2.2.6a) were 
electroeluted from 0.5cm x 0.5cm excised gel pieces using a Schleicher and Schuell 
Biotrap BT 1000 apparatus following the method outlined in the accompanying 
manual. The gel pieces were placed in a 1cm x 1.2cm mini elution chamber and the 
apparatus placed into a horizontal electrophoresis tank and both filled with elution 
buffer (40mM Tris/20mM acetic acid/lmM EDTA buffer containing 0.025% (w/v) 
SDS, pH 8 ; or, 25mM Tris/192mM glycine buffer containing 0.025% SDS, pH 
8.3) to the level of the submerged gel pieces. A voltage of 100V was applied 
overnight at 4°C, which promoted the migration of the protein molecules through the 
microporous membrane wall into a 200-800pl capacity trap whereupon further 
movement was prevented by a second membrane. The protein concentration of the 
eluted protein was then determined using the micro-assays outlined in section 2 .2 .1.
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2.2.7 Procedure for Western blotting
Proteins, resolved by SDS-PAGE, were electrolytically transferred to 
nitrocellulose membranes for subsequent immunological detection following the 
method of Towbin et al. (1979). Gels were overlaid with pre-wetted Hybond-C 
extra transfer membrane and placed into cassettes, between pre-wetted Whatman 
3MM chromatography paper. Cassettes were then placed into a Bio-Rad 
Transblot™ tank filled with transfer buffer (25mM Tris, 0.19M glycine, 0.02% 
(w/v) SDS, 20% (v/v) methanol) and a current of 40mA applied overnight. A non­
fixative stain, Ponceau S, was used to check that proteins had transferred 
successfully onto the nitrocellulose and this was then rinsed off with wash buffer 
(20mM Tris/HCl buffer, pH 7.2, containing 0.15M NaCl, 0.5% (v/v) Tween 20). 
The nitrocellulose was agitated in wash buffer for lh  at room temperature, before 
addition of 1:100  diluted antiserum, and 1:20  diluted heat-inactivated donkey serum 
in 50ml fresh wash buffer, for a further 90min. Antisera was prepared employing 
the method of Hunter & Lindsay (1986), except where the electroelution technique 
listed in section 2.2.6 was used in the isolation of protein from SDS-PAGE gels. 
Unbound antiserum was removed using repeated washings with buffer over lh, 
before addition of 125I-labelled Protein A (3 x 106 cpm, in 50ml wash buffer), for 
lh  at room temperature. Again, unbound label was removed using several changes 
of wash buffer over lh, the nitrocellulose air-dried, and placed into an 
autoradiography cassette for exposure at -80°C to X-OMAT S film.
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2.2 .8  Isolation of the pyruvate dehydrogenase and 2- 
oxoglutarate dehydrogenase complexes from bovine heart 
mitochondria
The isolation of PDC and OGDC from bovine heart tissue was carried out at 
4°C following the method of Stanley & Perham (1980) with the modifications stated 
below.
Fresh ox heart, trimmed of fat and connective tissue, was diced and used 
directly or stored at -80°C and thawed overnight before use. To 600g, 500ml of 3% 
(v/v) Triton X-100 buffer (50mM MOPS, 2.7mM EDTA, 3% (v/v) Triton X-100, 
O.lmM DTT, ImM PMSF, ImM benzamidine, 0.2% (v/v) anti-foam, adjusted to 
pH 7 with 6 M NaOH) was added, before blending for 5min, and the final volume 
adjusted to 2 litres with buffer. The homogenate was then clarified at lOOOOg (rav 
8.5cm) for 20min, the pellets discarded and the supernatant adjusted to pH 6.45 
with 10% (v/v) acetic acid. The complexes were precipitated by the addition of 
0.12vol. of 35% (w/v) poly(ethylene glycol), stirred for 30min, and pelleted at 
18000g (rav 8.5cm) for 15min. The pellets were resuspended in 400ml, 1% (v/v) 
Triton X-100 buffer (50mM MOPS, 2.7mM EDTA, 1% (v/v) Triton X-100, ImM 
PMSF, ImM benzamidine, 1.5pM leupeptin, 0.2mM DTT, adjusted to pH 6 .8  with 
6 M NaOH) by homogenisation with a loose fitting glass-teflon homogenizer, before 
clarification at 25000g (rav 8.5cm) for 40min.
The supernatant was filtered through muslin to remove fat and 0.013vol. of 
1M MgCl2 , and 0.05vol. of 1M sodium phosphate buffer, pH 6.3 were added 
together with 0.5M NaOH to maintain pH 6 .8 . After adjusting the pH to 6.45 with 
acetic acid, a second 0.12vol. of 35% (w/v) poly(ethylene glycol) was added and the
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supernatant stirred for 30min at 4°C. The complexes were pelleted at 25000g (rav 
8.5cm) for lOmin, resuspended by homogenisation in 160ml of 1% (v/v) TX-100 
buffer, pH 6 .8 , and fresh solutions of ImM PMSF, benzamidine, leupeptin and 
0.5% (v/v) rat serum added, and left overnight at 4°C.
Re-homogenisation was followed by a clarifying spin at 25000g (rav 8.5cm) 
for lh, and the supernatant adjusted to pH 6.45 before the addition of 0.04-0.06vol. 
of 35% (w/v) poly(ethylene glycol) for 30min with stirring. This differential cut 
enables the separation of OGDC, subsequently pelleted at 25000g (rav 8.5) for 
lOmin, from PDC which remains in the supernatant and is pelleted thereafter, either: 
by addition of 0.14vol. of 35% (w/v) poly(ethylene glycol) for 30min followed by a 
lOmin 25000g (rav 8.5cm) spin; or, by an ultracentrifugal 200000g (rav 9cm) spin, 
for 2.5h. In a successful separation, 95% of the OGDC activity is found in the 
pellets leaving 90% of PDC activity in the supernatant. Complex activities are 
assayed by monitoring NADH production at 340nm, as outlined in section 2.2.11.
The pelleted complexes were subsequently resuspended in 1% (v/v) TX-100 
buffer, pH 6 .8  (no protease inhibitors), and were further purified employing a 
100cm x 3cm Sepharose CL-2B gel filtration column, equilibrated overnight at 4°C 
with 50mM sodium phosphate buffer pH 7, containing 2.7mM EDTA and 1% (v/v) 
Triton X-100, at a flow rate of 24ml.min_1. Approximately lOOmg of protein were 
routinely resolved, 12ml fractions collected and assayed for PDC and OGDC 
activities, and pooled accordingly. The individually purified complexes were then 
pelleted at 200000g (rav 9cm) over 2.5h, and resuspended by hand homogenisation 
in 1% (v/v) TX-100 buffer.
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2.2.9 Preparation of isolated E2/X core
Purified PDC (30-50mg) treated 1:1 with 4M NaCl (in 50mM Tris/HCl, pH 
9) for lh at 4°C, or 20min at room temperature, was dissociated into E2/X and 
E1/E3 fractions after resolution on a 100ml (100cm x 1cm) Superose 6  gel filtration 
column, previously equilibrated with 50mM Tris/HCl buffer, pH 9, containing 1M 
NaCl and 0.01% (v/v) Triton X-100, at a flow rate of lm l.m hr1 and with a pre­
injection of 4M NaCl. Protein was detected by absorbance at 280nm and fractions 
containing E2/X pooled, dialysed overnight against 50mM imidazole/HCl buffer, 
pH 7.4 containing O.lmM EDTA, to remove salt, and poly(ethylene glycol) 
concentrated as described in section 2.2.2. The purity was assessed by SDS-PAGE 
and if residual E l and E3 remained attached to the core, salt treatment was repeated, 
and the isolated E2/X core pelleted at 130000g (rav 9cm) over 16h, leaving 
dissociated E1/E3 in the supernatant fraction.
2.2.10 Preparation of reconstituted PDC
a) Dissociation of PDC into enzymatically active E2/X and E1/E3 
fractions
Purified PDC (30mg) treated 1:1 with 4M NaCl (in 50mM Tris/HCl buffer, 
pH 7) for lh at 4°C was dissociated into E2/X and E1/E3 fractions on a 100ml 
(100cm x 1cm) Superose 6  gel filtration column, at neutral pH, and the E2/X and 
E1/E3 fractions pooled, dialysed and concentrated as described in section 2.2.9.
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b) Reconstitution of PDC activity
The protein concentration and residual PDC activity of each fraction was 
determined and the optimum ratio (w/w) for reconstitution determined -- normally 1: 
0.7-0.8 (E2/X:E1/E3). Typically, 10-20p.l samples of either fraction were pre­
incubated, for lOmin at 33°C, in assay buffers A and B (see section 2.2.1 li) to a 
final volume of 50-60pl, and 5jil of the reconstituted PDC removed to assay activity. 
The extent of reconstitution was then determined as a percentage of the original 
specific activity of PDC determined before salt treatment.
2.2.11 Enzyme assays
i) 2-oxoacid dehydrogenase complexes
The overall activ ities of PDC and OGDC were assayed 
spectrophotometrically at 340nm, as the rate of formation of NADH, at 30°C 
(Danson & Perham, 1978). Approximately 2-5pg of complex were assayed in the 
presence of 670jil solution A (50mM potassium phosphate buffer, pH 7.6, 
containing 3mM NAD+, 2mM MgCl2 , 0.2mM TPP), 14pl solution B (0.13M 
cysteine HC1, 0.13mM I^CoASH), and 14pd solution C (lOOmM pyruvic acid 
(PDC), or 2-oxoglutarate (OGDC)). The reaction was initiated by the addition of 
enzyme to the above solutions, preincubated at 30°C in a quartz cuvette, and activity 
expressed in nkatals (the amount of enzyme which is required to produce 1 nmole of 
NADH.s-1 at 30°C).
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ii) Lipoamide dehydrogenase (E3)
The activity  of lipoam ide dehydrogenase was determ ined 
spectrophotometrically at 340nm as the rate of formation of NADH, at 30°C, from 
the conversion of dihydrolipoamide to lipoamide.
a) Preparation of dihydrolipoamide
Dihydrolipoamide was prepared from the oxidised form of DL-6 ,8 -thioctic 
acid amide (DL-lipoamide) following the method of Kochi & Kikuchi (1976), 
whereby 60mg of DL-lipoamide was dissolved in 1.2ml of 50% (v/v) ethanol in 1M 
potassium phosphate buffer pH 8 , to which 2.4ml of freshly prepared 5% (w/v) 
NaBH4 (in lOmM NaOH), was added for lOmin, followed by neutralisation with 
1.2ml of 3M HC1. The dihydrolipoamide was then extracted, after mixing, into the 
upper solvent layer by the addition of 3 x 3ml volumes of toluene. Evaporation of 
the toluene under N2 left crystalline dihydrolipoamide which was stored at -20°C 
until use, whereupon 20.7mg was dissolved in 1ml of 70% (v/v) ethanol.
b) Conditions for assay
Approximately 2-5pg of complex or isolated E3 were added to 670pl of 
solution A (50mM potassium phosphate buffer, pH 7.6, containing 3mM NAD+, 
2mM MgCl2 , 0.2mM TPP), and 10-20pl fresh dihydrolipoamide (preincubated 
at 30°C in a quartz cuvette), and the resultant activity expressed as nkatals (the 
amount of enzyme required to produce lnmole of NADH.s' 1 at 30°Q.
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iii) Pyruvate dehydrogenase (E1)
El activity was measured spectrophotometrically at 600nm as a colour 
change, due to the reduction of coloured 2,6-dichlorophenolindophenol (DCPIP), to 
a colourless form. Various amounts of 2-oxoacid dehydrogenase complex or 
isolated El were added to 670pl solution A (50mM potassium phosphate buffer, 
pH 7.6, containing 3mM NAD+, 2mM MgCl2 , 0.2mM TPP), 14p.l solution C 
(lOOmM pyruvic acid (PDC), or 2-oxoglutarate (OGDC)), and 14pl D C PIP  
(lm g.m l-1), preincubated at 30°C in the assay cuvette, and the resultant activity 
expressed as the amount of enzyme required to reduce ljimole of DCPIP.min-1 at 
30°C.
2.2.12 Crosslinking of N-ethylmaleimide (NEM) pretreated 2- 
oxoacid-dehydrogenase complexes
This method was used in the elucidation of the structural organisation of 
component X in bovine heart PDC. This involved the covalent crosslinking of 
adjacent lipoyl groups followed by Western blot analysis. Prior to the crosslinking 
of the reduced lipoyls of E2 (OGDC), or X (PDC) with N,N-l,2-phenylene- 
dimaleimide (PDM), PDC and OGDC were pretreated with cold NEM to block non­
specific crosslinking to reduced sulphydryl groups. The unbound NEM was then 
removed by centrifugal gel filtration (Penefsky, 1977).
64
a) Pretreatment with NEM
lmg of complex, diluted in lOOmM Tris/HCl buffer, pH 7.5 to a final 
concentration of 2pg.pl-1, was incubated at 4°C for lh  in the presence of ImM TPP, 
ImM MgCl2,0.5mM NEM and 0.25% (v/v) Triton X-100. Immediately following 
this, unbound NEM was removed using centrifugal gel filtration (see section 
2 .2 .1 2b).
b) Removal of unbound NEM via centrifugal gel filtration
Mini (0.4mm x 7mm) gel filtration columns, made from 1ml syringes fitted 
with glass wool filters, were packed with Sephadex G-25 gel (medium grade) which 
had been pre-swollen in lOOmM Tris/HCl buffer, pH 7.5 overnight at 4°C, and 
warmed to room temperature prior to use. The gel matrix was packed by several 
2min spins at 800g (rav 15cm) in a TJ-6  Benchtop centrifuge, equilibrated twice by 
the addition of 200pl column buffer, followed each time with a 800g (rav 15cm) 
spin, before the addition of the protein sample (maximum: lOOpg in 50-100pl), 
which was eluted into an Eppendorf by a 2min 800g (rav 15cm) spin. The % 
recovery was estimated by assaying complex activity (see section 2 .2 . l l i) ,  and 
traces of NEM detected by virtue of an NADH-induced inhibition of complex 
activity, whereby lipoyl groups are reductively labelled with NEM in the presence of 
0.2mM NADH over 30min, thereby causing inactivation.
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c) Crosslinking with N,N-1,2-phenylene-dimaleimide (PDM)
The lipoyl domains of E2 from PDC were proteolytically cleaved by 
treatment with 10% (w/v) collagenase in 50mM Tris/HCl buffer, pH 7.5, containing 
0.5mM MgCl2 , 0.2mM TPP and 2mM CaCl2 at 30°C, leaving the lipoyls of 
component X intact for subsequent treatment with crosslinker, PDM. Digestion was 
monitored through direct assay of complex activity, and by the removal of aliquots 
to Laemmli sample buffer for subsequent immunoblot analysis, until only 20% of 
the original activity remained (i.e., after 60min), upon which, the reaction was 
arrested by the addition of 4mM EGTA at 4°C. Control samples were also included 
to monitor non-specific proteolysis.
Prior to crosslinking, stock solutions of 4mM NAD+, 4mM NADH, 50mM 
substrate and O.lmM PDM were freshly prepared in lOOmM Tris/HCl buffer pH 7.5 
— in the latter case, by the serial dilution of a lOmM stock (i.e., 0.0135g PDM in 
5ml DMSO).
The lipoyls of E2 (OGDC) and component X (PDC) were then reductively 
crosslinked by the addition of 0.2mM NADH or, 2mM pyruvate/2-oxoglutarate and 
ImM NAD+, to 0.5ng.nl_1 concentrations of complex in the presence lOOmM 
Tris/HCl buffer, pH 7.5 containing 5mM MgCl2, ImM TPP, and 0.25% (v/v) 
Triton X-100. A range of crosslinker concentrations were used (typically 5 - 1 0 jiM ) ,  
and the reaction initiated by the addition of crosslinker immediately after addition of 
NADH or the appropriate substrate, and the removal of 20|il and 5pl samples to 
20mM 2-ME for subsequent immunological and complex activity analysis. Control 
crosslinking was also carried out in the presence of 0.2mM NAD+. Incubation was 
carried out at 30°C for 10-30min during which time, 5pg aliquots were removed to
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20mM 2-ME at 4°C and complex activity assayed. Once 80-90% inhibition was 
achieved, the reaction was terminated by addition of 20mM 2-ME after which 
samples were resolved on 8 % (w/v) SDS-polyacrylamide gel electrophoresis prior to 
immunological detection of the crosslinked species with a variety of component 
specific antisera.
2.2.13 Measurement of incorporation of radioactive precursors
The measurement of incorporation of [ l-14C]acetyl CoA and [2-14C]pyruvic
acid onto the lipoyls of E2 and X of PDC was used in the quantification of 
component X, as follows.
a) Incorporation of radioactive precursors, [2-14C]pyruvic acid 
and [1-14C]acetyl CoA
Samples of PDC were diluted to l- 2 mg.mH in solution A (see section 
2 .2 . l l i )  and pre-incubated for a few minutes at room temperature prior to the 
initiation of acetylation by the addition of 0.25-ImM [2-14C]pyruvic acid 
(10.4mCi.mmol'1; 50-150jiCi/tube), followed by a further 30min incubation at room 
temperature. In the case of 0.5mM [ l-14C]acetyl CoA (54pCi.mmoH; 3|iCi/tube), a 
lOmin preincubation with 0.3mM NADH was followed by the addition of [1-14C] 
acetyl CoA for an additional 60min at room temperature. Control samples lacking 2- 
oxoacid dehydrogenase complex were treated in a similar manner. The reaction was
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terminated by the addition of 45mM 2-ME and each sample diluted in Laemmli 
buffer and treated at 70°C for 2min prior to resolution by 8 % (w/v) SDS-PAGE.
b) Measurement of radioactivity
Following Coomassie blue staining and subsequent destaining, the gels were 
rinsed in distilled water, then dried onto Whatman 3MM chromatography paper at 
60°C under vacuum to facilitate the excision of the resolved E2 and X bands from 
triplicate loadings of 20|ig or 30pg PDC (determination of incorporation from 40,60 
or 80jig PDC involved 2, 3 or 4 x 20jig loadings). Gel pieces were also taken from 
the equivalent positions of control samples lacking PDC, for the calculation of 
background incorporation. The excised bands were then removed to scintillation 
vials, the gel re-hydrated in 0.5ml distilled water and the chromatography paper 
removed. Vials were then drained and the protein solubilised overnight in 1ml of 
SOLVABLE NEF-910G at 37°C. ECOSCINT A (4.5ml) was then added and the 
incorporation of 14C-acetyl groups determined over lOmin, in triplicate, in an LKB 
WALLAC 1209 Rackbeta liquid scintillation counter. The ratio of incorporation into 
E2 and X was then calculated as a mean value of the triplicate results, differing by 
<10% and from which the corresponding background count was subtracted.
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2.2.14 Labelling of individual enzyme components with [2,3-14C] 
NEM
This method was used to analyse diacetylation in both Arg C/collagenase 
treated and untreated intact/reconstituted PDC.
b) Pretreatment with Arg C/collagenase
In some cases, prior to labelling, the intact complex was digested in 
solution A (see section 2.2.1 li) with either, 3% (w/v) Arg C for 90min at 33°C 
(with an additional 3% (w/v) at 60min); or, 10% (w/v) collagenase for 60min at 
33*C (in 50mM Tris/HCl buffer, pH 7.5, containing 2mM CaCl2 , 3mM NAD+, 
0.5mM MgCl2 , 0.2mM TPP), and the decrease in complex activity assayed at 
340nm at regular time intervals (see section 2.2. lli) . With reconstituted complex, 
protease treatment was carried out on the isolated E2/X core before reconstitution 
with E1/E3 (see section 2.2.10b). In either case, the reaction was stopped by the 
addition of appropriate inhibitors (Arg C -  5mM benzamidine; collagenase — 5mM 
EDTA). Undigested complex treated under the same conditions was used as a 
control.
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b) Conditions for [2,3-14C]NEM labelling
Five conditions were set up in 1ml Eppendorf tubes for both control and 
digested samples with 100-200pg of sample (l-2mg.ml_1) per tube. All five 
conditions were run simultaneously as follows:-
1) 0.85mM[2,3-14C]NEM for lOmin.
2) 0.85 mM[2,3- 14C]NEM addedJ following 4mM pyruvate -- incubated 
for lOmin.
3) lOmin preincubation with 0.2mM NADH, followed by 0.85mM[2,3-14C] 
NEM for lOmin.
4) lOmin preincubation with 0.2mM NADH, lmin with 0.4mM acetyl CoA, 
followed by 0.85biM[2,3-14C]NEM for lOmin.
5) lOmin preincubation with 0.2mM NADH, 60min with 0.4mM acetyl 
CoA, followed by 0.85mM[2,3-14C]NEM for lOmin.
The labelling reaction was terminated by the addition of 45mM 2-ME, the 
samples diluted in Laemmli sample buffer lacking DTT and warmed to 70°C for 
2min before analysis by SDS-polyacrylamide gel electrophoresis (see section 2.2.4). 
Radioactive incorporation was visualised by fluorographic analysis (see section 
2.2.4e).
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2.2.15 Preparation for C-terminal peptide sequence analysis
This method was employed in the preliminary isolation of the C-terminal 
tryptically derived peptides of components E2 and X prior to the determination of the 
N-terminal amino acid sequence and therefore, the possible presence of an 
acetyltransferase active site-like sequence.
Anhydrotrypsin is a catalytically inert derivative of trypsin in which the 
active site residue, Ser-195, has been converted to a dehydroalanine residue which 
selectively binds, under weakly acidic conditions, peptides that have arginine, lysine 
or S-amino-ethylcysteine at the C-terminus. Thus, assuming no arginine or lysine 
residues at the C-terminus of the protein of interest, following complete tryptic 
digestion, isolation of the C-terminal peptide is facilitated by virtue of its non­
adsorption to the anhydrotypsin column. The method used was as described in the 
accompanying manual but with the following modifications.
Prior to column treatment, 100-200|il of a 2-4mg.ml_1 sample of purified 
E2/X core (see section 2.2.9), denatured by treatment at 65-100°C for 5min and 
diluted in 0.1M NH4 HCO 3 buffer, pH 8 containing O.lmM CaCl2 (to inhibit 
autolysis), was incubated with 1% (w/v) trypsin overnight at 37°C, with a second 
1% (w/v) addition for a further 2h. Samples (5|ig) were removed before and after 
tryptic degradation and following the subsequent dilution and termination of 
proteolysis in binding buffer (0.05M sodium acetate buffer, pH 5, containing 0.02M 
CaCl2 , 0.05% (w/v) sodium azide) at a 1:10  (v/v) dilution, and precipitation of 
insoluble protein in an Eppendorf microfuge. The pH of the sample was then 
checked and adjusted to pH 5 by addition of acetic acid, and all the following 
procedures carried out at 4°C.
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A 500|il aliquot was then layered onto a 1ml (0.5cm x 2cm) column (pre­
equilibrated with 20ml of binding buffer; 0.5ml.min_1), and allowed to adsorb to the 
column matrix before addition of 20ml binding buffer and subsequent elution of 
unbound protein. Elution of the adsorbed peptides employed an alteration in pH to 
2.5, with the addition of 10ml elution buffer (0.1M formic acid), and the column 
regenerated with 20ml binding buffer. Fractions (1ml) were collected and an elution 
profile constructed from A280 readings and silver stained gel samples.
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RESULTS CHAPTER 3:
Investigation of the E3 binding function of 
protein X in reconstituted and intact PDC 
employing selective proteolysis.
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3.0 INTRODUCTION
In general, binding of the peripheral components El and E3 to the core of the 
2 -oxoacid dehydrogenase complexes involves a highly conserved sequence of amino 
acids situated between the innermost lipoyl domain and the inner catalytic domain of 
the E2 component, termed the subunit binding domain. This function varies in 
acyltransferases between complex type and species; for example, whereas this 
domain of E2 from E. coli PDC and OGDC is thought to bind only E3, 
acetyltransferases from A. vinelandii and B. stearothermophilus bind both E l and 
E3 with the possible specific additional involvement, in E l binding, of the N- 
terminus of the inner catalytic domain (Schulze et al., 1991c). Furthermore, 
sequence analysis of a cDNA clone of the rat OGDC E2 gene recently revealed the 
absence of this subunit binding domain motif (Nakano et al., 1991), a finding made 
more interesting by the discovery of E3 binding properties associated with the N- 
terminus of bovine heart OGDC E l (Rice et al., 1992). In addition, whilst antisera 
raised against protein X detected species of Mr 67000 and 48000 from pea 
mitochondrial and chloroplast sources, respectively, it is unclear whether for the 
former this represents a separate protein X molecule or, the presence of X-like 
sequences on the 67000-Mr E3 component from the same organelle. Hence, the 
recent implication of an E3 binding function in protein X, which to date has only 
been found in yeast and mammalian PDC, simply adds to an already complex picture 
of peripheral subunit binding in the 2 -oxoacid dehydrogenase complexes.
The involvement of component X in the binding of E3 to the 
acetyltransferase core was first proposed from studies on bovine heart and kidney 
PDC by Rahmatullah et al. (1989b). They noted that the proteolytic degradation of 
component X in an isolated E2/X/kinase core fraction, by either Arg C or trypsin,
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resulting in the release of the lipoyl domain, was prevented by the addition of 
exogenous E3. In addition, prior incubation of the core fraction with a specific IgG 
raised against component X, led to an 85% reduction in overall PDC activity upon 
reconstitution with El and E3. This inhibition was greatly reduced by the addition 
of E3 to the core prior to IgG incubation and subsequent reconstitution. In contrast, 
E l was only found to protect E2, and N-terminal amino acid sequence analysis of 
the truncated E2 core revealed that in the presence of E l, trypsin generated a larger 
lipoyl fragment with the additional presence of the subunit binding domain.
From these findings, Rahmatullah and co-workers (1989b), proposed that 
component X was essential for E3 binding and although E2 may contribute, the 
latter component appeared to be involved primarily in El binding interactions.
In support of this conclusion, Gopalakrishnan et al. (1989) employing 
microtitre-plate binding assays, found that bovine kidney PDC-derived core 
preparations devoid of X, or with truncated protein Xj present (the lipoyl domain 
released by Arg C) bound 50% less E3, yet the equivalent amount of E l as the intact 
E2/X/kinase core isolate. In addition, a protein X-enriched E2/X core fraction 
bound considerably more E3 but less El whereas, an isolated component X/kinase 
fraction (with minor E3 contamination) bound equivalent amounts of E3 to the intact 
E2/X/kinase core fraction, yet no E l. These results suggested that an intact 
component X was essential for maximal E3 binding and that a full complement of E2 
was likewise required for maximum El binding. Gopalakrishnan and co-workers 
(1989). postulated that an E3 binding site might be formed from the lipoyl of protein 
X and the subunit binding domain of E2.
In addition, Powers-Greenwood et al. (1989) using 3-step sucrose gradient 
centrifugation to study the binding affinities of various mammalian PDC-derived
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core fractions for El and E3, also found that E2 core or E2/Xj core (treated with Arg 
C to remove the lipoyl of X) bound less E3, but the equivalent amount of E l as 
intact E2/X/kinase core. Furthermore, reduced PDC activity was achieved upon 
reconstitution with E l and E3 compared with the intact E2/X/kinase core, 
underlining the importance of an intact protein X for overall complex activity.
Gopalakrishnan et al. (1989) related removal of the lipoyl domain of protein 
X, by Arg C, in isolated E2/X/kinase core to the resultant decrease in reconstituted 
PDC activity, and noted that the rate of loss of intact X initially exceeded the rate of 
loss of reconstituted activity. These results suggest that the lipoyl of protein X is 
essential but not rate-limiting to the activity of PDC; however, it should be noted that 
residual E3 present in the core sample could afford some degree of protection and 
hence, alter the pattern of protein X degradation. Notably, once 90% of component 
X had been degraded only 10% of PDC activity remained.
In direct contrast, Neagle & Lindsay (1991), presented evidence suggesting 
that complete removal of the lipoyl domain of protein X, by Arg C, is accompanied 
by only a slight decrease (i.e., 15%) in complex activity. They criticised the 
methods used in the production of the various core fractions which, in some 
instances, involved high salt in combination with 5M urea, with the addition of 
mercurial reagents in the isolation of the protein X/kinase fraction. Under such 
conditions, proteins could be much more easily denatured leading to altered binding 
affinities. Furthermore, they argued that the loss in activity reconstituted was a 
result of non-specific Arg C degradation of residual core-bound E la  rather than the 
cleavage of the lipoyl domain of protein X, and demonstrated that in the presence of 
cofactors, TPP and Mg2+, full protection of E la , and hence complex activity, was 
possible. However, lowered core E3 affinity and increased salt sensitivity, leading 
to rapid complex inactivation, was noted by Neagle & Lindsay (1991) in the absence
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of intact protein X, indicating that the combination of both Arg C and high salt led to 
a great reduction in E3 affinity.
In support of these findings, Lawson & coworkers (1991a), produced viable 
S. cerevisiae cells in which the gene for component X (PDX1) was disrupted, 
resulting in an inactive PDC devoid of both protein X and E3, yet exhibiting full 
wild type E2 activity and core structure. Transformation of these cells with a single 
copy plasmid containing either the entire PDX1 gene or, with the lipoyl encoding 
region deleted, resulted in both cases in active complexes possessing both protein X 
and E3. In contrast, cells transformed with the PDX1 gene minus a region located 
between the lipoyl and C-terminal domains, exhibited no PDC activity and, although 
the truncated protein X appeared to be associated with the E2 core, no E3 was 
present. This region, through comparison of the recently sequenced S. cerevisiae 
protein X gene (Behai et al., 1989), with known acetyltransferase gene sequences, 
has been identified as a putative subunit binding domain.
Similar studies in S. cerevisiae involving transformation of disrupted E2 
gene (LAT1) mutant cells with deleted forms of the LAT1 gene indicated an E l, but 
not E3, binding role for the subunit binding domain of E2 (Lawson et al., 1991b). 
Hence, from these and the above findings, it would appear that the similar domain in 
protein X functions in the binding of E3 to the E2/X core.
Nevertheless, the slight reduction in intact complex activity observed by 
Neagle & Lindsay (1991) upon the removal of the lipoyl domain of protein X, was 
mirrored by a similar (30%) reduction in complex activity exhibited by the mutant 
S. cerevisiae cells transformed with the PDX1 gene minus the lipoyl encoding 
sequence. This may represent some loss of stability in the truncated E2/X core 
whereas, the complete loss exhibited by the reconstituted complex may be due, in
77
part, to non-specific E la  degradation by Arg C or, increased instability resulting 
from the denaturing conditions used in the preparation of the core samples.
The importance in gaining a full understanding of the precise nature of the E3 
binding function of protein X in bovine heart PDC necessitated the investigation of 
the plausibility of this explanation to the discrepancies described above. This 
involved further proteolytic studies of protein X, employing Arg C, and 
encompassing the points raised by Neagle & Lindsay (1991) — specifically, the 
protection of E la , and the importance of non-denaturing conditions for core 
preparation. In addition, the lack of quantification provided by previous authors 
concerning the precise conditions used in reconstitution, prompted a more detailed 
analysis herein. Furthermore, the accompanying alterations in E3 binding affinity 
were also studied in both intact and reconstituted complex.
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3.1 METHODS
3.1.1 Dissociation of bovine heart PDC into isolated E2/X core 
and E1/E3 fractions
Crucial to the study of the E3 binding properties of protein X in isolated 
E2/X core was the dissociation of bovine heart PDC into native E2/X and E1/E3 
fractions, which upon reconstitution, give reproducibly high recovery of initial 
complex specific activity. This was achieved through the modification of a standard 
method used in the isolation of kinase which employs 2M NaCl treatment of PDC 
for 20min at room temperature, followed by resolution on a 100ml Superose 6  gel 
filtration column in 50mM Tris/HCl buffer, pH 9, containing 1M NaCl, ImM DTT 
and 0.025% (v/v) Triton X-100 (modified from Linn et al., 1972 and Stepp et al., 
1983). The resulting fractions exhibit only 20% reconstitution of complex activity 
indicating possible denaturation of the individual components.
Thus, an initial study of intact complex activity incubated at room 
temperature in high salt and at different pHs was carried out. Fig. 3.1.1.1 illustrates 
that at neutral pH complex activity is only marginally affected by high salt whereas, 
at a more alkaline pH, such as that used in the original core preparation, a dramatic 
loss in PDC activity, amounting to a 70% reduction over 30min at room 
temperature, is noted. This can probably be attributed to the E la  component which 
is known to exhibit enhanced instability at alkaline pH (Kresze et al., 1980). In 
addition, greater maintenance of complex activity was achieved if salt treatment was 
carried out at 4°C (results not shown).
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Figure 3.1.1.1 Loss in complex activity with Incubation In high salt at pH
7 . 4 - 9
Samples of PDC (lm g.m H ) were incubated in column buffer (50mM 
Tris/HCl, 1M NaCl, ImM DTT, 0.025% (v/v) Triton X-100), at different pHs 
over 30min at room temperature. At the intervals shown, 2-5pl duplicate aliquots 
were removed to assay for intact PDC activity (see 2.2.11), and the resultant 
decrease, expressed as a % of the original activity (each time point is an average of 
duplicate results differing by less than 10%).
(o-o) pH 7.4; (•—•) pH 8 ; 0 ) pH 8.5; (»-«) pH 9.
A preliminary dissociation of bovine heart PDC with 2M NaCl at pH 7.5 
over lh at 4°C resulted in significantly increased reconstitution (i.e., 50-60%), and 
subsequent analysis of the isolated E2/X core and E1/E3 fractions by SDS-PAGE 
revealed no loss in resolution. Following success in reproducibility, the modified 
salt treatment was adopted (see section 2.2.10 for full method). Figs. 3.1.1.2 and 
3 . 1.1.3 illustrate a typical elution profile after resolution by gel filtration, and the 
resulting E2/X and E1/E3 fractions analysed by 10% (w/v) SDS-PAGE, with 
subsequent immunoblotting using E3 and protein X-specific sera. Clearly good 
separation was achieved where only traces of undissociated E3 remained attached to 
the E2/X core, with E2/X virtually undetectable in the E1/E3 fraction. Notably, 
such good resolution was not achieved by Rahmatullah et al. (1989) or 
Gopalakrishnan et al. (1989), whilst employing the more stringent conditions listed 
therein.
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Figure 3.1.1.2 Typical elution profile of d is so c ia te d  E2/X and E1/E3 
fractions from a Superose 6 gel filtration column
15-30mg of PDC, treated in high salt as described in section 2.2.11, were 
resolved on a 100ml Superose 6  gel filtration column resulting in two clearly dissociated 
peaks. The protein concentrations of each fraction (2ml) were analysed at 280nm.
Figure 3.1.1.3 Coomassie and immunological analysis of the E2/X core 
and E1/E3 peak fractions
The purity of the peak fractions obtained in Fig. 3.1.1.2 was assessed 
following dialysis and PEG concentration by 10% (w/v) SDS-PAGE where 
samples were a) Coomassie blue stained; b) transferred to nitrocellulose and 
screened with protein X (panel B) and E3 (panel A) specific sera.
a) Lane M, lOpg of low Mr marker proteins; lane 1, 20pg of purified 
bovine heart PDC; lane 2 ,15pg of isolated E2/X core; lane 3, 15pg of dissociated 
E1/E3.
b) Lane M, lOpg of low Mr markers proteins; lane 1, lOpg E1/E3; lane 2, 
10pg E2/X.
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3.2 RESULTS
3.2.1 Establishing optimal conditions for maximum 
reconstitution of complex activity
3.2.1.1 Determination of an optimal preincubation length for 
reconstitution
Following the preparation of the isolated E2/X core and E1/E3 fractions as 
detailed in section 3.1.1, the residual PDC activity of each fraction was determined 
by direct assay. Protein concentrations were also determined employing both Lowry 
and BCA protein assays, and the resultant specific activity expressed in terms of % 
residual PDC reconstituted (see section 2.2.10).
The effect of preincubation at 33°C on the residual activities was then 
examined and Fig. 3.2.1.1.1 illustrates both the typical residual activity of either 
fraction, and the affect on these of increased incubation at 33°C. Clearly there is 
little change with time, suggesting that the components in either fraction are in a 
native and fully functional conformation or, that any refolding and reactivation 
occurs within the first 2 min following addition to the assay buffers.
With reconstitution, equal volumes (10-30p.l) of both fractions were 
preincubated together for varying times in the assay cuvette at 33°C before the 
addition of substrate. From Fig. 3.2.1.1.2, it would appear that reassembly of the 
complex from the dissociated fractions occurred very rapidly (within 2 min),
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0 5 10 15 2 0  25  3 0  35  40
Incubation length (min)
Figure 3.2.1.1.1 Effect of time of preincubation on the  residual
com plex activity of the purified E2/X and E1/E3 fractions
Residual complex activity was determined by the direct addition of 10-30pl 
of both fractions to the assay cuvette (containing 670pl Soln A and 14pl Soln 
B), with preincubation at 33°C for the times shown, before the initiation of 
catalysis by the addition of 14pl of substrate (see 2.2.11). Specific activity for 
each time point was determined from duplicate results differing by less than 1 0%, 
and expresed as a % of the original intact complex specific activity (see 2 .2 .10). 
(o- -□) E2/X; (■—■) E1/E3.
0 5 1 0 1 5 20  2 5  30
Incubation length (min)
Figure 3.2.1.1.2 Profile of reconstitution with increased  len gths  of  
p rein cu bation
Equal volumes (10-30jil) of E2/X (O.lmg.ml-1) and E1/E3 (0.2mg.ml_1) 
fractions (1:10 in Soln A), were preincubated at 33°C in the assay cuvette 
(containing 670pl Soln A, and 14jil Soln B), for the times shown, before 
addition of 14|il of substrate. Specific activity reconstituted was determined from 
duplicate results differing by less than 10%, and expressed as a % of the original 
intact complex specific activity.
presumably reflecting the time taken for subunit interactions involved in complex 
reassembly or possibly, cofactor TPP binding. Although, the % reconstitution at to 
is not illustrated in Fig. 3.2.1.1.2, additional results (not shown) suggested, at 
most, a 2 0 % stimulation in reconstitution over the first 2 min of preincubation. 
Hence, a standard lOmin preincubation was used throughout the following 
experiments in agreement with the 10-15min preincubation employed by Schulze et 
al. (1991c), in similar reconstitution experiments involving A. vinelandii PDC, and 
of Kresze et al. (1980) and Rahmatullah et al. (1990), employing bovine kidney 
PDC.
3.2 .1 .2  Identification of the optimal stoichiometric ratio of 
E2/X:E1/E3 for reconstitution
Although in intact complex the ratio, according to subunit stoichiometry and 
molecular mass, of E2/X core to E1/E3 is approximately 1:1.3, following high salt 
treatment and column purification variable yields of either fraction were possible; 
hence, a range of ratios of E2/X:E1/E3 were examined for maximum reconstitution 
(see Fig. 3.2.1.2.1). The % reconstitution for each ratio was calculated by the 
division of the activity obtained upon reconstitution (minus residual activities) by the 
total fractional protein present in the assay cuvette, and the resulting specific activity 
expressed as a % of the original complex specific activity (see section 2 .2 .10).
Notably, maximum reconstitution was achieved at a reproducible 
E2/X:E1/E3 ratio of 1:0.7-1.3 (w/w), which is within the range of normal complex 
stoichiometry. Clearly, the lower ratio of 1:0.7 may be attributed to minor 
inactivation, proteolytic degradation or aggregation of the E2/X core following pre-
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Figure 3.2.1.2.1 Profile of reconstitution at different stoichiom etric
ratios of E2/X : E1/E3
3.5-60|il of E2/X core (O .lm g.m l'1) were added in the assay cuvette to a 
constan t 15jil of E1/E3 (O .lm g .m l1) — diluted as in Fig. 3.2.1.1.2, and 
preincubated for lOmin at 33°C prior to the initiation of catalysis by the addition of 
substrate. The % complex activity reconstituted was determined as before (see 
2.2.10), from duplicate values differing by less than 10%.
longed high salt treatment and column purification — to which, the dissociated El 
and E3 components appear less susceptible. Alternatively, this could reflect the 
ability of PDC to function normally in the absence of a full complement of El and 
E3.
As increases from a ratio of 1:0.3 to 1:4.0 (E2/X:E1/E3),were implemented 
by reducing the amount of E2/X core in relation to a constant amount of E1/E3, it is 
likely that both the decline in specific activity and net activity reconstituted (latter not 
shown), from a ratio of 1:2 onwards, resulted from limitations in the E2/X core 
either as a consequence of partial inactivation or arising from competition between 
the El and E3 components for one or both of the subunit binding domains of E2 and 
X. However, such competition has only been documented for the El binding sites 
of E2 from A. vinelandii PDC (Schulze et al., 1991c), and this is discussed further 
in sections 3.2.2.1-3. Alternatively, such a decline could reflect decreasing 
concentrations of E2/X in the assay cuvette from 9pg.ini-1 to 0.5pg.ini-1 (a dilution 
effect varying from 1 in 100 to 1 in 1500), which was also observed where 
reconstitution involved a constant amount of E2/X and varying amounts of E1/E3. 
The effect of component dilution on reconstitution was therefore investigated.
3.2.1.3 Effect of protein concentration on the rate and extent of 
reconstitution of overall PDC activity
In addition to a range of ratios of E2/X:E1/E3, and in light of the results of 
section 3.2.1.2, reconstitution was also studied under conditions of significantly 
higher component concentration to assess whether the extent of reconstitution within 
the limited preincubation period is further dependent upon the relative intimacy of the
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ratio of E2/X : E1/E3 (w/w)
F igure  3.2 .1 .3 .1  R eco n s titu t io n  at high and low co m p o n en t
con cen tra t io n
5-60pl of E2/X core sample were preincubated with a constant volume of 
E1/E3, in the presence of Soln A and B for lOmin at 33°C, at high concentration 
(final volum e lOOpl), and 5-10pl aliquots rem oved for assaying; or, low 
concentration whereby, 5-60pJ of E2/X were preincubated with a constant volume 
of E1/E3 (both 1:10 with Soln A), in the assay cuvette containing 700pl of Soln 
A & B, prior to the addition of substrate. Resultant activities were expressed as % 
reconstitution and represent an average of duplicate results differing by less than 
10% (see 2.2.10). Where (0) low concentration; (•) high concentration.
dissociated components. Samples were preincubated at the usual low concentration 
of 0.7- \9jig.mH E2/X, 4pg.ml_1 E1/E3 -- whereby reconstitution was carried out 
in the assay cuvette; or, at a 70-fold higher concentration of 0.05-0.6mg.ini-1 E2/X, 
0.3mg.mH E1/E3 and aliquots removed to cuvettes for assaying.
From the results (Fig. 3.2.1.3.1), it would appear that component 
concentration has little effect on the extent of reconstitution over the lOmin 
preincubation period, since similar values were obtained at high and low 
concentrations. In addition, little difference was noted in the net activity 
reconstituted for either condition (results not shown). It is possible that at higher 
concentrations reassembly of the complex occurs at a faster rate, as would be 
expected for conditions of greater intimacy. However, if as previous results 
suggest, this occurs rapidly — possibly within seconds, over the relatively long 
preincubation period this would not become apparent. Since similar values of 
reconstitution were obtained with a constant 70-fold difference in dilution, the 
results suggest that the decrease in reconstitution observed, with increasing ratios 
(by weight), of E2/X:E1/E3 in Fig. 3.2.1.2.1, was not an effect of increasing 
component dilution.
3.2.1.4 Effect of storage of purified E2/X and E1/E3 fractions on 
reconstitution
The ability of the dissociated E2/X core and E1/E3 fractions to maintain 
reconstitution after storage in 50mM imidazole/HCl buffer, pH 7.5, containing ImM 
EDTA, 0.5mM benzamidine and 50% (v/v) glycerol at either 4°C or -20°C over 34 
days was studied and the results presented in Fig. 3.2.1.4.1.
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Figure 3.2.1.4.1 Stability profile of reconstitution after storage of the
dissociated fractions at 4 °C  or -20°C
Duplicate 10-30pl aliquots of E2/X and E1/E3 (diluted as before), were 
preincubated at 33°C for lOmin in an assay cuvette, in the presence of Soln A and 
B, and resultant activity assayed by the addition of substrate (see 2.2.11). % 
reconstitution was determined from duplicate values agreeing within 10%. Where 
(■) storage at 4°C; ( 0 )  storage at -20°C in 50% (v/v) glycerol.
Clearly, the fractions exhibit a high degree of stability at either storage 
temperature with only a 50% reduction in activity reconstituted over 34 days. 
However, with subsequent preparations, glycerol was replaced by 1% (v/v) Triton 
X-100, as the former appeared to interfere with the specific proteolytic degradation 
of the E2/X core by Arg C. Benzamidine was also omitted as this is a potent 
inhibitor of Arg C. In the absence of both, the component fractions became 
considerably more unstable with large losses (i.e. 50%) in reconstitution after 4-5 
days at 4°C (results not shown). This was presumably due to non-specific 
degradation by contaminating proteases in addition to minor conformational changes 
and possible aggregation, indicated by the presence of precipitation after a few days 
at 4°C. Instability of proteins increases with dilute solutions and evidently, the 
presence of 1% (v/v) Triton X-100 did not provide the same degree of viscosity and 
hence stability, as glycerol (see Kresze et al., 1980). Furthermore, since glycerol 
was found to reduce the efficacy of Arg C, perhaps due to high viscosity, it is 
possible that some protection from proteolysis could be provided.
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3.2.2 Proteolytic studies on the E3 binding function of 
protein X in reconstituted complex involving Arg C
Having established both a relatively non-denaturing method for the isolation 
of E2/X core and, the optimum conditions for maximum reconstitution with E1/E3 
(i.e., 70-100%), it was then possible to examine the E3 binding function of protein 
X in reconstituted complex, following removal of the lipoyl domain by Arg C. This 
was carried out in the presence of cofactors, TPP and Mg2+, to provide protection 
for residual E la  present in the purified core which has been shown previously to be 
susceptible to proteolysis by Arg C (Neagle & Lindsay, 1991).
3.2.2.1 Reconstitution in the presence or absence of excess E3 
during the progressive cleavage of protein X by Arg C
Gopalakrishnan et al. (1989) and Powers-Greenwood et al. (1989), 
demonstrated that removal of the lipoyl domain of protein X, by Arg C, was 
accompanied by both an immediate loss in reconstituted complex activity and E3 
binding potential. Thus, initial experiments investigated the validity of this result 
under the conditions described herein and in addition, in the presence of excess 
exogenous porcine E3.
This involved the proteolytic degradation of isolated E2/X core, with Arg C, 
in the presence of TPP and Mg2+, and the stepwise removal of samples for 
reconstitution with E1/E3 at a ratio of 1:0.8 (w/w), in the presence or absence of 
porcine E3, at a 3-fold excess (w/w) with respect to the E1/E3 fraction. Samples
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Figure 3.2.2.1.1a) Profile of reconstitution during the progressive cleavage  
of protein X by Arg C
E2/X core (1 : 5 in Soln A), was treated with 3% (w/v) Arg C over 90min at 
33°C and at the intervals shown, samples removed and treated with 5mM benzamidine to 
arrest proteolysis. Duplicate aliquots were then preincubated for lOmin at 33°C with 1 
in 10 diluted E1/E3 at an E2/X:E1/E3 ratio o f 1:0.8 (w/w), in an assay cuvette 
containing Soln A and B, and in the presence (o- -o) or absence ( •—• )  o f a 3-fold 
excess (w/w) of porcine E3, with respect to E1/E3. PDC activity was then initiated by 
the addition of pyruvate to duplicate assay cuvettes and, the resultant specific activity 
expressed as % reconstitution calculated to within ±  5% error (see 2.2.10). (NB: the 
protein content of commercial E3 was not included in the calculation of specific activity).
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b) Western analysis of Isolated E2/X core treated with Arg C
The remainder of the benzamidine-arrested, Arg C-treated E2/X core was 
diluted in Laemmli buffer and analysed by immunological screening with antisera 
raised specifically to protein X, the immunoblot developed and overlaid with E2 
antiserum. Lane M, lOgg low Mr marker proteins; PDC, 3pg purified, bovine 
heart PDC; C, control, undigested E2/X core; 4pg of E2/X /  track .
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were also removed for analysis by SDS-PAGE and immunological screening (see 
Fig. 3.2.2.1.1).
From the results it is clear that the immediate removal of the lipoyl domain by 
Arg C is accompanied by a parallel loss in the ability to reconstitute overall complex 
activity resulting, in the absence of excess E3, in a residual 9% of activity after 
90min reflecting the significant reduction in intact protein X. Immunological 
analysis of the E2 component (Fig. 3.2.2.1.1b), and E l component (result not 
shown), revealed minor and no detectable degradation by Arg C, respectively, in 
support of the findings of Rahmatullah et al. (1989a), where complete removal the 
lipoyl of protein X was accompanied by <6 % E2 degradation. These results suggest 
that any loss in complex activity is due primarily, to the removal of the lipoyl domain 
of protein X, and therefore, not due to the degradation of residual core El proposed 
by Neagle & Lindsay (1991). However, in agreement with the criticisms of Neagle 
& Lindsay (1991), it is possible that the partial inactivation of the E2/X core noted 
during the preparation from purified complex (see section 3.2.1.2), has somi effect 
on the binding ability of E3 and hence reconstitution, since in the presence of excess 
E3, the initial activity reconstituted is approximately 25% higher. Alternatively, this 
could simply reflect a return to 100% E3 occupancy following unavoidable E3 
dissociation during the original purification of PDC from bovine heart mitochondria. 
(A 5-10% enhancement of intact PDC activity has been observed upon addition of 
excess porcine E3).
Notably, this constant 25% difference in real terms represented, at to, a 40% 
increase over and above that achieved in the absence of excess E3 and progressed to 
a 200% increase following extensive protein X degradation over 90min. This 
significant enhancement was also observed in the presence of excess E1/E3 (results 
not shown), and suggests that any reduction in the overall extent of E3 binding,
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following the removal of the lipoyl domain of protein X, by Arg C, may be partially 
recovered in the presence of higher concentrations of E3.
Nevertheless, full recovery of reconstitution was not achieved and may 
reflect a requirement for yet higher concentrations of E3, where non-specific binding 
to the subunit binding domain of E2, and competition from the E l component for the 
similar domain of protein X cannot be entirely ruled out. Alternatively, this could 
indicate a more profound effect on E3 binding than a simple lowering of affinity. 
The nature of the loss in E3 binding was therefore investigated further.
In a similar study, employing isolated E2/X core and E1/E3 fractions, 
Gopalakrishnan et al. (1989) noted that protein X degradation initially exceeded the 
corresponding loss in reconstituted PDC activity, suggesting an essential but non­
rate limiting function for the lipoyl of protein X. Whilst a precise quantification of 
protein X degradation is not presented here, a similar pattern is possibly suggested 
by direct comparison of Figs. 3.2.2.1.1a & b, yet may reflect a lag in E3 
dissociation due to the aforementioned <100% E3 occupancy of the reconstituted 
complex.
3.2.2.2 Analysis of the loss in E3 binding in intact, reconstituted 
and Arg C-treated reconstituted PDC following resolution by 
Superose 6 gel filtration
In section 3.2.2.1, it was observed that the activity of untreated reconstituted 
PDC could be increased by the presence of excess bovine heart E1/E3 or, porcine 
E3, suggestive of minor E3 dissociation. This could arise during the isolation from
8 8
Figure 3.2.2.2.1 Profile of E3 dissociation in intact, reconstituted and Arg 
C-treated recon st itu ted  PDC, following resolution by S u p ero se  6 gel  
filtration
In each case, approx. 0.5mg of complex (in 1ml of Soln A), was resolved 
on a 25ml (1 x 25cm) Superose 6  column equilibrated in 50mM Tris/HCl buffer pH 7 
(containing 0.01% (v/v) Triton X-100, ImM DTT) at a flow rate of 0.5ml.min"1, and 
the resultant 1ml fractions analysed for intact complex activity (Q- -□), and E3 
activity ( • —■), as described in section 2 .2 .11 .
a) Intact PDC: 0.5mg diluted to 1ml in Soln A prior to loading.
b) Reconstituted PDC: E2/X core was preincubated with E1/E3 at a ratio of 1:0.8 
(w/w) for lOmin at 33°C in the presence of Soln A and B (final volume 1ml), to 
give approx. 0.5mg of reconstituted complex, the % reconstitution determined by the 
removal of duplicate 5pl aliquots to assay cuvettes, and found to be 95%. The 
remaining sample was then loaded as described above.
c) Arg C treated reconstituted PDC: E2/X core was treated with 3% (w/v) Arg 
C over 75min at 33°C and the drop in activity monitored by the removal of timed 
aliquots for reconstitution with E1/E3 until only 10% remained. 5mM benzamidine 
was added and preincubation with E1/E3 then followed as described above. Total E3 
activity in jimol.min_1m H  was determined for each condition and from this the % 
dissociation of E3 was calculated and found to be as follows:-
a) 3%; b) 22%; c) 8 8 %.
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bovine heart mitochondria and/or preparation of the dissociated fractions where 
slight denaturation and/or proteolytic degradation could result in both inactivation of 
the E1/E3 components and disruption of the E3 binding function of E2/X.
In addition, in agreement with the results of Powers-Greenwood et al. 
(1989), and Gopalakrishnan et al. (1989), following cleavage of the lipoyl domain 
of protein X, by Arg C, a rapid loss in reconstitution was noted presumably due to 
an accompanying loss in E3 binding. The extent of this loss in both untreated and 
Arg C treated complex was subsequently investigated by the following qualitative 
and semi-quantitative analysis of E3 dissociation employing gel filtration (Fig. 
3.2.2.2.1).
From the results it is clear that whereas little E3 (i.e., 3%) becomes 
dissociated in intact complex following resolution by gel filtration, 2 0 % was 
released or failed to rebind in the reconstituted sample. Since 95% reconstitution 
was achieved prior to column treatment, the release of E3 most likely results from 
the combination of a lowered E3 binding affinity and the subsequent effect of 
column treatment on the weakened core-E3 interactions, rather than the presence of 
unbound and/or inactive E3 in the reconstituted sample prior to resolution. 
Nevertheless, as the results of section 3.2.1.2 suggest the ability of PDC to function 
at substoichiometric levels of El and E3, and since the maximum % reconstitution 
achieved varied between preparations, from 70 to 100%, the presence of unbound 
and/or inactive E3 cannot be ruled out especially for cases of lower recovery. In 
addition, continued inactivation of the dissociated fractions was noted in section 
3.2.1.4 where instability, upon storage, resulted in a rapid decline in reconstitution 
over the period of 4-5 days.
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In contrast, following Arg C treatment a significantly larger % of E3 (i.e., 
8 8 %) eluted from the column as dissociated enzyme, suggesting that in the absence 
of intact protein X, the E3 binding affinity of the E2/X core is greatly reduced. 
Since only 10% of activity remained, it is likely that the majority of E3 in the 
reconstituted complex was unbound prior to column treatment.
The effect of column treatment, in conjunction with Arg C digestion, on E l 
binding was also examined qualitatively by analysis of each fraction by SDS-PAGE 
and the resultant gels silver stained (results not shown). Unlike E3, E l remained 
associated to the E2/X core in both untreated and treated reconstituted complex. 
Since E2 is thought to bind E l and, since immunological analysis of the isolated 
core with anti-E2 serum revealed insignificant degradation by Arg C (results not 
shown), this result is in agreement with those of Powers-Greenwood etal. (1989), 
and Gopalakrishnan et al. (1989), which demonstrated no loss in E l binding with 
the removal of intact protein X.
3.2.2.3 A study of reconstitution in the presence of varying 
concentrations of excess porcine E3 with untreated, partially and 
fully Arg C degraded E2/X core
The results described in section 3.2.2.1 indicated a lowering of E3 binding 
affinity with the removal of the lipoyl domain of protein X, which could be partially 
compensated for by the addition of excess E3. The following experiments were
I
i
designed to investigate the effect of various concentrations of excess E3 on 
reconstitution with untreated, partially, and fully Arg C degraded E2/X core.
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As before, isolated E2/X core was treated with 3% (w/v) Arg C at 33°C in 
the presence of TPP and Mg2+, and reconstitution monitored until 40% (partial 
digestion), or 5% (full digestion), of the original activity remained. Samples were 
then used to study reconstitution in the presence of O-lOmg.mF1 porcine E3 (i.e., a 
0-50-fold (w/w) excess with respect to E1/E3). The results are presented in Fig. 
3.2.2.3.1 where a) represents fully Arg C digested; b) partially Arg C digested; and
c) undigested reconstituted complex.
All three complexes exhibited increased reconstitution in the presence of 
excess porcine E3 suggestive of reduced E3 binding. However, with undegraded 
complex the approximate 30% increase in reconstitution (facilitated by a 1.6-fold 
excess in E3; O.Smg.mW) may simply represent recovery of E3, dissociated during 
isolation of PDC from bovine heart mitochondria and/or preparation of the 
dissociated fractions as originally proposed in section 3.2.2.1, and supported by the 
results of section 3.2.2.2. A similar 25% increase in reconstitution was observed 
with partially degraded complex following addition of a 1 .6 -fold excess of porcine 
E3, but rose to a 50% increase in the presence of 2mg.ml_1 porcine E3 and 
therefore, presumably reflects limited recovery from the combined effects of E3 
disssociation as described above, and the additional lowering, or loss, of E3 binding 
affinity in those protein X molecules from which the lipoyl domains had been 
cleaved by Arg C. In contrast, with almost fully degraded complex the same range 
of excess porcine E3 (0.5-7.5mg.ml_1; i.e., a 1.6-32 fold excess with respect to 
E1/E3), resulted in a 60-200% enhancement in reconstitution, suggesting an 
increasing dependence for recovery of complex activity upon higher concentrations 
of E3 which, could result from an increasing involvement in PDC activity of the low 
affinity binding of E3 to the subunit binding domain of E2 (see Discussion).
9 1
Figure 3.2.2.3.1 Profile of reconstitution, in the presen ce  of various  
concentrations of porcine E3, of untreated, partially amd fully digested  
E2/X core
E2/X core was treated with 3% (w/v) Arg C in the presence of TPP and 
Mg2+, and the resultant decrease in complex activity reconstituted monitored by 
the removal of timed aliquots for preincubation at 33°C for lOmin with E1/E3 
(ratio by weight of 1:0.8), in the presence of Soln A and Soln B, and activity 
assayed at 340nm. Digestion was arrested by the addition of 4mM benzamidine. 
For a) digestion proceeded until 95% of activity was lost, for b) until 60% was 
lost, and for c) undigested core used. Equivalent duplicate aliquots of each 
sample were then preincubated for lOmin at 33°C with E1/E3 (ratio 1:0.8), in the 
presence of Soln A and B and a final concentration of O-lOmg.ml-1 (ie., 0-50 
fold excess (w/w) with respect to E1/E3), porcine E3 (resuspended in Soln A), 
to a final volume of 50-80jil. Catalysis was initiated by the addition of 20pl to an 
assay cuvette and the resultant specific activity expressed as % reconstitution 
calculated from duplicate values of <5% difference (see section 2.2.10).
(NB: the protein content contributed by the presence of excess E3 was not 
included in the calculation of specific activity).
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It should be noted that a similar 200% increase in reconstitution accompanied 
only a 3-fold excess of porcine E3 in Fig. 3.2.2.1.1a. This discrepancy may have 
resulted from the incomplete removal here, of 3.2M NH4SO4 from the porcine E3 
storage buffer. In support of this latter proposal, all three complexes exhibited 
decreased levels of reconstitution in the presence of highest E3 (and hence, trace 
salt) concentrations, where mild component dissociation could occur. However, 
such decreases could also reflect competition between E l and E3 for binding sites on 
the E2/X core as suggested previously (see sections 3.2.1.2 & 3.2.2.1).
Importantly, these results imply that full recovery of reconstitution is not 
possible in the presence of up to a 50-fold excess of porcine E3, following the 
complete or partial removal of the lipoyl domains of protein X. In addition, no 
further increase in reconstitution was observed when preincubation was extended 
over 4h at either 33°C or 4°C, in the presence of a 19-fold excess of porcine E3 (i.e., 
5mg.ini'1; results not shown). Whilst these results indicate a dramatic decrease in 
E3 binding affinity, it is unclear whether the inability of porcine E3 to facilitate full 
recovery simply reflects: a) low specificity binding to the subunit binding domain of 
the truncated protein X and/or E2 component; or alternatively, b) limitations 
associated with small but significant differences in the catalytic and/or binding 
efficiencies of bovine heart and porcine E3 (Saiqa Khan, University of Glasgow, 
unpublished results). These results are therefore in apparent agreement with 
Rahmatullah et al. (1989b), and Powers-Greenwood et al. (1989), but in opposition 
to Neagle & Lindsay (1991), and Lawson et al. (1991), who ascribe the E3 binding 
function of protein X solely to the E3 binding domains. However, if the overall 
stability of this latter domain necessitates the presence of the lipoyl domain, its 
removal by Arg C could result in the loss of both stability and therefore, the E3 
binding function.
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Notably, large deletions in the proposed E l binding site of E2 from 
A. vinelandii PDC, resulted in a complete and irreversible loss in E l binding, yet 
full recovery of reconstitution was achieved with excess E l following a small 
deletion or a single point mutation. This suggested a complete loss in binding 
function for the former, compared to an apparent lowering of binding affinity for the 
latter (Schulze et al., 1991c). Nevertheless, the proposed indirect yet essential 
involvement of the lipoyl domain in E3 binding is not supported by the research of 
Neagle & Lindsay (1991), suggesting the possibility of an alternative explanation. 
To this end the following research was carried out.
3.2 .2 .4 Reconstitution, following Arg C treatment of isolated 
E2/X core, in the presence of mediating molecules and excess 
E3
As the loss in E3 binding could only be partially recovered by the addition of 
excess E3 (see section 3.2.2.3), this suggested either a dramatic reduction or 
complete loss in the E3 binding capacity of the E2/X core. In either case, the 
introduction of a mediating molecule which could interact catalytically with the 
E2/X/E1 core and dissociated (or weakly associated) E3, might provide a means for 
increased reconstitution. This possibility was briefly investigated employing a) free 
lipoamide or, b) lipoamide with redox dyes — both in conjunction with excess 
porcine E3. Fig. 3.2.2.4.1 illustrates the possible mechanism for catalysis in the 
presence of such mediating molecules.
In agreement with the findings of Reed et al. (1958), whereby both free 
lipoic acid and lipoamide acted as substrates for E2 and E3 of E. coli PDC, this
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proposes that free lipoamide might interact with reduced lipoyl domains on the E2 
core, become converted to dihydrolipoamide and, due to accessibility as a free 
molecule in solution, interact with the weakly associated and/or dissociated E3 
components which would then catalyse the reoxidation. Alternatively, the additional 
introduction of an artificial electron acceptor in the form of redox dyes might 
improve the rate of electron transfer between E2, lipoamide and E3, as shown. This 
required a dye which although stable to air oxidation, could be easily reduced with a 
redox value close to that of the FAD/FADH2 pair (i.e. 0.26mV), and a minimum 
absorbance at 340nm. The following three dyes were chosen accordingly: 1) 
anthraquinone-sulphate; 2 ) hydroxynapthaquinone; 3) phenazine ethosulphate.
In both cases, samples of isolated E2/X core were treated with 3% (w/v) Arg 
C in the presence of TPP and Mg2+ and the decrease in reconstitution monitored 
until 5% remained at which point, digestion was arrested by the addition of 
benzamidine. Duplicate aliquots were then removed for reconstitution with E1/E3 in 
the presence or absence of lipoamide, excess E3 and redox dyes.
a) Reconstitution with lipoamide in the presence or absence of 
excess E3
From the results in Fig. 3.2.2.4.2 it is clear that the presence of lipoamide 
has little affect on reconstitution even at concentrations of 4mg.mH. Condition 8 
and 9 show minor increases but this is more likely due to the addition of lmg.ml-1 
and 5mg.ml_1 E3, respectively, as subsequent experiments employing higher 
concentrations of porcine E3, revealed no change in % reconstitution with the 
addition of lipoamide (results not shown).
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Figure 3.2.2.4.2 Profile of reconstitution in the presen ce  of varying  
concentrations of lipoamide following Arg C digestion of the E2/X core
E2/X core was incubated with 3% (w/v) Arg C in the presence of TPP and 
Mg2+ and the drop in activity reconstituted monitored by the addition of E1/E3 
(ratio of 1:0.8), as before (see 2.2.10). Once 95% of activity was lost, 4mM 
benzamidine was added and aliquots of E2/X core removed for a lOmin 
preincubation at 33°C with E1/E3 and varying concentrations of lipoamide ± 
excess E3, in the presence of Soln A and B (final volume 50-60pl). lOpl 
duplicate samples were then removed to a cuvette for assaying (see 2 .2 .1 1 ). 
Lipoamide was made up in 50% (v/v) ethanol /  Soln A.
Condition 1: reconstitution before Arg C treatment.
Figure 3.2.2.4.3 Profile of reconstitution in the p resen ce  of various  
redox dyes, following Arg C digestion of the E2/X core
Arg C digestion was as described in 3.2.2.4.2, and conditions 1 and 2 
illustrate activity reconstituted prior and following this treatment. Conditions 3 to 
11 illustrate reconstitution following digestion in the presence of
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The apparent failure of lipoamide to facilitate catalysis may reflect problems 
encountered with solubility which necessitated the presence of 50% (v/v) ethanol in 
the stock solution. High levels of solvent in the reconstitution volume were 
undesirable and kept between 2 -8 % (v/v) whereupon, lipoamide exhibited minor 
precipitation. Nevertheless, sufficient amounts could have remained in solution, but 
as lipoamide is a relatively poor substrate of E2, its conversion to dihydrolipoamide 
and subsequent reoxidation by E3, under such conditions could have occurred at a 
low rate requiring extended preincubation. Since previous experiments (not 
shown), highlighted problems with extended preincubation and, the insolubility of 
lipoamide presented further complications, this line of investigation was not pursued 
further.
b) Reconstitution with lipoamide and excess E3 in the presence 
or absence of redox dyes
From the results in Fig. 3.2.2.4.3 it is clear that, under the conditions used, 
the presence of redox dyes in the reconstitution volume has no apparent beneficial 
affect on activity recovered. The 200% increase expected (condition 5), upon the 
addition of 5mg.ml_1 porcine E3 (see section 3.2.2.3), actually decreased with 
subsequent additions of each or, all three dyes (conditions 6 ,7 , 8  and 9). However, 
it should be noted that preincubation was carried out (conditions 3-9), in the 
presence of Soln C, and not B, to eliminate any reduction of the dyes by L-cysteine 
(see section 2.2.11) -  present to maintain reduced CoA.
Since reconstitution in the presence of Soln C showed a slight reduction 
(compare conditions 2 and 3), reconstitution with all three dyes, 5mg.ml_1 E3 and
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lipoamide, was carried out in the presence of modified Soln B lacking L-cysteine 
(condition 10). A 100% increase resulted but, with such low recovery in 
reconstitution — below that achieved solely with excess E3, the significance of this 
result seemed in doubt. It is possible that higher concentrations of the dyes might 
have lead to increased reconstitution although, literature searches suggested lower 
concentrations to be more frequently employed
In light of the results obtained in sections 3.2.2.4a & b, it seems that the 
initial recovery in reconstitution achieved with high concentrations of porcine E3 
cannot be improved upon under the conditions described above.
3.2.2.5 N-terminal amino acid sequence analysis of the Arg C- 
truncated 35000-M r fragment of protein X from bovine heart 
PDC
From the results presented so far in this chapter, the apparent consequence of 
the removal of the lipoyl domain of protein X, by Arg C, is a dramatic loss in 
reconstitution, thought to reflect an equivalent loss in E3 binding capacity. In the 
presence of high concentrations of porcine E3, only partial recovery was possible, 
suggestive of a severe decrease in E3 binding affinity and/or the total loss of the E3 
binding function of protein X.
Both situations could arise if the lipoyl domain of protein X was involved in 
E3 binding either direcdy or indirectly, such as in the stabilisation of the E3 binding 
domain. This possibility is supported by similar studies in reconstituted bovine 
kidney PDC by Powers-Greenwood et al. (1989), and Gopalakrishnan et al. (1989)
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but disputed by the findings of Neagle & Lindsay (1991) (working in intact bovine 
heart PDC), and Lawson et al. (1991) (S. cerevisiae PDC), which point to a minor 
but non-essential role. This discrepancy could be explained if Arg C was found to 
remove more than simply the lipoyl domain of protein X and hence, N-terminal 
amino acid sequencing of the truncated protein X was carried out to determine the 
precise site of cleavage.
This involved the proteolytic cleavage of isolated E2/X core, by Arg C, 
which resulted in the release of a highly immunogenic 15000-Mr fragment, known 
from previous N-terminal amino acid sequencing to contain the lipoyl domain 
(Rahmatullah et al. 1989b); and a truncated, core bound 35000-Mr fragment (see 
section 3 .2 .2 .1). Samples were resolved by sequencing grade 15% (w/v) SDS- 
PAGE, and transferred to Immobilon PVDF membrane from which the 35000-Mr 
fragment was isolated and sent to the SERC Protein Sequencing Facility in Aberdeen 
(see Fig. 3.2.2.5.1 legend for details).
The sequence obtained was 23 residues in length and when matched with 
known acyltransferase sequences, a region of homology was identified within the 
E3 binding domain (see Fig. 3.2.2.5.1a). Previous N-terminal amino acid 
sequencing of the 35000-Mr fragment by Rahmatullah et al. (1989b), generated an 
almost identical sequence of 18 residues in length but failed to reveal any such 
sequence identity, probably owing to the misplaced assumption that Arg C cuts 
within the linker region joining the lipoyl and E3 binding domains.
Robien et al. (1992) published the 3-dimensional solution structure of a 51 
residue synthetic peptide comprising the E3-binding domain of E2 from E. coli 
OGDC, determined via NMR spectroscopy, which revealed a disordered N-terminus 
(residues 0 -12); followed by two parallel a-helices (residues 14-23 and 40-48),
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separated by a short extended strand (residues 24-26), and an irregular loop 
(residues 31-39; see Fig. 3.2.2.5.1b). Although, this represented the E3-binding 
domain from an octahedral E2 core-containing 2-oxoacid dehydrogenase complex, 
alignment of 15 such sequences from all three complexes and of various sources, 
with strict identity at the N- and C-termini of both helices, revealed 4 regions of 
absolute or, highly conserved residues. This included: 1) a core of hydrophobic 
residues at positions corresponding to lie-16, Leu-20, Leu-25, Ala-27, De-30, Leu- 
39, Val-44, with interhelical contacts providing stability; 2) glycine or asparagine at 
positions of tight turns (ie. 37 and 24); 3) a structurally restrictive proline at the N- 
terminal boundary of helix 1; and, 4) positively and negatively charged residues at 
specific positions corresponding to Arg-17, Arg-18, Arg-8 , Arg-41; and Glu-22, 
Asp-43, respectively, thought to be involved in the E2/E3 interface. The 3-D NMR 
resolution of the subunit binding domain of E2 from B. stearothermophilus PDC 
(icosahedral core), by Kalia et al. (1993), revealed a similar pattern of two a-helices 
but here, separated by a structured 3io-helix and overlapping p turns. In addition, 
the solvent exposed Thr-33 and Asp-43 of E2 from E. coli OGDC were buried, and 
therefore thought to be crucial for stability.
Alignment of the amino acid sequence obtained from the truncated 35000-Mr 
fragment of protein X (Fig. 3.2.2.5.1a), revealed the presence of conserved 
residues Pro-14, Arg-17, Arg-18, Leu-20, Glu-22, Gly-24, Thr-33; and, assuming 
that the subunit binding domain of protein X in bovine heart PDC is similarly 
positioned, these results place the site of Arg C cleavage at the extreme N-terminal 
edge of the E3 binding domain — specifically, at the proline boundary (Fig. 
3.2.2.5.1b). Hence, proteolysis would result in the release of the lipoyl domain 
with the attached linker region, exposing the truncated E3 binding domain (Fig. 
3.2.2.5.1c). Subsequent inactivation, due to partial unfolding, would seem highly 
probable under such conditions and would therefore, explain more satisfactorily the
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Figure 3.2.2.5.1 Isolation of the truncated 35000-Mr fragment of
protein X for N-termlnal amino acid sequencing
A preliminary digestion of isolated E2/X core by Arg C at 33°C followed 
by 12% (w/v) SDS-PAGE and immunological analysis, revealed the optimum 
incubation length for the production of the 35000-Mr fragment. This was then 
employed in a second digestion involving 300jig of isolated core, and the reaction 
arrested by the addition of an equal volume of sequencing gel sample buffer 1:1 
(v/v) with Bromophenol blue. Resolution by 15% sequencing grade SDS-PAGE 
followed (as described in section 2.2.5), and duplicate 50pg samples 
subsequently transferred to either nitrocellulose membrane for Western analysis, 
or to sequencing Immobilon PVDF membrane for staining with Coomassie Blue. 
Comparison of either membrane identified the 35000-Mr band which was excised 
from the Immobilon and sent to Aberdeen for N-terminal protein sequence 
analysis.
Figure 3 .2 .2 .5.1a) Alignment of 15 E3-binding domain amino acid  
s e q u e n c e s  reproduced from Robien et a!. (1992), and modified to show  
the 35000-Mr derived se q u en ce  from protein X
Areas of homology between the acyltransferases from OGDC (O), PDC 
(P), BCOADC (B) and protein X from PDC (X), isolated from E. coli (E), 
Bacillus subtilis (B),A.vinelandii (A), B. stearothermophilus (S), 5. cerevisiae 
(Y), Neurospora crassa MRP3 (N), rat (R), human (H), Pseudomonas putida 
(P), and bovine (C), are shown underlined. Positions of identity with the 
equivalent region from the 35000-Mr fragment of protein X (35X), are 
represented by asterisks. Two gaps were inserted on either side of the EKG 
motif in allowance of possible evolutionary changes such as deletions or 
insertions.
14 161718 19 20 222324 25 27 30 33 35 373839 41
E-O: SP AIRRLLAEHNLDASAIKGTGVGGRLTRE
B-O: SE S ARKL ARE KGT D T, S OVP T GP P T.GR VR KO
A-O: SE AARKIAEENAIAADSTTGTGKGGRVTKF.
E-P: TP LI RRL ARE F GVNL AKVKGT GRKGR T T. P E,
B-P: MP SVRKYAREKGVDIRKVTGSGNNGRWKF.
S-P: MP SVRKYAREKGVDIRLVOGTGKNGRVLKF.
A-P: GP AVROL ARE F GVE L AAIN S T GP RGR T L KF.
Y-P: S£ LAKTIALEKGT SLKDVHGTGPRGRITKA
N-P : L£ AAKRT.ARF.KGTDT.RNVKGSGPGGKTTF.F.
R-P: £P LAKKT, A AEKGIDLTOVKGTGPEGR TTKK
H-P : SP LAKKLAVF,KGTDT■ TOVKGTGPDGRTTKK
X-P : LPSVSLLLAENNISKOKALKEIAP SGSNGRLT.KF. 
P-B: SP AVRKRALDAGTF.LRYVHGSGPAGRTLHF.
B-B: TP AVRRLAMENNIKLSEVTGSGKDGRTT.KE
H-B: TP AVRRL AMENNIKL S E W  G S GKD GR ILKF.
^  ^  ^*1* ^  ^  ^  ^  ^  ^
35X : LS£ AARNTT, -EKG -ALDANOGTA?G
R o p i e r ,  e t  cti
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Figure 3.2.2.5.1b) Schem atic ribbon drawing of the E3-binding domain  
of E2 from E. coli OGDC (reproduced from Robien et al., 1992)
dramatic loss in E3 binding observed following Arg C treatment. Indeed, the close 
proximity of the cleavage site suggests that gross disruption, resulting in the 
complete loss of the E3 binding function may be more likely, then a partial unfolding 
leading to reduced affinity.
It should be noted however, that occasionally upon prelonged incubation 
(60min), further digestion of protein X to a 30000-Mr fragment occurred with the 
presumed release of the E3 binding domain (Mr 5000). Hence, a second site of Arg 
C cleavage is indicated in Fig. 3.2.2.5.1c. The involvement of this further digestion 
in the loss in reconstitution is unclear since significant loss in activity occurred 
before the appearance of the 30000-Mr fragment, which was often not detected by 
immunological analysis. Nevertheless, complete and irrecoverable loss in E3 
binding must ensue upon the removal of the E3 binding domain, if protein X is 
solely responsible for the binding of this component as suggested by the gene 
deletion studies in S. cerevisiae PDC of Lawson et al. (1991).
Importantly, this result offers strong support for the proposed significant 
disruption of the E3 binding domain following Arg C treatment and therefore, also 
offers a possible explanation to the disparate findings of Powers-Greenwood et al. 
(1989), Gopalakrishnan et al. (1989), and Lawson et al. (1991). Hence, in 
agreement with the latter group, possible disruption of the E3 binding domain by 
Arg C, and not the direct result of the removal of the lipoyl domain, may be 
primarily responsible for the loss in E3 binding. However, at this point it was still 
unclear why the equivalent loss in E3 binding and, complex activity, following 
complete digestion of protein X, by Arg C, was absent in intact PDC (Neagle & 
Lindsay, 1991). The possibility that the pattern of cleavage differed between intact 
complex and isolated core resulting in altered cleavage sites was therefore 
investigated.
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Figure 3.2.2.5.1C) A schem atic  representation of the E2 and protein X
com ponents of bovine heart PDC
The lipoyl domains are represented by hatched boxes; the lysine-linked 
lipoic acid moieties by L; the E3 binding domains by a boxed E3; the C terminal 
domains by open boxes; the active site o f E2 by a diamond; and the flexible 
interdomain linkers by zigzag lines.
3.2.3 Comparative proteolytic studies on the E3 binding 
function of protein X in intact complex involving Arg C
From the evidence presented in section 3.2.2 it is clear that Arg C digestion 
of protein X in isolated E3/X core results in a dramatic loss in reconstitution upon 
the appearance of the truncated 35000-Mr core fragment and the accompanying 
release of the lipoyl domain. Results suggest the loss in activity reflects an 
equivalent loss in E3 binding due to the proposed disruption of the E3 binding 
domain, brought about by the close proximity of the Arg C cleavage site to the N- 
terminal boundary of this domain.
In contrast, Neagle & Lindsay (1991), accomplished the complete removal 
of the lipoyl domain of protein X, by Arg C, in intact bovine heart PDC, 
accompanied by only a minor loss in complex activity (i.e., 15-20%), although the 
affinity of E3 for the core was reduced, leading to dissociation upon gel filtration in 
low ionic buffer. Since Rahmatullah et al. (1989b), reported protection of protein X 
from Arg C degradation by E3 in intact bovine kidney PDC, a possible explanation 
for the above discrepancy could involve an alteration in the extent of Arg C digestion 
in isolated core compared to intact complex. This possibility was investigated as 
follows.
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3.2.3.1 Analysis of the loss in intact complex activity following the 
selective degradation of protein X by Arg C
Intact PDC was treated with 3% or 6 % (w/v) Arg C at 33°C over 2h in the 
presence of TPP and Mg2+. At regular time intervals, samples were removed to 
measure complex activity, for analysis by SDS-PAGE of any non-specific E2/E1 
degradation, and for specific protein X degradation by subsequent Western analysis. 
Decreases in the E2, E l and X components were quantified by densitometric 
scanning of the resultant gels and immunoblot employing a Shimadzu FDU-3 gel 
scanner (see Figs. 3.2.3.l.la-d).
In direct contrast to the findings of Neagle & Lindsay (1991), a gradual but 
extensive loss in intact complex activity was noted, with 50% loss over the first 
60min (compared to 15% — Neagle & Lindsay, 1991), and a further 20%-30% 
decrease (3%-6% (w/v) Arg C), over the following 60min. Quantification of protein 
X degradation illustrated a similar overall loss of 40% over 60min, and 65-90% 
over 2h although, the initial rate appears to exceed that of PDC activity loss (see 
Discussion). Whereas Neagle & Lindsay (1991) achieved complete protein X 
digestion with 3% (w/v) Arg C over 60min, repeated trials employing various buffer 
systems and a range of % (w/v) Arg C of both analytical (Boehringer Mannheim) 
and sequencing (Sigma) grade, failed to remove all traces of protein X (as shown in 
Figs. 3.2.3.1.1b & c), supporting the findings of Rahmatullah et al. (1989b), which 
indicated protection of protein X from Arg C by E3 (complete removal was achieved 
in the presence of high salt ~  see Chapter 5). Notably, the proportion of protein X 
to Arg C (w/w), in isolated core, is two fold higher than in intact complex, yet more 
rapid and extensive degradation of protein X occurs with the former. In addition, 
this was unavoidably accompanied by significant non-specific Arg C degradation of
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Figure 3.2.3.1.1 Analysis of the lo ss  In intact complex activity following 
the degradation of intact protein X by Arg C
Freshly purified PDC was treated with 3% or 6 % (w/v) Arg C at 33°C 
over 2h in the presence of TPP and Mg 2+ (after lh, 50% of the volume was 
removed and treated with a second addition of Arg C i.e., 6 % (w/v)). At the 
times shown, samples were removed and the reaction stopped with 4mM 
benzamidine at 4°C. 5-10pl duplicate aliquots were used to assay complex 
activity at 33°C (see section 2.2.1) and the remaining volume diluted in Laemmli 
sample buffer for subsequent analysis by immunological screening (see section 
2.2.4).
Figure 3.2.3.1.1a) L oss  in intact com plex activity with time following 
Arg C treatment
Loss in intact complex activity with time, expressed as a % of the original 
untreated activity. (•--•) represents addition of 3% (w/v) Arg C over 2h. (•-- -•)
represents 3% (w/v) Arg C for 60min followed by an additional 3% (w/v) Arg C 
indicated by the arrow, (o- -o) indicates control untreated complex.
Figure 3 .2 .3 .1 .1b) Im m unological a n a ly s is  of the  degradation of  
protein X by Arg C
Western analysis of Arg C degraded protein X resolved by 10% (w/v) 
SDS-PAGE, and screened with antiserum raised specifically to protein X. Lane 
M, 10pg low Mr marker proteins; samples were removed at the times shown 
(15pg/well), and 90', 120' represent samples removed after 6 % (w/v) Arg C 
treatment. Intact protein X is represented by "X", and the various peptides 
generated are labelled "35, 30, 28, 15 K".
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Figure 3 .2 .3 .1 .1c)  D ecrease  in intact protein X following Arg C 
treatm ent
A scan of the above immunoblot was carried out employing preflashed 
hyperfilm and a Shimazu FDU-3 gel scanner at 500nm (see section 2.2.4). The 
% loss in intact protein X was thereby quantified, and presented with respect to 
the initial Iband absorbance. Where (•--•) represents 3% (w/v) Arg C; (o- - o) 
represents 6 % (w/v) Arg C.
Figure 3.2.3.1.1d) D ecrease  in band intensity of com ponents  E2 and 
E1 from a 10% (w/v) SDS-PAGE C oom assie  stained gel, following Arg C 
treatm ent
Samples removed at the time points shown above, were also resolved by 
10% (w/v) SDS-PAGE and, following Coomassie blue staining, scanned with a 
Shimadzu FDU-3 gel scanner at 570nm (see section 2.2.4), to quantify the 
reduction in band intensity resulting from non-specific Arg C proteolysis. 
Where, (•— •) represents Eip; (•—•) E2; (o—o), E la ; and, hatched lines, a 
second addition of 3% (w/v) Arg C at 60min.
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the E2 component, which at most exhibited a 30-40% decrease over 2h with 6 % 
(w/v) Arg C illustrated by Fig. 3.2.3.1.Id -- with an initial 20% drop over the first 
hour.
Similar studies in isolated E2/X/K core employing 5% (w/v) Sigma Arg C 
(Rahmatullah et al., 1989a), suggested an initial cleavage of E2 to the 28000-Mr 
inner catalytic domain (E2i), and the combined 49000-Mr subunit binding domain, 
linker and lipoyl domain regions ( E 2 b l )  — identified through the ability to bind E l 
and become acetylated; with further degradation of the latter species to a 39000-Mr 
lipoyl domain. An identical pattern of protein X cleavage to that illustrated in Fig. 
3.2.3.1.1b, was also observed by this group whereby, release of the 15000-Mr 
lipoyl group resulted in a truncated 35000-Mr inner catalytic and subunit binding 
domain (X j b ) , subsequently degraded to a 30000-Mr (Xj), then 28000-Mr (Xp) 
inner catalytic domain fragment following the presumed cleavage of the subunit 
binding domain. Notably, the pattern of protein X cleavage here, differs from that 
observed for isolated E2/X core (see Fig. 3.2.2.1.1b) or, for intact complex cleaved 
in the presence of 1M NaCl (see Chapter 5; Fig., 5.2.2.2.2), and may therefore, 
reflect some degree of E3 mediated protection. However, as protein X degradation 
was accompanied by extensive complex activity loss, such protection cannot be 
offered as an explanation to the disparate results of Neagle & Lindsay (1991).
In addition, although relatively little degradation of the E la  and p subunits 
was noted in the presence of TPP and Mg2+ even over the extended 2h incubation 
where some loss resulted (i.e., a 10-12% and 20-30% decrease for p and a, 
respectively), the complete protection of E la  presented by Neagle & Lindsay 
(1991), was never fully reproduced. Therefore, it is highly likely that the additional 
Arg C degradation of E2, and possibly of E la , contributed to the overall reduction
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in PDC activity noted over 2h, and their apparent absence may explain the smaller 
loss in PDC activity recorded by Neagle & Lindsay (1991).
3.2.3.2 Release of E3 from intact complex following removal of 
the majority of intact protein X by Arg C
The results in section 3.2.3.1 revealed that removal of the majority of intact 
protein X, by Arg C, was accompanied by an equivalent loss in intact complex 
activity. However, due to the partial degradation of E2, this loss can only be partly 
attributed to the degradation of protein X. In reconstituted complex, this loss 
reflected a reduction in the E3 binding capacity of the isolated E2/X core, hence, a 
similar study was performed to monitor the dissociation of E3 from intact PDC 
following incubation with Arg C.
This involved the incubation of PDC with Arg C at 33°C in the presence of 
TPP and Mg2+ during which, complex activity was monitored by direct assay at 
340nm (see section 2.2.11), and samples removed for the analysis of E3 
dissociation involving centrifugation at 180000g. At this centrifugal field, 
dissociated E3 remains in solution whereas, bound E3 co-precipitates with the 
E2/X/E1 core fraction. Thus, by the removal of supernatants, and subsequent 
resuspension of pellets, the percentage bound and released E3 can be determined 
through E3 assays (see section 2.2.11).
From the results in Fig. 3.2.3.2.1, the rate of loss of complex activity is 
presented in relation to the rates of loss of intact protein X and of bound E3. The 
loss in intact protein X was determined following Western analysis employing
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Figure 3.2.3.2.1 Plot of the lo s s  in intact com plex activity, intact 
protein X and, bound E3 with time following Arg C digestion of intact 
PDC
Freshly prepared PDC was diluted to 3mg.ml' 1 in 2ml Soln A, complex 
activity assayed at 340mm and aliquots (20pl) removed to Laemmli sample 
buffer. 1ml was then treated to 3+3+3% (w/v) Arg C at 0, 45 and 90min over a 
2h incubation period at 33°C; and the remaining control sample treated likewise 
but with three additions of buffer. At the times shown, complex activity was 
assayed in duplicate by the removal of 5-10pl aliquots from a sample (20pl diluted 
to lOOpl in Soln A and 4mM benzamidine), to assay cuvettes. Samples were 
also removed for immunological analysis; and to 1ml centrifuge tubes, kept at 
4°C, for the quantification of E3 release (i.e. 83pl diluted to 500pl in 5mM 
benzamidine and Soln A). Centrifugation was at 180000g (rav 2.5cm) for 2.5h 
at 4°C, the supernatants removed and the resultant pellets resuspended overnight 
in 1% (v/v) TX-100 buffer pH 6 .8 , before both were assayed in duplicate for total 
E3 activity at 340nm (see section 2.2.11). Protein X degradation was determined 
following resolution by 10% (w/v) SDS-PAGE of duplicate 5p.g samples (for 
subsequent scanning); or, 10|ig (for 125I-incorporation), from each time point. 
Protein was then transferred to nitrocellulose and probed with protein X-specific 
sera, coupled to 12^I-protein A.
a) Quantification by light scanning: exposed preflashed hyperfilm 
was developed and the intact protein X band subsequently scanned at 600nm 
using a Shimadzu FDU-3 gel scanner (see section 2.2.4), to quantify the loss in 
intact protein X.
b) Quantification by 125l-incorporatlon: exposed film was matched 
with the nitrocellulose filter to determine the precise location of the intact protein 
X bands which were then excised and the resultant y radiation counted in 
duplicate in an iodine counter over 60 seconds. Re-exposure of the nitrocellulose 
blot revealed that the complete removal of each individual band was successful. 
Each point represented in Fig. 3.2.3.2.1, is an average of duplicate samples 
which differed by <15%.
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PDC activity was determined in nkat.ml-1 and converted to a % of the 
initial activity (•—•). Released E3 activity, in nkat.ml'1, was expressed as a % of
the total E3 activity (released and bound), determined for each individual time 
point (o- -o). Loss of intact protein X-determined by scanning (■-- -■); or 125I- 
incorporation (o—□), was also expressed as a % of the initial value.
protein X-specific antiserum by either: 1) quantification o f 125 I- iodinated protein A 
incorporation of the nitrocellulose-bound intact protein X band; or, 2) by 
densitometric scanning of the intact protein X band from a preflashed hyperfilm 
exposure (see Fig. 3.2.3.2.1 for details). Both reveal a similar pattern of proteolytic 
degradation, but a slightly higher rate of loss is apparent for the latter method 
presumably reflecting differences in the degree of sensitivity in relation to 
experimental error. In agreement with the results of section 3.2.3.1, a close 
similarity between the extent of protein X degradation and loss in complex activity 
was apparent -  characterised by an initial higher rate of loss over the first 10-15min 
followed by a slow, extensive reduction. Yet, when compared to the degree of E3 
dissociation it becomes clear that the reduction in complex activity and intact protein 
X over 2h, exceeds that of the former which exhibited only a 60% increase in E3 
release over and above the 10% released in the absence of Arg C treatment, although 
Fig. 3.2.3.2.2 reveals an immediate increase in E3 release into the supernatant 
fractions.
As slight dissociation of the rate limiting E l component was also observed in 
Fig. 3.2.3.2.2, the higher rate of complex activity loss may, therefore, result from 
minor E2 degradation, in support of the findings of section 3.2.3.1. Indeed, from 
Fig. 3.2.3.2.3, it is clear that whereas almost a direct correlation exists between loss 
in complex activity and intact protein X, the former loss initially exceeds that of E3 
release, suggestive of an additional variable. Alternatively, the lag in E3 release may 
reflect the time taken for the subunit binding domain on X to unfold, following 
removal of the lipoyl domain by Arg C. In addition, if E3 binding were organised 
such that dissociation of each E3 dimer required the proteolysis of both or, one less 
accessible subunit, of an equivalent protein X dimer (see Chapter 5), significant 
degradation of the latter could precede a loss in E3 binding yet parallel PDC activity
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Figure 3.2.3.2.2 Immunoblot of the E3 and E1 com p onents  present In 
the resu sp en d ed  pe lle ts  and isolated supernatants  following Arg C 
treatment and centrifugation at 180 OOOg
5pg samples o f each time point were resolved by 10% (w/v) SDS-PAGE 
for subsequent W estern analysis employing E3 and E l-specific antisera. In either 
case, control samples were also loaded to illustrate the degree of dissociation, of 
either component, resulting from centrifugation treatment alone. Lane M, low Mr 
markers proteins; lane C, control undigested PDC.
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Figure 3.2.3.2.3 Comparison of the % lo s s  in complex activity with both 
the % lo ss  in intact protein X, and the resultant % release of E3
The % loss for each variable was determined as detailed in Fig. 3.2.3.2.1 
(o- -o) represents the correlation between PDC activity and E3 release; (o— -a) 
represents the correlation between PDC activity and protein X degradation 
determined via 125Iodine incorporation; and, (•— •) represents the correlation 
between PDC activity and protein X degradation determined via scanning.
loss, due to lowered E3 affinity and hence, catalytic efficiency. This possibility is 
discussed further in Chapter 4.
Thus, in conclusion it would appear that the proteolysis of protein X in intact 
complex results in an accompanying loss in PDC activity, which may be mainly 
attributed to the loss in E3 binding but may also partly reflect non-specific E2 
degradation and the resulting minor E l dissociation. This result is therefore in direct 
disagreement with those of Neagle & Lindsay (1991).
3.3 DISCUSSION
Central to the research presented in this chapter was the successful separation 
of bovine heart PDC into native, isolated E2/X core and dissociated E1/E3 fractions, 
which upon recombination, gave reproducibly high levels of reconstituted complex 
activity. Thus, in contrast to the harsh conditions employed by Rahmatullah et al. 
(1987; 1989b -- modified from Linn et al., 1972; Stepp et al., 1983), in the 
preparation of E2/X/kinase core, which involved high salt treatment at pH 9 for lh at 
room temperature, followed by column separation and ammonium sulphate 
precipitation — both in the presence of high salt and alkaline pH; with the additional 
use of 5M urea and monosodium hydroxymercuriphenyl sulphonate in further core 
purification (Powers-Greenwood et al., 1989; Gopalakrishnan et al., 1989); 
improved resolution was achieved here with the relatively mild conditions of 2M 
NaCl over lh  at neutral pH and 4°C. In addition, whereas 70-100% reconstitution 
of complex activity was routinely recovered here, the absence of a clear indication of 
the conditions and extent of control reconstitution in the above publications raised 
doubts over the degree of component denaturation and the interpretation of data 
(Neagle & Lindsay, 1991).
Excellent reconstitution of overall complex activity was observed with a 
range of E2/X:E1/E3 ratios of 1:0.7-1.3 (w/w), which compares well with that of 
intact complex (1:1.3), calculated from subunit stoichiometry and molecular mass 
values. A tendency to achieve maximal reconstitution was observed using sub- 
stoichiometric levels of E l and E3. This may reflect partial loss of activity of E2/X 
during purification or, favoured by the high recoveries in reconstitution obtained, 
indicate that maximal occupancy of El and/or E3 binding is not required for maximal 
levels of reconstitution. Furthermore, this appeared to be independent of component
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concentration, in contrast to the findings of Schulze et al. (1991c) which, in 
investigating E l and E3 binding in A. vinelandii PDC found better recovery at 
higher protein concentrations, due to competition between the E l and E3 
components for E l binding sites. Reassembly of the complex occurred rapidly, 
apparently within l-2min, which is in agreement with the 10-15min preincubation 
employed by Schulze et al. (1991c), in similar reconstitution experiments involving
A. vinelandii PDC, and of Kresze et al. (1980), and Rahmatullah et al. (1990), 
employing bovine kidney PDC.
Analysis of reconstitution, following the removal of the lipoyl domain of 
protein X by Arg C, revealed a dramatic loss in complex activity and subsequent 
resolution by gel filtration indicated a significant decrease in E3 binding affinity. 
Reconstitution of undegraded, partially and fully Arg C degraded E2/X core with 
E1/E3, in the presence of high concentrations of porcine E3 (O-lOmg.mH; 1.6-50 
fold excess (w/w) with respect to E1/E3), resulted in successively higher recoveries 
yet failed to achieve full recovery of original activity. Notably, untreated 
reconstituted complex also exhibited an increase in activity with excess porcine E3 
which, in agreement with earlier findings and an observed 5-10% enhancement of 
intact PDC activity following addition of excess E3 (results not shown), suggested 
the possibilty of both incomplete E3 occupancy and minor inactivation during 
complex purification and subsequent component isolation.
In contrast, the increasing dependency upon higher concentrations of porcine 
E3, during the progressive cleavage of the lipoyl domain of protein X (accompanied 
by enhanced recoveries), may reflect an increasing contribution to complex activity 
from the low affinity binding of E3 to the subunit binding domain of E2. This could 
arise following a dramatic reduction or, total loss, in E3 binding affinity for the 
equivalent domain on protein X. The low specificity of this binding would also
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account for the inability of excess porcine E3 to completely overcome losses in 
reconstitution associated with the disruption of protein X/E3 interactions. Indeed, 
no further enchancement followed extension of the preincubation period from lOmin 
to up to 4h, nor the addition of putative mediating molecules such as free lipoamide 
or redox dyes, to the reconstitution assay. The latter failure may, however, reflect 
problems of lipoamide insolubility and the incompatibility/non-feasibility of the 
proposed reaction mechanism, which required efficient rates of catalysis between the 
various components and mediating molecules, and therefore, that free lipoamide is a 
good substrate of both E2 and E3. Whilst this has been shown to be the case for 
E. coli PDC (Reed et al., 1958), reductive acetylation by E l and presumably, 
enhanced E2/E3 interactions, are dependent upon attachment to the lipoyl domain 
(see Perham, 1991).
Thus, the inability to achieve full recovery of reconstitution in the presence 
of excess porcine E3 led to the proposal that, following removal of the lipoyl domain 
of protein X by Arg C, the substantial reduction or complete loss in E3 binding 
affinity could result from disruption and hence, unfolding of the exposed subunit 
binding domain.
Support for this proposal came from the results of N-terminal amino acid 
sequencing of the truncated 35000-Mr fragment of protein X, which located the 
point of Arg C cleavage at the extreme N-terminal boundary of the subunit binding 
domain (Robien et al.y 1992; Kalia et al., 1993). Although the exact location of this 
domain in mammalian protein X is as yet undetermined, such proximity of the 
cleavage site would most likely still cause disruption and hence instability if the 
margin of this domain was subsequently found to be several amino acids upstream. 
Further indication, came from previous reports of truncated E2/X core instability and 
losses in peripheral subunit binding, following selective proteolysis of the lipoyl
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domain of E2 or, X, in the presence of detergent, CHAPS, (Rahmatullah et al., 
1990), or high salt (Neagle & Lindsay, 1991). Indeed, the proteolytic sensitivity of 
the E1/E3 binding region has also been observed in E2 from A. vinelandii,
B. stearothermophilus and E. coli PDC (reviewed in Schulze et al., 1991b).
At this point it remains unclear whether the action of Arg C promoted 
unfolding of the exposed subunit binding domain or, induced heat-lability of a 
specific E3 binding site within this domain. Initial attempts to address this question, 
involving Arg C treatment of intact PDC at 4°C over 24h, were unsuccessful owing 
to minimal protein X degradation at this temperature (results not shown), in 
agreement with previous observations (Rahmatullah et al., 1989a,b).
Notably, complete removal of the lipoyl domain of protein X, by Arg C, in 
intact PDC, in the absence of accompanying E2 and E l proteolysis, and with only 
minor losses in complex activity (i.e., 15% over lh), was not accomplished, in 
contrast to the findings of Neagle & Lindsay (1991). Here, complex activity 
decreased to 50% over the first hour, in line with protein X cleavage, with a further 
20-30% loss accompanying a parallel decrease in protein X although, possibly also 
in combination with minor E l and E2 degradation. However in agreement, 
following Arg C treatment, E3 dissociation increased dramatically, yet from the 
results presented here, this release appeared to lag behind that of intact protein X and 
complex activity loss. Whilst some reduction in PDC activity may be attributed to 
<100% E3 occupancy and/or minor E2 degradation and the accompanying release of 
a small but significant population of E l molecules, this disparity could also reflect 
the nature of E3 binding whereby dissociation of each E3 dimer requires the 
degradation of more than one protein X molecule. In addition, some variation in the 
accessibility of the protein X molecules could arise from its positioning within the 
E2/X core and, involvement in E3 binding. Indeed, although the proportion of
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protein X to Arg C (w/w), in isolated core is two fold higher than with intact 
complex, the incomplete removal of protein X from intact PDC both here and 
elsewhere (Rahmatullah et al., 1989b), indicates an enhanced inaccessibility in the 
presence of E3 (see Chapter 5). Furthermore, if loss of E3 binding affinity involves 
some conformational change in the subunit binding domain of protein X, E3 
dissociation may not occur immediately, although any decrease in affinity could lead 
to reduced catalytic efficiency.
Thus in conclusion, the decrease in E3 binding affinity following Arg C 
treatment of both intact and reconstituted complex, appears to be a direct result of the 
proposed disruption of the subunit binding domain of protein X, following removal 
of a larger fragment comprising the lipoyl and linker regions; and is therefore in 
agreement with the findings in S. cerevisiae PDC of Lawson et al. (1991). A 
similar complete and irreversible loss in E l binding followed the deletion of a large 
segment of the proposed E l binding site from the E2 core of A. vinelandii PDC, yet 
E1/E3 binding and E2 core assembly were unaffected by the complete deletion of the 
lipoyl domain from E2 (Schulze et al., 1991c). Nevertheless, the 30% loss in 
complex activity observed by Lawson et al. (1991), upon the precise and exclusive 
removal of the lipoyl domain of protein X, was noted upon closer examination to be 
accompanied by a small but significant decrease in E3 binding (not detailed by the 
authors). In addition, investigation of the dissociation constants (K j^) of E3 for the 
subunit binding domain and an overexpressed di-domain (comprising the lipoyl, 
linker and binding regions) of E2 from B. stearothermophilus PDC (Hipps et al., 
1994), revealed a tighter association with the latter domain, and as a previous study 
(Hipps & Perham, 1992) discounted any interaction of the lipoyl domain with E3, it 
was postulated that stability was provided by the linker region. Yet, removal of a 
lipoyl-like sequence from the N-terminus of component E l of OGDC, by trypsin, 
resulted in both loss of E3 binding and complex activity (Rice et al., 1992); where
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sequence analysis of a full length cDNA clone for E2 from rat OGDC revealed the 
absence of a subunit binding domain motif (Nakano et al., 1991). Hence, whilst the 
subunit binding domain of protein X is primarily responsible for E3 binding 
interactions within the E2/X core of bovine heart PDC, evidence suggests that the 
lipoyl and/or linker regions may also play an indirect role in the stabilisation of this 
domain.
Furthermore, evidence presented here suggests that, following loss of E3 
binding potential from protein X, low affinity binding of E3 to the subunit binding 
domain of E2 results in partial recovery of complex activity. Whilst not observed in 
the protein X mutants of S. cerevisiae PDC (Lawson et al., 1991a), this proposal is 
supported by the findings of two case studies in which residual PDC activity (i.e., 
10-2 0 %), was noted in the absence of immunologically detectable levels of protein 
X (levels of all other components including E3, were normal), in patients suffering 
from severe lactic acidemia resulting in early death (Marsac et al., 1993; Robinson et 
al., 1990). The significance of this low level binding to E2 may prove important 
especially in consideration of recent evidence (S. Khan, University of Glasgow, 
unpublished observations), which suggests that, in spite of the highly conserved 
nature of E3 and the successful employment of bovine heart E3 in the reconstitution 
of E . coli PDC, and, of porcine heart E3 with bovine kidney PDC (Kresze et al., 
1980), differences exist in the catalytic and/or binding requirements of E3 from 
porcine and bovine heart sources which led with the former, to reduced levels of 
reconstitution in bovine heart OGDC. This area is therefore the subject of current 
research.
I l l
RESULTS CHAPTER 4 :
Investigation into the catalytic role of protein 
X in bovine heart PDC.
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4.0 INTRODUCTION
While involvement in E3 binding has unequivocally established a structural 
role for protein X (see Chapter 3), discussion still surrounds its precise contribution 
to overall complex catalysis. Initial functional characterisation of protein X by De 
Marcucci & Lindsay (1985), De Marcucci et al. (1985; 1986), Jilka et al. (1986) and 
Hodgson et al. (1986), revealed: pyruvate or NADH/acetyl CoA-linked acetylation — 
including S6 ,S8-diacetylation (a phenomenon apparently unique to mammalian 
PDC); deacetylation; and, NEM incorporation identical to that of the E2 component. 
Furthermore, the discovery of significant N-terminal amino acid homology between 
the lipoyl domains of E2 and X in bovine heart PDC (Neagle et al., 1989), raised the 
question of whether protein X might exist as an isoenzyme of E2. Yet production of 
component-specific antisera, and the subsequent isolation of a separate gene 
(PDX1), encoding S. cerevisiae protein X (Behai et al., 1989), simultaneously 
ruled out exon splicing, pointing to gene duplication and independent evolution as a 
possible origin of this component.
Antibody screening of ten different rat tissues by De Marcucci et al. (1986), 
suggested a wide tissue distribution for both components. In addition, sequence 
analysis of the protein X gene (PDX1), from S. cerevisiae revealed the absence of a 
region equivalent to the extreme C-terminal portion of the inner catalytic domain of 
E2 in which resides the "His Xaa Xaa Xaa Asp Gly" active site consensus sequence 
proposed by Guest (1987), and therefore implied a structural/functional role distinct 
from that of E2 (Behai et al., 1989).
Initially, the high affinity of protein X for the E2 core prevented elucidation 
of the precise nature of its catalytic properties. Clearly, (de)acetylation of protein X
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could occur directly, although the requirement for acetyltransferase activity was not 
supported by the evidence of Behai et al. (1989), and of unpublished observations 
from the same group (Lawson et al., 1991b). Alternatively, these processes could 
occur indirectly either, through the intramolecular transfer of acetyl groups between 
E2 and X lipoyl domains or, by the lipoyl domain of protein X visiting the active site 
of E2. However, by employing a procedure originally devised by Stepp et al. 
(1983), involving the use of high salt, alkaline pH and mercurial reagents over 
extended periods, Rahmatullah et al. (1987) purified a protein X/kinase fraction 
from bovine kidney PDC and thereby, produced the first evidence for direct E l- 
mediated acetylation of the lipoyl domain of protein X from pyruvate, in the absence 
of E2. In contrast, acetyl CoA-linked acetylation was dependent upon the inclusion 
of the inner catalytic and subunit binding domain of E2 (E 2j; prior treatment with 
papain facilitated removal of all lipoyl domains), suggestive of the absence of 
acetyltransferase activity, yet indicative of E2-active site servicing by the lipoyl 
domains of X. This was further supported by the discovery of a residual 12-15% 
complex activity in S. cerevisiae null mutants for the E2 gene (LAT1), following 
transformation with LAT1 single copy plasmids in which, the lipoyl domain plus or 
minus, linker-encoding regions were deleted; or, lysine47 (essential for lipoic acid 
attachment), substituted for by an arginine. Whereas acetyltransferase activity and 
component binding remained unaffected, total loss of complex activity only occurred 
upon substitution of both lysine47 and lysine43 of E2 l  and X l, respectively 
(Lawson et al., 1991b).
In agreement, following the complete removal of the lipoyl domains of E2 
from bovine kidney PDC, via collagenase treatment and centrifugal fractionation 
Rahmatullah et al. (1990), noted a residual, apparently X lipoyl domain-mediated, 
10% complex activity. In addition, no loss in PDC activity was observed until 40% 
of the E2 lipoyls were removed, adding to the already extensive evidence for active
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site coupling in which, a given E2 component may service more than one E l or E3 
active site and participate in transacetylation (see Graham et al., 1986, for review; 
Stanley et al., 1981). In contrast, in investigating the E3 binding function of protein 
X in bovine kidney PDC, Gopalakrishnan et al. (1989) noted that cleavage of the 
lipoyl domains, by Arg C, only slightly exceeded the initial rate of loss in complex 
activity, proposing an essential but non-rate limiting transfer of reducing equivalents 
from E2 to E3 via protein X, and citing the E3 binding potential of a protein 
X/kinase fraction (X/Kc/Kb), as strong evidence of direct interactions. Whilst Arg C 
was later found to remove both lipoyl and linker regions, overall loss in complex 
activity was therefore, correlated to the possible disruption of the E3 binding domain 
(see Chapter 3), although gene deletion of only the lipoyl domain of protein X from 
S. cerevisiae also resulted in a 30% reduction in PDC activity (Lawson et al., 
1991a). Further, through N-terminal amino acid sequencing, collagenase was also 
found to remove both lipoyl and linker, cleaving at the boundary of the E l binding 
domain of E2 (Rahmatullah etal., 1990), yet leaving E l binding unaffected.
Hence, Rahmatullah et al. (1990) proposed preferential upstream utilisation 
of the lipoyls of E2 and, a more restricted downstream utilisation of protein X in the 
transfer of electron pairs from E2 to E3. Whether the inherent transacetylase 
potential of protein X is maintained in intact PDC at the residual (10-15%) level, 
therefore, only becoming apparent in the absence of E2 lipoyl domains or, 
suppressed through competition for acetyl groups and, only expressed in the 
absence of E2, is as yet unclear. Furthermore, the significance of this apparently 
superfluous activity in mammalian and yeast PDC, absent in all other 2-oxoacid 
dehydrogenase complexes from various species, is intriguing expecially in view of 
the unique diacetylation properties of mammalian PDC (see discussion). While the 
full extent of the involvement of protein X in complex activity remains to be seen, 
little evidence exists for acetyltransferase activity associated with X. In addition, as
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debate continues over the organisation of protein X within the E2 core, growing 
evidence for a peripheral location fuels further doubt over the presence of a fully 
functional acetyltransferase active site in mammalian protein X (see Chapter 5 for 
references within).
Despite these considerations, the possibility of a protein X-mediated 
acetyltransferase activity should not be excluded at this stage. Indeed, in light o f : an 
estimated 2000-Mr disparity between yeast (48000-Mr) and mammalian (50000-Mr) 
protein X — compatible with the presence of an extra 20 C-terminal amino acid 
residues in the latter species; the presence of a single lipoyl domain on E2 from yeast 
PDC, in contrast to two in mammalian dihydrolipoamide acetyltransferase; and the 
absence of diacetylation in either E2 or X from S. cerevisiae, it seems quite plausible 
that differences in the structural/functional properties of protein X should exist 
between these species. Furthermore, the possibility of a partially degraded/ 
denatured C-terminal domain in protein X from bovine heart PDC cannot be 
completely ruled out, following employment of the exhaustive 5-day preparation of 
Rahmatullah et al. (1987), which involved high salt, alkaline pH and mercurial 
reagents together with repeated precipitation and overnight dialysis — all in the 
absence of pro tease inhibitors (Rahmatullah et al., 1987). In addition, initial 
sequence analysis of a 241 base pair cDNA clone from the extreme C-terminal 
segment of mammalian protein X revealed the presence of an active site-like "His 
Xaa Xaa Xaa Ser Gly" sequence (J.C. Neagle, University of Glasgow, unpublished 
observations). However, verification of this finding has been precluded by the 
absence of other published gene sequences for protein X from mammalian sources 
and has therefore, prompted more detailed analyses, at both nucleotide (J.E. Rice, 
University of Glasgow, unpublished observations), and amino acid level.
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This latter work, involved N-terminal amino acid sequence analysis of the C- 
terminus of both E2 and X, following purification of E2/X core from bovine heart 
PDC, extensive tryptic degradation and, subsequent isolation of the extreme C- 
terminal peptides employing a specialised anhydrotrypsin resin. The preliminary 
results from this work are presented, together with additional investigations into the 
putative catalytic role of protein X in bovine heart PDC. These comprised studies of 
N-ethyl[2,3-14C]maleimide incorporation in intact and reconstituted complex, 
following specific proteolysis of the lipoyl and linker regions of E2 or X, with 
collagenase or Arg C,| respectively.
4.1 METHODS
4.1.1 Investigation into an improved method for E2/X core 
purification
Prior to the isolation and N-terminal amino acid sequencing of the tryptically 
cleaved C-terminal fragments of components E2 and X, following purification by 
resolution on an anhydrotrypsin column, endeavours to improve upon the standard 
E2/X isolation procedure described in section 2.2.9, were carried out. Whilst low 
yields and residual E1/E3 contamination were acceptable and unavoidable where 
retention of native activity was essential (see Chapter 3); here, the requirement for 
maximum purity and yield led to the investigation of various additional methods. 
These included: repeated high salt treatment with subsequent resolution by gel 
filtration or, centrifugal fractionation; treatment with the chaotrophic reagent, 
guanidinium chloride (GdnHCl) followed by gel filtration; or, prior proteolysis of 
the lipoyl domains of E2 and X in intact PDC, by trypsin, to facilitate the 
dissociation of El and E3 upon gel filtration.
A summary of the procedures used, together with a description of the 
component composition of each ’’purified" core fraction, as visualised on 10% (w/v) 
SDS-polyacrylamide gels stained with Coomassie blue, and the % recovery of total 
protein for each core fraction at each stage (with the overall % recovery in brackets), 
are presented in Table 4.1.1.1.
Whereas high salt treatment in conjunction with centrifugal fractionation gave 
poorer purification compared to that obtained for high salt treatment in combination
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Treatm ent S a m p le  Condition %
Recovery 
of original 
protein
la) 20mg PDC 2M NaCl, lh, 4°C; 54%
core pelleted at 1 2 0 0 0 0 g,
16h.
lb) 9.6mg of 38%
“E2/X” as in la) (20%)
from la)
2a) 20mg PDC 2M NaCl, lh, 4°C; core 7-11%
resolved by 100ml 
Superose 6  column, pH 9 
(see 2.2.9).
2b) 1.2mgof as in la) 85%
“E2/X” (6-9%)
from 2 a)
3a) 20mg PDC 4M NaCl (solid), lh, 42%
4°C; core pelleted at 
1 2 0 0 0 0 g, 16h.
3b) 7mg of as in 3a). 41%
“E2/X” (17%)
from 3a)
4 30mg PDC 1M GdnHCl lh, 4°C; N.D.
core resolved by 10 0ml 
Superose 6  column, pH 9 
(see 2.2.9 but GdnHCl 
used for NaCl). E2/X 
fractions spun at 
1 2 0 0 0 0 g, 16h.
5 30mgPDC 1 % (w/v) trypsin, 5min, 2%
30°C; inhibited with 
1 0%(w/v) soyabean 
trypsin inhibitor then, as 
in 2 a).
Table 4.1.1.1 Purification table of E2/X core preparations
C om ponen t
composit ion
E2, X
El (reduced) 
E3 (reduced)
E2, X
El (reduced) 
E3 (trace)
E2, X 
E3 (trace) 
El (trace)
E2, X 
El (trace)
E3 (no trace)
E2, X, E3 
El (reduced)
E2, X
E3 (reduced) 
El (reduced)
E2, X
El (reduced) 
E3 (trace)
27K fragment of E2 
30K fragment of X 
El & E3 (no trace)
The summarised results of five separate E2/X core purification procedures 
are presented detailing conditions used; descriptions of the purity of each E2/X 
core isolate, and % recoveries.
with column separation (Table 4.1.1.1, treatments 1 & 2), yields were considerably 
higher, although clearly reflecting greater contributions to total core protein from 
contaminating El and E3. Replacement of NaCl with the chaotroph, guanidinium 
chloride, resulted in a similar pattern of E1/E3 release to that of condition lb  (see 
treatment 4). Furthermore, tryptic degradation of intact PDC for the purpose of 
removing, or disrupting, the subunit binding domains of E2 and X, and thereby 
causing complete E l and E3 dissociation, respectively, resulted in further 
complications involving yield, solubility and detection of the truncated core samples. 
Thus, the standard E2/X isolation procedure of section 2.2.9 (Table 4.1.1.1., 
treatment 2 a), with additional salt treatment and centrifugal fractionation (treatment 
2b), produced the purest samples of E2/X core where all traces of E3 and the 
majority of E l were successfully removed. Yet the extremely poor yields following 
both procedures remained problematic, discouraging the additional purification step 
of 2b and hence, all E2/X purifications employed in this thesis followed the method 
outlined in section 2.2.9.
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4.2 RESULTS
4.2.1 Preliminary research into the isolation of a C- 
terminal peptide of protein X containing an 
acetyltransferase active site motif
The surprising discovery of an acetyltransferase active site-like sequence 
motif within the C-terminal domain of protein X, as determined through nucleotide 
sequence analysis of a partial cDNA clone isolated from a human hepatoma Xgt 11 
expression library screened with protein X specific antiserum (J.C. Neagle, 
University of Glasgow, unpublished results), necessitated further attempts to verify 
the identity of the cDNA clone and the proposed active site motif within. Direct 
analysis, shown here, involved N-terminal amino acid sequencing of the extreme C- 
terminal portion of protein X in which, if present, would reside the acetyltransferase 
active site motif.
Isolation of the C-terminus relied upon extensive tryptic degradation of both 
E2 and X and the assumption, based on probability, of there being no trypsin- 
accessible lysine or arginine residues between the active site motif and the C- 
terminus, nor at the C-terminus itself. Fulfillment of these requirements would then 
enable purification, on immobilised anhydrotrypsin, of the C-terminal peptides of E2 
and X which, would fail to bind to the modified matrix by virtue of the (presumed) 
absence of a C-terminal lysine or arginine residue. Anhydrotrypsin is a catalytically 
inert derivative of trypsin, in which the active site s e r in e ^  has been converted to 
dehydroalanine, which selectively binds under weakly acidic conditions peptides 
with arginine, lysine or, S-amino-ethyl cysteine at the C-terminus. Hence, the
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former would elute immediately leaving the latter tightly bound until addition of 
elution buffer and the alteration of the pH would facilitate dissociation. In addition, 
in the unlikely possibility of a C-terminal lysine/arginine residue on X, digestion of 
E2/X by chymotrypsin would result in peptides ending in tyrosine, tryptophan, 
phenylalanine or, methionine and, therefore, only the C-terminal peptides of X 
would adsorb to the matrix. Owing to constraints upon time, only preliminary data 
were obtained for direct sequencing and this is presented as follows.
4.2.1.1 Establishing optimal conditions for extensive tryptic 
degradation of isolated E2/X core
To enable efficient N-terminal amino acid sequencing, it was necessary to 
generate short (10-30 amino acid residues; Mr 1100-3100) C-terminal peptides, 
containing the proposed active site sequence. As rapid and extensive degradation 
requires initial unfolding of the proteins in conditions in which they are maintained 
in a soluble state, a range of denaturing conditions was employed including 3-6M 
urea, TCA precipitation (see Fig. 4.2.1.1.1), and brief heat treatment at 65-100°C 
(results not shown).
Following overnight treatment of native E2/X core with 1% (w/v) trypsin at 
37°C (Fig. 4.2.1.1.1; lane 1), both E2 and X were substantially cleaved, with 
34000, 22000 and 18000-Mr (E2 derived), and 29000-Mr (X derived) fragments 
remaining, and evidence of low Mr fragments (<15000), at the gel front (see Neagle 
et al., 1989). Further degradation of the E2 component to the 22000 and 18000-Mr 
fragments (identified through immunological screening), was obtained with 3-6M 
urea (diluted to a compatible 2M prior to the addition of trypsin), indicating some
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Figure 4.2.1.1.1 Analysis of SDS-PAGE resolved E2/X core samples
following overnight treatment with 1% (w/v) trypsin at 37°C, under  
various conditions
Samples of E2/X core (diluted to 0 .4m g.m H  in 0.1M NH4 HCO 3 buffer, 
pH 8  containing 0.1 mM CaCl2 ), were treated to denaturing conditions (sample 2: 
3M urea, 30min; sample 3: 6 M urea, 30min; sample 4: TCA precipitation). Buffer 
was then added to dilute urea to 2M, and pellets resuspended prior to overnight 
incubation with l% (w /v) trypsin (diluted in buffer) at 37°C (conditions 1-4). 
Control, undigested samples were included to assess non-specific degradation 
(conditions 5 & 7), loss in yield from TCA precipitation (6 ), and autolysis of 
trypsin ( 8  & 9) where overnight incubations were omitted for conditions 7 and 9. 
E2/X core (15pg) and trypsin (lOpg) were then resolved by 8 % (w/v) SDS-PAGE 
as shown and stained with Coomassie Blue. Lane M, low Mr marker proteins 
( x l O - 3).
increased accessibility due to unfolding (lanes 2 & 3). Notably, although the 
proteolytic resistance of the contaminating E3 traces was not affected by the presence 
of urea, TCA precipitation resulted in the successful cleavage of both E3 and the 
E2/X core to fragments <10000-Mr, with only traces of the 29000-Mr protein X- 
derived Xj fragment evident (lane 4).
From comparison of conditions 5, 6  and 7 it is clear that whilst no non­
specific degradation of the core samples occurred with overnight incubation at 37°C 
(condition 5), approx. 50% loss in yield resulted from problems with solubilisation 
of the protein pellet obtained by TCA precipitation, despite overnight resuspension 
in 0.1M NH4HCO3 buffer. Equally efficient proteolysis coupled with smaller 
losses in yield, due to a more easily solubilised pellet, followed denaturation at 
100°C for 5min (results not shown). Finally, although trypsin exhibited minor 
autolysis even in the presence of 0.1 M CaCl2 , the undesirable presence of low levels 
of such proteolytic products, was outweighed by the improved degradation achieved 
with a second 1% (w/v) addition for a further lh  incubation, following overnight 
treatment. Hence, the standard method for maximum tryptic degradation listed in 
section 2.2.15 and employed in section 4.2.1.2, combined heat denaturation and 
treatment with 1+1% (w/v) trypsin at 37°C.
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4.2.1.2 Preliminary isolation of the C-terminal peptides of E2 and 
X employing a specialised anhydrotrypsin column
Following elucidation of the optimal conditions for maximal tryptic 
degradation, trial separations of the resulting peptides on a pre-packed immobilised 
anhydrotrypsin column were carried out as described in the accompanying mannual, 
but with the modifications listed in section 2.2.15.
Fig. 4.2.1.2.1 illustrates one such elution profile of approx. 140jig of 
tryptically degraded E2/X core, from which fractions were collected and sent to the 
SERC-funded Protein Sequencing Facility at Aberdeen University for further 
purification by reverse phase micro-bore HPLC. Samples were also collected 
following proteolysis, both before and after precipitation of insoluble material and, 
following column resolution, for analysis on a silver stained 15% (w/v) SDS-PAGE 
gel (not shown). These results suggested that while extensive tryptic degradation 
had occurred as previously noted, significant levels of the partially digested 29000 
and 15000-Mr (protein X), and 27000 and 18000-Mr (E2 derived), fragments 
remained -  although, subsequently substantially precipitated by a brief spin in a 
benchtop Eppendorf microfuge. Of more concern however, was the considerable 
accompanying removal of peptides <14000-Mr as evidenced, by a similar reduction 
in the level of silver stained protein migrating at the gel front. Nevertheless, it is 
possible that while some peptides of Mr 10000 were precipitated, smaller fragments 
remained in solution but, due to their relative size and quantity, were not easily 
visualised by silver stain.
Indeed, unlike the immediate elution of non-adsorbed peptides in peak 1 
(fractions 2-4), including the 29000, 27000, 18000 and 15000-Mr fragments of E2
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Figure 4.2.1.2.1 Elution profile of tryptically  degraded E2/X core
peptides from an anhydrotrypsin column
Purified E2/X core (100pg, 2 .8m g.m H ) denatured, degraded and diluted 
as described in section 2.2.15, was briefly spun in an Eppendorf microfuge to 
pellet insoluble material, and 500jil (~37pmoles), analysed on anhydrotrypsin 
resin. 1ml fractions were analysed at 280nm. Arrows indicate changes in column 
buffer used (1st & 3rd arrow — binding buffer; 2nd arrow — elution buffer).
and X, and traces of undigested E3 (E2/X from the standard procedure of section 
2.29 exhibited minor E3 contamination), no protein bands were apparent on the 
silver stained gel in samples taken from the second peak (fractions 9-11). In 
contrast, the elution of adsorbed peptides was signified by a small peak, and the 
predominance of the 18000-Mr peptide of E2, with traces of peptides <14000.
Peak fractions 2 and 9 (200pl each), were then subjected to reverse phase 
micro-bore HPLC analysis which resulted, in each case, in one major and 6-7 minor 
peak fractions (currently being sequenced in Aberdeen) — clearly reflecting the 
incomplete proteolysis of the E2/X core and minor E3 contamination.
It is possible that improvements in the preparation of the trypically digested 
core could result in cleaner elution profiles and ultimately, less follow-up work. Of 
major concern were the relatively low yields of tryptic peptides generated. Whilst 
the manufacturer recommended a starting sample concentration of lOmg.ml-1 
followed by a 1:20 (v/v) dilution in binding buffer to give 250pg of protein in 500pl 
(or, as exemplified, 20nmoles of ribonuclease), PEG concentration of the E2/X core 
isolate from volumes of 10-20ml to 0.5ml gave maximal concentrations of 2- 
4mg.mH E2/X (see section 2.2.9). Furthermore, dilution in binding buffer at a 
reduced 1:10  (v/v) ratio, in order to maintain concentrations, may have proved 
counterproductive owing to the subsequent precipitation of insoluble material -- 
probably resulting from the hydrophobic nature of the C-terminal regions of E2 (and 
possibly X). This, combined with the large Mr of E2/X core of 3.6 x 106, resulted 
in a maximum loading of 26-37pmoles of digested core onto the anhydrotrypsin 
column. However, attempts to produce more E2/X and therefore increase the final 
concentration, were unsuccessful with poorer column resolution accompanying the 
dissociation of larger quantities of PDC (i.e., 50-100mg).
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The solution may lie in the combination of several samples of E2/X core, 
precipitated through treatment at 65°C, rather than 100°C, with removal of the 
supernatant, prior to the addition of a small but sufficient volume of incubation 
buffer containing 1% (w/v) trypsin. This would achieve both the efficient removal 
of contaminating E3 (soluble by virtue of its heat stability), and further concentrate 
E2/X allowing the recommended 1:20 (v/v) dilution in binding buffer ~  possibly 
also resulting in improved solubility. Adoption of the above improvements in a 
second attempt to isolate the C-terminal peptides of E2 and X will depend upon the 
outcome of the aforementioned amino acid sequencing, and the re-examination of the 
241 nucleotide protein X clone (J.E. Rice, University of Glasgow). However, if 
problems with insolubility persist, due to the hydrophobic nature of the C-terminal 
region of E2 (and maybe of X), identification by this method may remain difficult. 
In this regard, employment of a molecular approach in the verification of the origin 
of the cDNA clone may prove more successful (see Chapter 6 ).
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4.2.2 Investigation of a putative catalytic role for 
protein X employing selective proteolysis of E2 or X in 
conjunction with N-ethyl[2,3-'|4C]maleimide labelling
4.2.2.1 Establishing optimal conditions for maximal E2 and 
minimal protein X cleavage in the presence of collagenase
To investigate the proposed involvement of protein X in overall complex 
catalysis, initial work centred on reproducing the findings of Rahmatullah et al. 
(1990), and thereby establishing optimal conditions for the controlled maximal 
removal of the lipoyl and adjoining linker region of E2, in isolated E2/X core, by 
collagenase, in the absence of similar protein X degradation. This is possible since 
collagenase only cleaves at a specific tetrapeptide sequence, “Pro Leu Gly Pro”, 
which occurs only once in E2, and presumably, not at all in protein X (minor 
additional proteolysis by a contaminating protease was noted with some preparations 
of collagenase -- Rahmatullah et al.y 1990).
In bovine kidney E2/X core isolates, Rahmatullah et al. (1990) employed 
either, 20% (w/v) collagenase over lOmin or, 2% (w/v) over 90min, at 30°C. 
However, the former condition was found to result in unfavourable protein X 
degradation and thus, Fig. 4.2.2.1.1 illustrates the results of a 60min incubation at 
30°C with 10% (w/v) collagenase. The gradual loss in reconstituted PDC activity to 
approx. 20% (Fig. 4.2.2.1.1b) appeared to mirror the gradual cleavage of intact E2 
until less than 5% remained (Fig. 4.2.2.1.1c; as determined through densitometer 
scanning of the Coomassie blue stained gel shown in Fig. 4.2.2.1.1a). A plot 
correlating one with the other, revealed a similar, although less marked, pattern to
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Figure 4.2.2.1.1 Effect of co llagen ase  treatment of purified E2/X on
its ability to reconstitute overall PDC activity
Freshly isolated E2/X core (lmg.ml'1) diluted in 50mM Tris/HCl 
buffer, pH 7.5, containing 2mM CaCl2 , 3mM NAD+, 0.5mM MgCl2 and 
0.2mM TPP was treated with 10% (w/v) collagenase (preincubated with 2mM 
CaCl2 at 30°C for lOmin), over 60min at 30°C, and at the intervals shown, 
aliquots (80pl) removed to 3mM EGTA at 4°C and 20j±l portions preincubated 
at 30°C for lOmin with E1/E3 in the presence of Soln A and B prior to 
measurement of reconstitution by the direct removal of aliquots (5pl) to pre­
equilibrated assay mixtures. The remaining solution (60pl) was then removed 
to Laemmli sample buffer and used for subsequent SDS-PAGE analysis and 
antibody screening. A control, undigested sample was treated likewise.
a) illustrates the successive cleavage with time of the lipoyl domain of 
E2 in isolated E2/X core following 10% (w/v) SDS-PAGE and Coomassie 
blue staining, (lane M, low Mr marker proteins; PDC, 10pg purified bovine 
heart PDC; E2/X, 5pg loadings where C6o represents control undigested 
samples; lane C, collagenase; E 2 l  represents the released lipoyl and linker 
regions, and E2i, the truncated subunit and catalytic domains).
b) illustrates the loss in reconstitution resulting from the successive 
cleavage of intact E2 over 60min. The % complex activity reconstituted was 
calculated as specific activity from duplicate results of < 10% difference as 
described in section 2 .2 .1 0 , where ( •— •) represents 1 0% (w/v) collagenase
treated reconstituted activity, and (o- -o) control, undigested reconstituted 
activity.
c) illustrates the results of densitometer scans at 550nm of intact E2 
and X from Coomassie stained gels as described in section 2.2.4d, where 
('- -#) represents intact E2, and (•--•) intact protein X peak areas (arbitrary 
units).
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that presented by Rahmatullah et al. (1990), whereby the release of E2 lipoyl 
domains initially exceeds that of complex activity loss (results not shown), 
suggestive of the active site coupling demonstrated in ox heart PDC by Stanley et al. 
(1981).
Through N-terminal amino acid sequencing and E1/E3 binding assays, 
Rahmatullah et al. (1990), identified the site of collagenase cleavage at the N- 
terminus of the El binding domain. Thus, the cleavage of intact E2 is revealed by 
the appearance of the released lipoyl and linker region and, the truncated inner 
catalytic and subunit binding domains of E2 on SDS-PAGE, represented by E 2l 
(39000-Mr) and E2j (33000-Mr), respectively (see Fig. 4.2.2.1.1a). Extension of 
the incubation period by a further 30min ensured the complete removal of all E2 
lipoyl domains, characterised by the presence of a basal level (i.e., 10-15%) of 
reconstituted PDC activity apparently, protein X lipoyl domain-mediated.
In close agreement, Lawson et al. (1991b) found gene deletion of the lipoyl, 
plus or minus, linker regions; or, substitution of the essential lipoic acid attachment 
site lysine47, resulted in the retension of 12-15% complex activity — deemed, in the 
presence of intact protein X and fully functional acetyltransferase activity, to 
represent servicing of the E2 active site by the lipoyl domains of protein X. In 
addition, while Rahmatullah et al. (1990) observed a residual 8 % activity, this was 
clearly a reflection of the partial insolubility of the truncated E2/X, as addition of 
heparin resulted in both improved solubility and reconstitution (i.e., 1 2 %). 
However, in the absence of relevant figures, this may also have resulted from minor 
protein X degradation. Of note, solubility problems were not encountered here 
under the different buffer conditions used.
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4.2 .2 .2  Analysis of reconstituted PDC activity during the 
sequential digestion of components E2 and X by collagenase 
and Arg C
In section 4.2.2.1, the optimal conditions for the complete removal of intact 
E2, by collagenase, were established whereby, following a 90min incubation with 
10% (w/v) collagenase at 30°C, a residual apparently X-mediated 10-15% complex 
activity remained. This assumption was then verified by the analysis of component 
E2 and X degradation, and the resultant loss in reconstituted activity during the 
sequential digestion of isolated E2/X core employing 12% (w/v) collagenase, then 
3% (w/v) Arg C.
As in Fig. 4.2.2.2.1, the characteristic decrease in reconstituted PDC activity 
(here to a residual 15%), was observed upon the digestion of more than 98% of 
intact E2 (as determined through densitometric scan analysis of Coomassie blue 
stained gels and immunoblots) over 60min. Equivalent analysis suggested only 
minor protein X degradation comparable to that of the control sample; however, 
following addition of 3% (w/v) Arg C, immunological screening and silver stain 
analysis of 10% (w/v) SDS-PAGE resolved samples (results also not included), 
revealed the rapid cleavage of the majority of protein X-derived lipoyl domains (i.e., 
within 2 0 min), accompanied by an equally rapid decline in reconstituted activity to 
3% — apparently complete within 60min. Further cleavage of E2, by Arg C, was 
not observed. Notably, little difference was observed between the two control, non- 
Arg C treated samples, suggesting that extended treatment with collagenase results in 
insignificant protein X degradation (supported by immunological evidence). Taken 
together, these results provide further support for the presence of X-mediated PDC 
activity.
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Figure 4.2.2.2.1 A n alys is  of reconstituted  PDC activity during the  
s u c c e s s iv e  treatment of Isolated E2/X core with co llagenase  and Arg C
Isolated E2/X core (lmg.ml"1) was treated with 12% (w/v) collagenase 
over 60min at 30°C, as described in Fig. 4.2.2.1.1, a control undigested sample 
included and subsequent analyses of components E2 and X carried out as listed 
therein. Where (•-•) represents % PDC activity reconstituted with 12% (w/v) 
collagenase treatment, and (o- -o) represents % PDC activity reconstituted with 
undigested core. After 60min, the collagenase treated sample was removed to ice, 
split into three equivalent samples and the following additions made: A: (•-•) no 
further addition; B: (A- -A ) 3mM EGTA; C: (A— -A) 3mM EGTA, 5mM MgCl2 , 
3% (w/v) Arg C. All three were then placed at 30°C (indicated by arrow) and the 
% reconstitution (determined from duplicates of <10% difference and calculated as 
in section 2.2 10), and E2 and protein X degradation monitored as before.
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4.2.2.3 Analysis of the involvement of components E2 and X, in 
intact or reconstituted complex activity, following treatment with 
proteases, collagenase and Arg C; determ ination of 
substrate/NADH induced incorporation of N -ethyl[2,3-14C] 
maleimide
Following observations of an X lipoyl domain-mediated residual PDC 
activity from bovine sources both here and elsewhere (Rahmatullah et al., 1990), 
and from S. cerevisiae (Lawson et al., 1991b), analysis of the intimate component 
interactions in both protease treated and untreated, intact and reconstituted bovine 
heart PDC were carried out employing fluorographic visualisation of N-ethyl[2,3- 
14C]maleimide ([2,3-14C]NEM), incorporation in the presence of substrates -  
pyruvate, acetyl CoA and NADH. Details of the five separate conditions used — run 
simultaneously for both control and digested samples, are listed in section 2.2.14b.
Preliminary studies of [2,3-l4C]NEM incorporation, employing untreated 
intact complex at various concentrations, confirmed the findings of Hodgson et al. 
(1986), whereby component E2 and X incorporation was dependent upon the 
presence of pyruvate or NADH and, where prior incubation with acetyl CoA and 
NADH led to a time-dependent diminution in the extent of radiolabelling. As these 
results were not included this is best exemplified by the control sample of intact PDC 
in Fig. 4.2.2.3.3. Hence, whereas incubation with [2,3-14C]NEM in the absence of 
all other substrates resulted in the prominent labelling of thiols of accessible cysteine 
moieties in E l (Eip exhibited variable modification — see Fig. 4.2.2.3.1; the reason 
for this is unclear); simultaneous incubation with pyruvate, led to the reductive 
acetylation of the S^-thiols and [2,3-14C]NEM modification of the adjacent, reduced 
S6-thiols of the lipoyl domains of E2 and X and was therefore, indicative of normal
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E1/E2 interactions. Upon NADH preincubation, greater modification by [2,3-14C] 
NEM was observed, due to the availability of both reduced S6 ,S8-thiols. However, 
prior addition of acetyl CoA resulted in a dramatic diminution of radiolabel through 
competition, initially (i.e., 60s) for one thiol and, over longer preincubation (i.e., 
60min) for both thiols, demonstrating both the S6 ,S8-diacetylation properties of E2 
and protein X (believed to be unique to mammalian PDC -- Hodgson et al., 1986), 
and normal E2/E3 interactions. Notably, minor modification of the active site thiols 
of E3 followed addition of [2,3-14C]NEM in the presence of NADH, under which 
conditions, such thiols would be reduced.
Analysis and comparison of complex functioning and hence, component 
interactions, following the removal of the majority of the lipoyl domains of E2 in 
intact (Fig. 4.2.2.3.1), reconstituted (Fig. 4.2.2.3.2) and intact-column resolved 
complex (Fig. 4.2.2.3.3) were then carried out, as described in the next section.
a) Collagenase treated complex
From Figs. 4.2.2.3.1-2 it is clear that the reduction in intact and 
reconstituted complex activity to approx. 2 0 % of the to activity was accompanied by 
the cleavage of the vast majority of intact E2 components (a trace of E2 can be seen 
in lanes 2 & 3). Notably, following the release of the lipoyl and linker regions 
(labelled in Fig. 4.2.2.3.1 as E2l; and co-migrating with E lp  in Fig. 4.2.2.3.2), 
intact protein X continued to exhibit pyruvate (lane 2) and, NADH (lane 3) 
dependent incorporation and, acetyl CoA-related diminution of radiolabel (lanes 4 & 
5), in the collagenase treated complex, suggestive of functional interactions with El 
and E3. In addition, a similar pattern of [2,3-14C]NEM modification was seen with
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Figure 4 .2 .2 .3 .1  F lu orograp h ic  a n a ly s is  of [2, 3-1 4 C ] N E M
modification of co llagen ase  treated and native bovine heart PDC
Sepharose CL-2B purified intact bovine heart PDC was diluted to 
2 mg.ml_1 and treated to a monitored 10% (w/v) collagenase digest at 30°C over 
80min, as described in Fig. 4.2.2.1.1. Following addition of EGTA on ice, 
control and digested complex were found to be approx. 84% and 20% active, 
respectively, and both were then treated with [2,3-14C]NEM as described in 
section 2-2- 14b. Lane 1, lOmin preincubation at room temperature with 
0.85mM[2,3-14C]N^M; lane 2, 0.85WV1 [2,3-14C]NEM added prior to 4mM 
pyruvate and incubated for lOmin; lane 3, lOmin preincubation at room
i
temperature with 0.2mM NADH, followed by incubation with 0.85mM [2,3- 
14C]NEM for a further lOmin; lane 4, lOmin preincubation at room 
temperature with 0.2mM NADH, lmin with 0.4mM acetyl CoA, followed by 
incubation with 0.8Sn^vl [2,3-14C] NEM for a further lOmin; lane 5, as in lane 
4, but with acetyl CoA incubation extended for 60min. Labelling was 
terminated by addition of 45mM 2-ME, the samples prepared in Laemmli 
sample buffer lacking DTT, and warmed to 70°C for 2min prior to resolution 
of 80pg samples by 10% (w/v) SDS-PAGE. The position of low Mr marker 
proteins is also shown.
Figure 4 .2 .2 .3 .2  F lu orograp h ic  a n a ly s is  of [2 ,3 -1 4 C ] N E M
m odification  of c o l la g e n a s e  treated and control, recon st itu ted  
bovine heart PDC
Freshly isolated E2/X core and E1/E3 were analysed for optimal 
reconstitution prior to the monitored digestion of the former employing 1 0% 
(w/v) collagenase over 60min at 30°C, as described in Fig. 4.2.2.1.1. Control 
undigested sample was included, and both treated with 5mM EGTA on ice, 
prior to reconstitution with E1/E3 (to give approx. lmg PDC), in the presence 
of Soln A and B (see section 2.2.10). Values for % reconstitution were 85% 
and 20% of the original to value for control and digested PDC, respectively. 
[2,3-14]NEM incorporation was then carried out as described in section 
2.2.14b. A description of lane conditions is given in Fig. 4.2.2.3.1 but, 40pg 
PDC loaded per track.
Mr
(x10
Mr
( x 1 0 ‘3)
1 2 3 4 5  1 2 3 4 5
U n trea ted  in tac t  10% C o l la g e n a s e
PDC tre a ted  in tac t PDC
9 4  —
67 —
43 —
—  E2
—  E3
E 1 u  
’  E 1 p
30 —
1 2 3 4 5  1 2 3 4 5
U n t r e a t e d  10%  C o l l a g e n a s e  t r e a t e d
r e c o n s t i t u t e d  PD C  r e c o n s t i t u t e d  PD C
the released lipoyl and linker regions of E2 and X (resulting in the latter case, from 
low level collagenase degradation). The latter domain migrated with the gel front 
and also appeared to exhibit substrate-independent labelling (lane 1), suggestive of 
either additional modification of cysteine-derived thiols -- exposed through the action 
of collagenase or, of co-migrating low Mr species.
At this point it was unclear whether the characteristic labelling of the clipped 
lipoyl domains indicated a direct participation in PDC functioning or, indirect 
interactions with the active sites of the E l, E3 and truncated E2 components. 
Transformation of PDC-deficient mutant E. coli strains with two plasmids — one 
encoding E2 lipoyl domain-depleted complexes, and the second, encoding discrete 
lipoyl domains, have demonstrated only low level complementation, suggestive of 
either the inability of untethered lipoyl domains to invade assembled complexes or, 
of only low affinity interactions between the two (Guest et al., 1989). Indeed, 
following complete cleavage of intact E2 with 10% (w/v) collagenase (as seen by the 
disappearance of a Coomassie stained band and corresponding radiolabel at 72000- 
Mr), and removal of the clipped lipoyl domains by resolution on a Superose 6  
column (see Fig. 4.2.2.3.3 legend for details), the residual complex activity and 
substrate-dependent [2,3-14C]NEM incorporation observed clearly resulted from 
protein X-mediated complex activity. Furthermore, as the total yield and % recovery 
following column treatment, was identical for both control and treated complex, no 
additional decrease in complex activity appears to have occurred upon removal of the 
lipoyl domains of E2, in agreement with the findings of Rahmatullah et al. (1990) 
and Lawson et al. (1991b). Hence, whilst the released E 2 l fragments may interact 
and thereby participate in the partial reactions of the collagenase treated core and 
associated E l and E3 components, this does not appear to contribute to the overall 
extent of complex activity. Although some loss in [2,3-14C] NEM modification was 
apparent in the fluorograph shown here, equivalent labelling was repeatedly obtained
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Figure 4.2.2.3.3 Fluorographic analysis of [2 ,3-14C] NEM modification  
of collagenase treated and native bovine heart PDC subjected to gel 
filtration on Superose 6
Two 5mg samples of Sepharose CL-2B column purified bovine heart PDC 
were treated at 30°C over 90min — one, in the presence of 10% (w/v) collagenase, 
as described in Fig. 4.2.2.1.1. Following addition o f 5mM EGTA at 4°C, both 
samples were subjected to resolution on a 100x1cm Superose 6  column (flow rate 
lm l.m n r1), by which,separation of the clipped lipoyl domains of E2 was achieved 
(as determ ined through A280> E3 and PDC activity elution profiles). Column 
buffer contained 0.1M  NaCl, and peak fractions corresponding to the resolved 
complexes were pooled for subsequent [2 ,3-14] NEM incorporation as described 
in section 2.2.14b. A description of lane conditions is given in Fig. 4.2.2.3.1 but 
50jig of PDC loaded per track.
for control and collagenase treated complex (results not shown). In addition, an 
increase in substrate-independent [2,3-14C]NEM modification of all components, 
especially E3, was noted both here and with reconstituted complex (see Figs. 
4.2.2.3.1 & 4.2.2.3.3), and was presumably the result of mild dissociation and 
exposure of active site thiols following high salt and column treatment
Thus in conclusion, the results presented here provide strong support for the 
proposed servicing of the active site of truncated E2 by the lipoyl domains of protein 
X and therefore, the ability of this component to maintain complex activity at a 
residual level. In addition, normal protein X diacetylation is demonstrated in the 
absence of intact E2, indicating independence from the lipoyl domains of E2 in this 
latter process.
b) Arg C treated complex
In Chapter 3, it was observed that, following removal of the lipoyl and linker 
regions of protein X, loss in reconstituted PDC activity resulted from the proposed 
disruption to the exposed E3 binding domain of truncated protein X and, the 
accompanying reduction in E3 binding potential. Furthermore, as partial recovery of 
complex activity in the presence of excess porcine E3 was found to increase with 
increasing protein X degradation, this was thought to reflect enhancement of a low 
affinity binding of E3 to the subunit binding domain of E2 or of X.
Thus, in light of the possible involvement of E2 in E3 binding, and of the 
proposed role of protein X in the downstream channelling of reducing equivalents 
from E2 to E3 (Rahmatullah et al., 1990), it was of interest to observe [2,3-14C]
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Figure 4.2.2.3.4 Fluorographic analysis of [2,3-14C] NEM m odification  
of Arg C treated and native bovine heart PDC
Freshly prepared bovine heart PDC was diluted in Soln A and treated to 
6% (w/v) Arg C, as two 3% (w/v) additions at 0 and 60min, over 120min at 30°C. 
Activity was assayed, and protein X degradation m onitored by im m unological 
screening, until the majority of intact protein X had been cleaved and 25% of PDC 
activity remained. Control PDC, incubated for the equivalent time, exhibited 85% 
activity. To both, 5mM benzamidine was added, at 4°C, prior to [2 ,3-14] NEM 
incorporation, as listed in 2.2.14b. A description o f lane conditions is given in 
Fig. 4.2.2.3.1 and 80pg of PDC loaded per track.
NEM incorporation of E2, in both intact and reconstituted complex, following the 
extensive and complete removal, respectively, of the lipoyl and linker regions of 
protein X by Arg C.
In agreement with Chapter 3, the discrete degradation of protein X in intact 
complex by Arg C, was not possible in the absence of minor E2 proteolysis and Fig. 
4.2.2.3.4, illustrates the results of an incubation over 120min at 33°C with 3+3% 
(w/v) Arg C. Here, cleavage of the majority (i.e., 85%) of protein X, as determined 
by immunological analysis and, from the low level of [2,3-14C]NEM incorporation 
at the 50000-Mr position in Fig. 4.2.2.3.4, was accompanied by an approx. 75% 
loss in activity (in agreement with the findings of section 3.4.2) and, the apparent 
low level release of the 46000-Mr fragment comprising the lipoyl, linker and El 
binding domain of E2  (designated E 2 b l  or» E 2 l  in Fig. 4.2.2.3.4). These were 
subsequently degraded to an 39000-Mr lipoyl and linker fragment (E 2 l  or, E 2 l * in 
Fig. 4.2.2.3.4), in agreement with iRahmatullah et al. (1989a, 1990). These latter 
lipoyl-containing species, together with the released lipoyl and linker regions of 
protein X, exhibited pyruvate (lane 2) and NADH (lane 3) induced [2,3-14C]NEM 
incorporation and, an acetyl CoA-linked reduction in [2,3-14C]NEM modification 
(lanes 4 & 5) identical to that observed in section 4.2.2.3a yet, presumably in the 
absence of the majority of bound E3. Once again, evidence of substrate-independent 
[2,3-14C]NEM modification is apparent with the released lipoyl domains of protein 
X (compare lane 1 from Figs. 4.2.2.3.1-4).
In consideration of the results obtained in section 4.2.2.3a, it seems unlikely 
that the released lipoyl domains of either component E2 or X participate directly in 
overall PDC activity. However, whilst a small number of protein X molecules 
remained intact, it was unclear whether the residual complex activity also resulted 
from the low affinity binding of E3 to the subunit binding domain of E2 and hence,
133
Figure 4.2.2.3.5 Effect of Arg C treatment of purified E2/X core on its 
ability to reconstitute overall PDC activity
E2/X core, diluted to 1ml in Soln A (0.2mg.ml_1), was incubated at 
33°C with 3% (w/v) Arg C over 90min, and at the times shown, aliquots (50pl) 
removed to 5mM benzamidine on ice prior to a lOmin preincubation at 33°C with 
E1/E3 at a ratio by weight of 1:0.8 (E2/X:E1/E3). The % reconstitution was then 
determined by direct assay at 340nm (see sections 2.2.10-11). The remaining 
E2/X core was then diluted in Laemmli sample buffer for subsequent resolution 
on 10% (w/v) SDS-poylacrylamide gels, and immunological analysis with anti- 
X, E2 and El a  specific sera.
a) illustrates the loss in reconstituted PDC activity, with time, following 
the progressive cleavage of protein X by Arg C.
b) illustrates immunological analysis of the E2/X core with anti-serum 
specific to protein X, during incubation with Arg C. The cleavage of intact X 
(50000-Mr), to a 35000-Mr subunit binding and inner core domain ( X i b ) , the 
released 15000-Mr lipoyl and linker regions (X l ) , and subsequently, to a 30000- 
Mr inner core domain (Xj), is shown. Lane M, low Mr marker proteins; lanes Cl 
& C2, duplicate control E2/X core samples incubated for 90min at 33°C in the 
absence of Arg C; lanes C3 & C4, duplicate control E2/X core samples incubated 
for 90min at 33°C in the absence of Arg C, and stored on ice for 60min.
c) illustrates an exposure from an immunoblot of the E2/X core with anti­
serum specific to E2, overlaid with anti-serum specific to El a. Lanes are defmed 
as in 4.2.2.3.5b.
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the downstream channelling of reducing equivalents by E2 to E3. To answer this 
question, complete Arg C degradation of intact protein X was carried out in isolated 
E2/X core, employing incubation with 3% (w/v) Arg C at 33°C over 90min during 
which, loss in complex activity was monitored, following reconstitution with E1/E3 
at a subunit stoichiometric ratio of 1:0.8 (E2/X:E1/E3) -- see section 2.2.10 and 
Chapter 3. Fig. 4.2.2.3.5a illustrates a typical plot of reconstituted activity loss, and 
from accompanying immunological analyses (see Fig. 4.2.2.3.5b & c), it is clear 
that the complete release of the lipoyl domains of protein X was achieved in the 
absence of significant E la  and E2 degradation, resulting in a residual 6 % of 
(apparently) E2 lipoyl domain-mediated complex activity.
Subsequent analysis of [2,3-14C]NEM modification in Arg C treated, 
reconstituted complex, following loss of approx. 90% of original activity, revealed 
an identical pattern of substrate-dependent E2 incorporation and diacetylation to that 
of untreated complex (see Fig. 4.2.2.3.6). Once again, complete protein X 
degradation, in the absence of similar E2 degradation, was evidenced by the absence 
of radiolabelled species at a Mr of 50000 (intact X), 46000 (E2bl) or 39000 (E2l).
Hence, assuming no involvement of the released lipoyl domains of protein X 
in complex activity, the residual 6-10% of reconstituted PDC activity observed in 
Figs. 4.2.2.3.5-6 would seem to reflect a low level of complex activity apparently 
independent of protein X lipoyl domain interactions and, presumably dependent 
upon a small number of E3 molecules, bound with low affinity to either, the 
truncated E3 binding domain of protein X or, the intact subunit binding domain of 
E2. Notably, little change in [2,3-14C]NEM modification of the active site (di)thiols 
of E3 was visible following Arg C treatment, suggesting no increase in exposure of 
these residues upon removal of the lipoyl domains of X (a small increase in [2,3- 
14C]NEM labelling was observed in Fig. 4.2.2.3.4 with Arg C treated intact
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Figure 4.2.2.3.6 Fluorographic analysis of [2,3-14C]NEM modification of 
Arg C treated and control, reconstituted bovine heart PDC
Identical samples of E2/X and E1/E3 prepared for Fig. 4.2.2.3.2 were used 
here whereby, complete removal of intact protein X was achieved with a 3% (w/v) 
Arg C digestion o f E2/X core in Soln A over 90m in at 33°C, until 10% 
reconstituted activity remained. Control and digested samples were then treated with 
5mM benzamidine at 4°C, and lm g of complex reconstituted from core and E1/E3 
fractions in the presence of Soln A and B at an E2/X:E1/E3 ratio o f 1:0.8 (w/w) 
(see section 2.2.10), prior to [2,3-14C]NEM treatment as described in 2.2.14b. A 
description o f lane conditions is given in Fig. 4.2.2.3.1, but 40pg of PDC loaded 
per track.
complex). As previously discussed in Chapter 3. support for the presence of a 
residual E2-mediated complex activity is provided by the findings of two 
independent clinical investigations of chronic lactic acidemia sufferers where, 
abnormally low levels of PDC activity were observed in the absence of 
immunologically detectable protein X (Robinson et al., 1990; Marsac et a l 1993).
4.3 DISCUSSION
Although the research presented in this chapter does not offer a definitive 
answer to the question of the existence of an acetyltransferase active site in 
mammalian protein X, support is provided for previous observations of a residual 
protein X-mediated complex activity in the absence of intact E2 from both 
mammalian (Rahmatullah et al., 1990), and yeast (Lawson et al., 1991b) PDC. 
Furthermore, confirmation and extension of the collagenase studies on reconstituted 
bovine kidney PDC of Rahmatullah et al. (1990), to include examination of 
component interactions, through [2,3-14C]NEM labelling in both intact and 
reconstituted complex, revealed the ability of the lipoyl domains of protein X to 
undergo diacetylation in the absence of the equivalent domain on E2.
In addition, following complete cleavage of the lipoyl domains of protein X 
in isolated E2/X core, by Arg C, and subsequent reconstitution with E1/E3, similar 
[2,3-14C]NEM modification studies indicated the presence of an exclusively E2 
lipoyl domain-mediated residual (i.e., 6 %) complex activity and, normal E2 
diacetylation. Hence, the ability of the lipoyl domains of either component to 
promote residual PDC activity in the absence of the other, was suggestive of a non- 
essential but rate-limiting involvement for both in overall complex catalysis. This is 
supported by the discovery of residual PDC activity (i.e., 10-20%), in the absence 
of immunologically detectable levels of protein X, in chronic lactic acidemia 
sufferers by Robinson et al. (1990), and Marsac et al. (1993). Further evidence is 
also provided by the gene deletion studies of Lawson et al. (199la,b) where a 
residual 15% and 6 6 % complex activity were measured for E2l" and X l" mutant 
S. cerevisiae cell lines, respectively. Loss of PDC activity in the latter case was 
thought, in Chapter 3, to partly result from a small yet significant reduction in E3
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binding not mentioned by the authors, but nevertheless notable from the evidence 
presented. However, some contribution could result from reduced catalytic 
efficiency. Furthermore, the disparity in the extent of restriction upon the overall 
rate of catalysis was reflected in the relative levels of PDC activity remaining. 
Clearly, if a direct result of the reduced number and/or (possibly) efficiency of the 
protein X-derived lipoyl domains in the servicing of the acetyltransferase active site 
of E2, in contrast to the non-limiting active-site coupling exhibited by the E2 
components, why has such activity remained intact in the face of evolutionary 
pressures? Hence, the question arises of whether the intrinsic potential of the lipoyl 
domains of protein X to undergo the various (de-, trans-) acetylation reactions of E2 
could be aj vestigial function, only expressed in the absence of competition from the 
equivalent domains of E2 or, a reflection of a low level participation in both up and 
downstream catalysis?
Examples of such apparendy superfluous activity exist elsewhere. Indeed, at 
first glance, the very nature of the lipoyl domains — varying in number across 
species and complex type and exhibiting active site coupling, suggests an intrinsic 
redundancy. For example, the apparently non-essential nature of two of the three 
lipoyl domains of E2 from E. coli PDC must confer some functional advantage in 
an organism so prone to rapid evolutionary change, where the potential for 
recombination/deletion in the tandemly repeated lip gene segments would be high 
(Graham et al., 1986). Whether the "excess" lipoyl domains function to enhance the 
conformational flexibility of the one catalytically involved lipoyl as proposed, is as 
yet unclear, and still leaves unresolved the essential question. Similarly, recent 
research now points to a specific kinase binding function (leading to enhanced 
kinase function), for one of the two lipoic acid moieties attached to the lipoyl 
domains of component E2 in mammalian PDC, although whether this is in addition 
to normal lipoyl functioning remains to be seen (Radke et al., 1993).
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It is possible that for protein X, the answer lies in the unique diacetylation 
properties of mammalian PDC whereby, during conditions of excessive lipid 
oxidation such as with mild starvation or diabetes, control of the [NADH]:[NAD+] 
ratio could be facilitated by the conversion of free acetyl CoA molecules to lipoic 
acid-bound acetyl groups. This would be accompanied by the reoxidation of NADH 
to NAD+ and hence, inhibitory levels of both acetyl CoA and NADH would be 
removed from the cytosol. Thus, the ability of both protein X and E2 to undergo 
diacetylation increases the buffering potential of PDC from a theoretical 132 to 264 
acetyl groups per PDC molecule. Following stabilisation of the [NADH]:[NAD+] 
ratio to a level favouring PDC activity, these acetyl molecules would then be 
channelled to the TCA cycle and metabolised to generate energy. In the absence of 
any published evidence supporting the existence of an acetyltransferase active site 
sequence in protein X, it seems likely that such diacetylation and subsequent 
deacetylation would occur via transacetylation with E2.
Notably, as published evidence of acetylation studies in S. cerevisiae PDC 
are not available, proof for catalytically active lipoic acid moieties on protein X does 
not exist, which together, with the presence of a single lipoyl domain on E2 and, the 
apparent absence of diacetylation in PDC from this species, may point to the 
additional utilisation of acetyl CoA molecules in the glyoxylate pathway. 
Futhermore, whilst the lipoyl-like sequence at the N-terminus of E l from bovine 
heart OGDC retains the ability to bind E3, in the absence of a catalytic requirement 
for this segment, no evidence for acetylation nor a lipoic acid attachment site exists 
(Rice et al., 1992).
Owing to problems with insolubility, attempts to isolate and sequence the C- 
terminal portion of protein X, and thereby confirm the findings of J.C. Neagle of an 
active site-like “Glu His Xaa Xaa Xaa Ser Gly” sequence within a partial cDNA
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clone (encoding the inner catalytic domain of human protein X and, also found to 
exhibit 70% homology to the equivalent region of the protein X gene from S. 
cerevisiae), remained in the initial stages. However, amino acid sequence analysis 
of the major tryptically-derived fragments of E2 and X, purified by anhydrotrypsin 
resin and subsequent HPLC analysis (B. Dunbar, SERC Protein Sequencing 
Facility, Aberdeen University); and, re-examination of the nucleotide sequence of 
the cDNA clone (J.E Rice, University of Glasgow), are currently underway and 
may provide further insight into the proposed catalytic role of protein X.
Following inference of the active site consensus sequence of 
chloramphenicol acetyltransferases by comparison to that of other acetyltransferases 
(Guest, 1987), and the proposed catalytic role of His602 an(i His375 of E2 from 
PDC and OGDC of E. coli, respectively (Spencer et al., 1984); amino acid 
alignments have revealed the characteristic "His Xaa Xaa Xaa Asp Gly" motif in 
aminoglycoside acetyltransferases and, all dihydrolipoamide acetyltransferases 
sequenced to date. Furthermore, although substitution of the consensus site 
histidine residue in E2 from E. coli PDC (Russell & Guest, 1990), and in E2 from 
bovine B CO ADC (Griffin & Chuang, 1990) resulted in loss of complex activity — 
apparently supporting the proposed catalytic involvement in the nucleophilic attack 
of CoA on S8-acyldihydrolipoamide; substitution of His427 within the truncated 
catalytic domain of E2 from S. cerevisiae PDC, whilst overexpressed in E. coli, had 
no affect on overall activity. In contrast, substitution of Asp431 (equivalent to 
Asp 199 from chloramphenicol acetyltransferases and believed to be involved in 
structural stability) to asparagine, alanine or glutamate resulted in a 16, 24 or 
approx. 4-fold reduction in complex activity, respectively, which was proposed as 
evidence for involvement of Asp431 in catalysis (Niu et al., 1990).
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Whilst this apparent difference in the catalytic importance of the putative 
active site residues in yeast is disputed by J.R. Guest (University of Sheffield, 
personal communications), who points to incomplete substitution of the His427 and, 
interference from the imidazole buffers used, as possible solutions, it also questions 
the functional plausibility of an active site sequence for mammalian protein X in 
which the highly conserved aspartate is replaced by serine. Examination of the 
nucleotide composition of all the degenerate codons for either residue, reveals that 
this non-conservative substitution from an acidic to a neutral yet hydrophilic 
molecule, requires the alteration of the first two determining base pairs in any triplet 
code. When viewed in light of the dramatic 16-fold decrease in PDC activity 
following a similar substitution of Asp431 in E2 from S. cerevisiae PDC to the 
neutral amide derivative, asparagine, such findings do not offer much support for 
the presence of dihydrolipoamide acetyltransferase activity in protein X.
However, an explanation could lie in the mistaken inversion, during the 
deduction of the nucleotide sequence from sequencing gels, of the first two base 
pairs of the aspartate-encoding triplet (GAU/C), which resulted in one of the 
following serine codons (AGU/C). Alternatively, the presence of a serine residue 
may be indicative of a catalytic role distinct to that of E2 — the nature of which 
remains unclear.
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RESULTS CHAPTER 5:
Stoichiometry and organisation of the protein 
X subunit of bovine heart PDC
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5.0 INTRODUCTION
Since the identification and characterisation of component X as a distinct 
polypeptide, related to the E2 component (De Marcucci et al., 1985), knowledge of 
its multi-domain structure has progressed rapidly, derived from deacetylation/ 
acetylation studies in combination with various proteolytic and N-terminal amino 
acid sequencing investigations (De Marcucci & Lindsay, 1985; De Marcucci et al., 
1986; Hodgson et al., 1986; Jilka et al., 1986; Neagle et al., 1989). In contrast, 
relatively little information has arisen concerning the subunit stoichiometry and 
detailed structural organisation of protein X within the E2 core, primarily owing to 
problems encountered in the isolation of intact native subunit, free of contaminating 
dihydrolipoamide acetyltransferase.
De Marcucci & Lindsay (1985), noted that the dissociation of bovine heart 
PDC into the constituent components, E l, E2 and E3, following treatment with 
0.25M MgCl2 (or 1M NaCl at pH 9.5), and separation by high pressure gel 
permeation on a TSK G3000 SW column (or employing Sepharose CL-6 B), was 
not accompanied by dissociation of protein X from the E2 core. Furthermore, 
subsequent treatment with the chaotrophic reagent, p-hydroxymercuriphenyl 
sulphonate, failed to remove protein X whilst causing the dissociation of the tightly- 
bound intrinsic PDC kinase. Indeed, as a result of this tight association, and 
consequent copurification, initial reports of the presence of an additional species of 
50000-Mr in preparations of porcine liver PDC, bovine heart PDC and core, and 
S. cerevisiae E2 core assemblies of PDC, misidentified protein X as a proteolytic 
fragment of E2 or, the core-bound kinase (Stanley & Perham, 1980; Bleile et al., 
1981; Rahmatullah etal., 1984,1985; Kresze eta l., 1980a, 1981).
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To date, the isolation of protein X has only been possible under denaturing 
conditions such as: 6 -8M urea; sodium dodecyl sulphate-PAGE (De Marcucci & 
Lindsay, 1985); or, by reverse phase HPLC employing a trifluoroacetic 
acid/acetonitrile gradient as detailed initially by Jilka et al. (1986).
In the quantification of protein X, Jilka et al. (1986) employed the above 
isolation techniques in the construction of a calibration curve relating various 
amounts of SDS-PAGE resolved bovine kidney PDC and protein X isolates, to the 
resultant absorbance of the silver stained bands, as determined through densitometric 
gel scanning. An estimate of 5mol protein X/mol bovine kidney PDC was 
calculated, and (apparently) substantiated by the determination, through E2 and X 
acylation in isolated core or complex samples employing [l-14C]acetyl CoA, [1-14C] 
propionyl CoA, [l-l4 C]butyryl CoA and [2-14C]pyruvate, of an average acylation 
ratio of 10:1 (E2:X).
As isotopic dilution analysis indicated the presence of a single lipoyl moiety 
in mammalian E2 (Cate & Roche, 1978; White et al., 1980), a ratio of 10:1 (E2:X) 
pointed to 6  molecules of protein X per molecule of complex. In contrast, a similar 
yet less detailed study of 14C-acetylation in bovine heart PDC, employing [2-14C] 
pyruvate, noted that protein X incorporated 14-18% of that bound by E2 which, in 
line with the estimate of one lipoyl domain per E2 chain, suggested 8-12 molecules 
of protein X per PDC molecule (De Marcucci & Lindsay, 1985). However, 
subsequent sequencing of a cDNA clone of human PDC E2 by Thekkumkara et al.
(1988), confirmed the existence of two lipoyl domains per E2 molecule, proposed 
by Hodgson et al. (1988), through covalent crosslinking studies of the lipoyl 
domains of E2 in bovine heart PDC. Hence, assuming equal rates and extent of 14C 
incorporation, a ratio of 1:10 and a percentage incorporation of 14-18% would 
indicate 12 and, 16-24 molecules of X, respectively.
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The question then arose, of how these protein X molecules would arrange 
within the E2 core whilst maintaining icosahedral (532) symmetry. In other words, 
is protein X an essential, integral core component, substituting for E2, and bound 
during assembly or, an external component bound after assembly is complete.
Initial investigations of Hodgson et al. (1988), involving careful molecular 
weight analysis and immunological screening of SDS-PAGE resolved samples of 
substrate-induced N,N’ 1,2-phenylene-dimaleimide (PDM) crosslinking of the lipoyl 
domains of E2 and X in bovine heart PDC, revealed the presence of X/X and E2/X 
dimers and an E2/E2/X trimer, pointing to close interactions between the lipoyl 
domains of both adjacent protein X and E2 molecules. However, the binding of 
radiolabelled protein X-specific antiserum to native PDC discounted the possibility 
of an entirely internalised protein X and indicated a peripherally extended and 
therefore, accessible region, such as the lipoyl domain (Hodgson et al., 1988).
In agreement, the isolation of active E2 core samples in the absence of 
protein X, suggests protein X is not an integral constituent of the dodecahedral core 
structure. For example, through the overexpression of the inner core domain of 
S. cerevisiae dihydrolipoamide acetyltransferase in E. coli, Niu et al. (1990), 
demonstrated self-assembly of a truncated yet active E2 core of apparent wild type 
core (532) symmetry, as determined by negative stain and cryoelectron microscopy 
(Stoops et al., 1992). In addition, in bovine heart PDC, Powers-Greenwood et al.
(1989), employed denaturing conditions to remove protein X from an active E2 core 
sample.
Further support for a partially accessible protein X, not involved in core 
assembly, came from the gene deletion experiments of Lawson et al. (1991a) where 
disruption of the protein X gene (PDX1), in S. cerevisiae resulted in a fully
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functional E2 core. Furthermore, transformation of these mutant cells with a single 
or multi-copy plasmid containing the PDX1 gene, resulted in fully active complexes 
with equivalent protein X incorporation, suggestive of a limited number of binding 
sites. Indeed, in support of Jilka et al. (1986), differences in the sedimentation 
coefficients of the wild type and protein X-deficient PDH complexes were consistent 
I with the absence of six E3 dimers and six protein X molecules. However, only
j
| partial reconstitution of complex activity (i.e., 2 0 % of wild type), was achieved
i employing PDX1 null mutant E2/E1 core, recombinant yeast E3 and a crude isolate
i
; of protein X produced by the overexpression of the PDX1 gene in mutant
II
| S. cerevisiae cells. Clearly such poor recovery could be a reflection of either a core
|
| integrated protein X or, simply limitations in the concentration of this species within
| the crude extract.
iti
i
| In apparent opposition, Li et al. (1992), argued that the inability to facilitate
the additional binding and/or exchange, of free protein X molecules for bound 
molecules, in various E2 core preparations of bovine kidney PDC, indicated a tight, 
irreversible integration during core assembly — in direct contrast to kinase, which 
exhibited reversible binding. In addition, Li et al. (1992), proposed that the partial 
reconstitution of S. cerevisiae PDC upon incubation of the mutant E2/E1 core with 
i E3 and X (Lawson et al.t 1991a), could result from partial core disassembly,
i
followed by protein X binding and reassembly and therefore, did not exclude the 
possibility of an integrated protein X. Equally however, the results of Li et al.
| (1992), could simply reflect: partial inactivation of both the E2 and X components in
the regions involved in binding; traces of mercurial reagents in the protein X
| preparation; or, inadequate reconstitution conditions such as, component
|
! concentration, and the temperature and length of preincubation.
|[
[
i
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Incidental information obtained from the recent sizing of frozen hydrated 
bovine heart and kidney PDC and E2 core (to 50-60nm and 20nm, respectively) by 
cryoelectron microscopy (Wagenknecht et al., 1991), and quaisielastic light 
scattering (Roche et al., 1993), indicated a uniform core distribution of protein X 
and, in conjunction with an equivalent study in E. coli (Wagenknecht et al., 1992), 
revealed variable positioning of the E3 component. In light of the confirmed E3 
binding function of protein X (see Chapter 3), and the postulated flexible tethering 
of E3 to the E2/X core (Wagenknecht et al., 1991), these results apparently dispute 
the face-centred model of E3 binding proposed by Reed & Hackert (1990), and 
further complicates the elucidation of the organisation of protein X within the core 
assembly. In this regard, future cryoelectron microscopic images of E2/X cores 
containing bound antibody specific for the inner domain of protein X provide a 
promising approach to further advances in the understanding of E2/X core 
organisation (Wagenknecht etal., 1991).
The work presented in this chapter represents a comprehensive investigation 
into the quantification and organisation of protein X from bovine heart PDC. 
Quantification involved the application of similar l4 C-acetylation experiments as 
those outlined previously by Jilka et al. (1986) and De Marcucci & Lindsay (1985). 
Furthermore, in the absence of published data concerning the quantification by 
densitometric scan analysis of silver stained SDS-PAGE resolved protein X and 
PDC samples by the former group, a more detailed analysis is described herein. 
Structural studies employed NADH-induced PDM crosslinking of protein X lipoyl 
domains in E2 lipoyl domain-depleted complex, following selective proteolysis by 
collagenase; and further proteolytic studies using ArgC.
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5.1 METHODS
5.1.1 Isolation of a purified protein X polypeptide by 
electroelution following resolution of E2/X core by SDS-PAGE
The first step in the quantification of protein X from bovine heart PDC 
involved the isolation of a highly purified preparation from a sample of E2/X, 
previously isolated by the routine dissociation of Sepharose CL-2B column-purified 
PDC using 2M NaCl at pH 9, followed by resolution by gel filtration (see sections 
2.2.8-9 for details). Analytical SDS-PAGE (7-8% (w/v) gels) were employed in the 
dissociation of the E2/X sample and gave maximum separation of protein X from 
traces of E3. In addition, the standard 20-well stacking gel was replaced to give one 
large (500pl) capacity well for loadings of lmg, with an additional marker protein 
track.
The resolved protein bands were visualised by a non-fixative Q 1CI2 stain, as 
transparent regions within an opaque blue background. The band corresponding to 
protein X was then carefully excised by scalpel, sacrificing yield for ensured purity, 
fragmented to 0.5cm2 and destained in 0.25M Tris/HCl buffer pH 9, containing 
0.25M EDTA. Following re-equilibration in 25mM Tris/192mM glycine/0.025% 
(w/v) SDS, the gel pieces were then transferred to a Biotrap apparatusjimmersedin 
elution buffer, and the negatively charged proteins electroeluted into a minitrap 
compartment (positioned at the anode) over 16-18h at 100V, 4°C (see section 2.2.6 
for details).
147
Sample purity was analysed by Coomassie blue stained 8 % (w/v) SDS- 
polyacrylamide gels, and the protein concentration determined in quadruplicate by 
both the micro BCA and modified Lowry protein assays (see section 2.2.1), 
following dialysis into a compatible 50mM sodium phosphate buffer, pH 7, 
containing 0.5% (w/v) Triton X-100. As care was taken during excision of the 
protein bands to ensure purity, recoveries were typically low (i.e., 40-50%). 
Several unsuccessful attempts to establish a more accurate protein concentration 
through the precise determination of amino acid content (B. Dunbar, SERC Protein 
Sequencing Facility, Aberdeen University), were precluded by insolubility resulting 
from the necessary exclusion of various buffers and detergents. Samples were 
stored at -20°C in the presence of 0.5% (v/v) Triton X-100 to maintain solubility.
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5.2 RESULTS
5.2.1 Quantification of the subunit stoichiometry of 
protein X in bovine heart PDC
5.2.1.1 Quantification of protein X  by densitometric scan 
analysis of SDS-PAGE resolved, silver stained X standards and 
comparison with the equivalent band in highly purified PDC
To determine the exact number of protein X molecules per PDH complex, 
calibration curves were constructed in which the absorbances of various standard 
protein X samples were related to the relative amounts of protein loaded (typically, 
0.05-lpg). From this, and the absorbances of the equivalent bands in various 
known duplicate loadings of purified PDC, the approximate quantities of protein X, 
in jig, were extrapolated. These were then expressed as a % of the total complex 
protein (in jig), and compared to those predicted, from the Mr values, for the 
presence of 6-12mol protein X/mol PDC.
Preliminary studies employing 10% (w/v) SDS-PAGE resolved Coomassie 
blue stained PDC (10-40pg) and (0.5-3jig) protein X revealed the need for increased 
resolution of the E3 and X components, in combination with reduced loadings, and 
an alternative more sensitive stain. Henceforth, 2.5-10pg of PDC and 0.05-lpg of 
protein X, were routinely resolved by 7-8% (w/v) SDS-PAGE and stained with the 
modified silver stain method of Wray et al. (1981).
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Figs. 5.2.1.1.1-3 demonstrate one of five separate calibration curves (each 
comprising several scans), which were constructed from four independent PDC and 
two protein X preparations — the results of which are summarised in Fig. 5.2.1.1.4.
Fig. 5.2.1.1.1 clearly illustrates both the successful isolation of highly 
purified protein X and PDC (minor contamination by high Mr species was observed 
with the lOpg loading), and the improved component staining and resolution 
achieved with silver stained 7-8% (w/v) SDS-PAGE gels — exemplified by the clear 
visualisation of the 46000-Mr and 43000-Mr subunits of PDC kinase (i.e., above 
E l a). High contrast between background and band staining resulted in two 
densitometer scans (for convenience only one is shown — see Fig. 5.2.1.1.2), of 
high peak resolution and little base-line drift. From each, a plot was constructed 
relating integrated peak area to the amount of protein X loaded in pg (see Fig. 
5.2.1.1.3). In agreement with Jilka et al. (1986), non-linear relationships were 
consistently obtained, indicating a degree of saturation in the band staining 
intensities. However, assuming equivalent rates of saturation for protein X in the 
isolated and complex samples, and by employing several samples of protein X and 
PDC, extrapolation of the results from the full length of each calibration curve would 
account for inaccuracies associated with decreased sensitivity.
Close duplicate protein X peak absorbances, differing by less than 5%, were 
obtained for the various loadings of purified complex. Direct extrapolation of five 
peak absorbances from both calibration curves resulted in an averaged estimate of 
13.7±0.8mol protein X/mol PDH complex. Similar values were obtained from four 
separate calibration curves which are summarised in Fig. 5.2.1.1.4. In direct 
contrast to the findings of Jilka et al. (1986), of 4.8-5.3mol protein X/mol bovine 
kidney PDC, the evidence presented here strongly suggests the presence of approx. 
12 molecules of protein X per molecule of bovine heart PDC. Since protein X is
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Figure 5.2.1.1.1 Analysis of purified protein X and bovine heart PDC
by SDS-PAGE
Standard protein X (0.2mg.ini'1), and duplicate PDC (19.5mg.ml'1), 
preparations were diluted in Laemmli sample buffer to 0.02mg.ml_1 and 
0 .5 m g .in i'1, respectively. Following brief treatment at 100°C in sealed 
Eppendorfs (to reduce evaporation), 2.4-47.6pl samples of protein X and, 6-18pl 
of the PDC duplicates were loaded on 8 % (w/v) SDS-polyacrylaminde gels to 
give the protein amounts shown. Electrophoresis was carried out at 40mA to 
prevent curvature of peripheral bands, and once complete, the gel soaked in 50% 
(v/v) methanol for 24h prior to silver staining (see section 2.2.4).
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Figure 5.2.1.1.2 Densitometric scan  analys is  of SDS-PAGE resolved,
silver stained protein X bands shown in Fig. 5.2.1.1.1
Densitometric scanning of the silver stained gel described in Fig. 
5.2.1.1.1, employed a Shimadzu FDU-3 dual wavelength flying spot gel scanner 
in transmission mode at 600nm which was shown to give minimum background, 
and maximum band absorbance (variation in the wavelength used resulted from 
variable background staining). The standard parameters for silver stained gels 
listed in the user manual were adhered to except where: pK = 125; drift line = 0- 
0.5; smoothing = off. Gels were scanned several times with slight alteration in 
beam mode (linear or zigzag), and size to obtain both optimum resolution and 
band coverage. Accordingly, one of two scans, using a linear beam of 0.5 x 
5mm, is shown here. Peaks 1-10, represent the protein X calibration curve of 
0.05-lpg; peaks 11-15, represent duplicate loadings of 3, 6  & lOpg.
4.0 -I
3.0 "
o
x
CO$
CO
•X
COa>
CL
T3a>
2.0 -
2cn©c
0.8 -
0.6 -
0.4 -
0.2  -
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
C om ponen t X (pig)
Figure 5.2.1.1.3 Correlation between band absorbance at 600nm and
the amount of protein X
The integrated peak area (in arbitrary units), calculated for each band 
absorbance, was plotted against the relevant amount of protein X resolved, in pg, 
and used as a standard calibration curve in the determination of pg of protein per 
pg of complex and hence, calculation of the number of protein X subunits per 
complex.
PDC (pg) Protein X N° of N° of protein X
(ng) sc a n s subunits / com j
error.
5.0, 10.0 0.05-1.0 4 12.8 ± 0 .5  : 1
20.0, 30.0 0.10-2.5 2 13.0 ± 2 .4 :  1
(12.8 ± 2 .3  : 1 )
2.5, 5.0, 7.5 0.05-1.0 2 13.8 ± 2.0 : 1
(13.9 ± 1.3 : 1)
2.5, 5.0, 7.5 0.05-1.0 2 12.0 ±  0.9 : 1
3.0, 6.0, 10.0 0.05-1.0 2 13.7 ± 0 .8  : 1
Figure 5.2.1.1.4 Estimation of protein X subunit sto ichiom etry from
five independent determ inations
Data represent the results of five independent evaluations employing four 
PDC and two protein X preparations. Duplicate quantities of PDC analysed (pg): 
the range of the calibration curves employed (pg): the number of scans taken for 
averaging and, the moles of protein X per mole of complex calculated, are 
shown. Bracketed values represent additional information determined from 
individual scans of component bands (see Fig. 5.2.1.1.5).
known to be directly involved in the binding of the six homodimers of E3 to the 
E2/X core in mammalian and yeast PDC (Rahmatullah et al., 1989b; Lawson et al., 
1991a), it seems unlikely that such disparity would result from differences in bovine 
tissue. Equally, if correct, the different methods of protein concentration 
determination employed, are unlikely to result in a two fold disparity (the procedure 
of Fried et al., 1985, was used by Jilka et al., 1986). As with all three protein 
assays, significant deviation from the BSA calibration curve through variable lysine 
(Fried), or tyrosine and tryptophan (Lowry/BCA -- latter also, cysteine and cystine) 
content of the sample protein remain possibilities and therefore, potential sources of 
error. However, in light of the scant information provided by Jilka et al. (1986), 
beyond that several silver stained aliquots of protein X (i.e., a range of 7-28ng), and 
PDC (i.e., 30.6-612ng) were analysed by densitometer scans, and in the absence of 
any accompanying illustrative figures indicating amongst many important factors, 
sample purity, further discussion of the observed discrepancy is difficult.
Fig. 5.2.1.1.5 illustrates additional scans, from a different calibration curve 
to that shown, carried out to assess variations in band staining intensity between 
individual components within and/or across duplicate PDC loadings. Independent 
scans of each component from duplicate 5 and 7.5jig loadings of PDC differed by 
approx. 10% indicating good reproducibility in loading and staining. Similarly, a 
constant peak ratio of 1: 0.4 : 0.2 : 0.6 : 0.9 (E2 : E3 : X ; E la : Elp), was obtained 
in individual scans of duplicate 5 and 7.5ng PDC loadings which, assuming 
consistency in staining and, taking into consideration component molecular mass 
and stoichiometry, corresponds well with the staining profile of bovine heart PDC of 
1: 0.21 : 0.19 : 0.83 : 0.71 (E2 : E3 : X : E l a : Elp), with the exception of E3 (and 
Elp), which show disproportionately heavy staining. Although rough estimates of 
the number of protein X molecules per molecule of PDC (derived from the direct 
expression of integrated peak area for protein X, as a % of the total peak area of a
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Figure 5.2.1.1.5 A sse ssm e n t  of reproducibility in loading and staining  
of protein bands
a) One of four control scans of duplicate loadings of 5 & 7.5|ig of PDC showing 
all 5 component absorbances which yielded a peak ratio of 1:0.4:0.2:0.6:0.9 
(E2:E3:X:Ela:Elp).
b) Control scan of the E2 band from duplicate loadings of 5pg (lanes 1&2), and 
7.5pg (lanes 3&4), of PDC. Equivalent scans of E3, X, E la , E lp were also 
carried out (results not shown).
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given PDC sample), correspond closely to that determined from the calibration 
curves (Fig. 5.2.1.1.4 — bracketed figures), the enhanced E3 and Elp silver staining 
exemplifies the potential for inaccuracy in such a direct determination.
The 10-20% error quoted in Fig. 5.2.1.1.4 suggests a range of 11-15 
protein X molecules/PDH complex and apparently reflects cumulative error 
originating from inaccuracies in protein determination, sample dilution, pipetting, 
graph construction. However, subsequent statistical analysis employing a Minitab 
programme and the additive linear model, gave a mean value of 13.410.4, with a 
95% probability of the true number of protein X molecules lying within two 
standard errors (ie., ± 0.8), of this mean (Tom Aitchison, Dept, of Statistics, 
University of Glasgow). The higher estimate of 13.4mol X/mol PDC may be due to 
variable occupancy of E l and E3 binding sites in individual PDC preparations 
resulting from minor component dissociation, and leading to errors in Mr 
calculations. An internal control, involving quantification of the E2 component, was 
carried out to further assess the degree of inaccuracy involved.
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5.2.1.2 Quantification of E2 by densitometric scan analysis of 
SDS-PAGE resolved, silver stained E2 and PDC samples -  an 
internal control
To verify the accuracy of the above method in the quantification of 
component X from bovine heart PDC, calibration curves of Biotrap-purified E2 
were also constructed, and the stoichiometric ratio of E2 in PDC extrapolated, from 
the absorbances of the equivalent bands in silver-stained samples of highly purified 
complex. Knowledge of the stoichiometry, structure and organisation of the E2 core 
of mammalian PDC was initially gained through : the negative stain electron 
microscopic images of Oliver & Reed (1968, 1982), Junger & Reinauer (1972); 
molecular mass determination (Bleile et al., 1981; reviewed by Perham, 1991); and, 
later verified by the cryoelectron microscopic and quasielastic light scattering studies 
of bovine heart and kidney PDC (Wagenknecht et al., 1991; Roche et al., 1993), 
together with additional information from equivalent electron microscopic analyses 
of S. cerevisiae PDC by Niu et al. (1990), and Stoops & Reed (1992). These 
studies indicated a core of 60 E2 components possibly arranged as cone-shaped 
trimers along the twenty vertices of a pentagonal dodecahedron of icosahedral (532) 
symmetry. Thus, comparison of the results obtained here with the predicted 
stoichiometry of 60 E2 molecules/PDH complex would reveal the degree of accuracy 
associated with this method of quantification.
Several E2 calibration curves were constructed employing identical 
component isolation, complex purification, silver staining and scanning procedures 
as detailed for protein X. Figs. 5.2.1.2.1-2 illustrate one of 5 separate scans at 
450nm, and the resultant calibration curve from a silver stained gel of 0.2-2pg E2 
and 1.5, 2.5 and 5pg of PDC (gel not shown). As before, good peak resolution,
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Figure 5.2.1.2.1 Densitometric scan  of SDS-PAGE reso lved , s ilver  
stained E2 and complex sam ples
Densitometric scanning of the E2 component from isolated and complex 
samples resolved by 10% (w/v) SDS-PAGE and silver stained as described in 
2.2.4, employed a Shimadzu FDU-3 gel scanner at 450nm. Standard conditions, 
as outlined in the user manual were employed with the exceptions listed in 
Fig.5.2.1.1.2 and, with a linear 0.4 x 5 mm light beam.
Peaks 1-9, represent the E2 calibration curve of 0.2, 0.4, 0.6, 0.8, 1.0, 
1.2, 1.6, 1.8, and 2.0pg derived from loadings of 5-50pl of a 1 in 5 diluted E2 
sample (0.2mg.ini'1). Peaks 10-15 represent duplicate loadings of 1.5, 2.5 & 
5ng purified PDC (0.5mg.ini'1).
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Figure 5.2.1.2.2 Correlation between E2 band absorbance  at 450nm  
and the amount of E2
The integrated peak area (in arbitrary units) calculated for each band, was 
plotted against the relevant amount of protein resolved (in pg), and used to 
construct a standard curve for the quantification of the number of E2 subunits per 
PDC by the direct extrapolation of the amount of E2 present in each PDC sample 
(in pg), from the relevant E2 band absorbances.
with low base line drift and close duplicate values were obtained and an estimated 
61.5±9.8mol E2/mol PDC determined. Two additional calibration curves, 
constructed from different E2 and PDC preparations, gave values of 53.6±5.4 and 
69.8±4.2mol E2 /mol PDC (results not shown), which together, suggest a range of 
48-74 E2 molecules (i.e., 60±20% error). Such scatter was originally thought to 
result from poor resolution of the heavier and therefore, more diffuse band staining 
which accompanied a 5-fold increase in resolved protein in samples of 2.5-10jig 
PDC (compared to protein X). However, calibration curves constructed with 
reduced 0.1-l|ig and 0.5-2pg loadings of E2 and PDC, respectively, also exhibited 
the same degree of inaccuracy. Statistical analysis of this variance (Tom Aitchison, 
Dept, of Statistics, University of Glasgow), using the Minitab programme and the 
additive linear model employed in section 5.2.1.1, obtained a mean value of 
61.8±2.5mol E2/mol PDC, with a 95% probability of the true number of E2 
molecules lying within two standard errors of 61.8 (i.e., ± 5.0). This result is in 
close agreement with the proposed 60mer cores of icosahedral bovine heart PDC, 
although the larger standard error presumably reflects the inherent inaccuracies listed 
in section 5.2.1.1. Further analysis of protein X quantification was carried out 
employing 14C-acetylation of both the E2 and X components.
5.2.1.3 Quantification of protein X via measurement of 14C - 
acetylation of the lipoyl moieties of E2 and X
In contrast to the findings of Jilka et al. (1986), the results presented in 
section 5.2.1.1 point to the possible presence of 12mol protein X/mol bovine heart 
PDC. However, as this quantification procedure was subject to a 10-20% degree of 
error, an additional method for quantification was employed involving measurement
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and comparison of the incorporation of 14C-acetyl groups into both E2 and X 
components in the determination of an E2:X acetylation ratio. In this application, the 
elucidation of the precise level of component incorporation and hence, the exact 
substrate concentration is not necessary. In addition, and in contrast to the previous 
method, quantification of protein X here, is not subject to variable E l and E3 
occupancy within a given PDC preparation. For, assuming an equivalent rate and 
extent of incorporation for both components, the proportion of protein X to E2 and 
hence the estimated number of protein X molecules, can be determined.
This requires that all lipoyl domains of the assumed 60 E2 components and 
proposed 12 protein X molecules are fully and equally lipoylated, and therefore, all 
functional in the acetylation reaction. Supporting evidence includes : the observed 
formation of various PDM-crosslinked E2 species in bovine heart PDC, such as 
hairpins, trimers and tetramers, indicative of two functional lipoyl domains 
(Hodgson et al., 1988); the presence of an essential lysine in both lipoic acid 
attachment sites of E2 from human PDC (Thekkumkara et al.y 1988); and, the 
maintenance of PDC activity following the successive removal, through gene 
deletion, of two of the three lipoyl domains of E2 from E. coli (Guest et al., 1985), 
which were subsequently shown to exhibit indistinguishable acetylation (Graham et 
al., 1986).
From the results presented in Fig. 5.2.1.3.1, it is clear that for 0.25-ImM 
[2 -l4 C]pyruvate, and for 0.5mM [ l - l 4 C]acetyl CoA over 30min at room 
temperature, incorporation ratios of 9.2-8.2:l (E2:X), were obtained which, 
assuming full acetylation of the E2 lipoyl domains, suggests the presence of 13-15 
protein X molecules per PDC. In close agreement, Jilka et al. (1986), employing 
higher specific activity [2-14C]pyruvate (65-82mCi.pmol-1) at 20 or lOOpM 
concentrations over 20-600s at 30°C, observed a range of protein X incorporation of
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Figure 5.2.1.3.1a Summary of the 14C-acetylatlon of the lipoyl dom ains  
of co m p o n en ts  E2 and X from bovine heart PDC employing [2-14C]  
pyruvate and [1-14C] acetyl CoA
Presented are the results of four independent 14C-acetylation studies 
employing three PDC preparations. Control samples, lacking PDC were treated 
in an equivalent manner. In each case, purified PDC (l-4mg.ml_1), was 
preincubated for several minutes in buffer prior to acetylation by [2-14C] pyruvate 
or [1-14C] acetyl CoA as described in section 2.2.13. Concentrations of the 
radioactive substrates, PDC and, additional reagents are shown, as are the 
amounts of PDC, resolved by SDS-PAGE, from which the % 14C incorporations 
of the E2 and X components were calculated as listed.
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E2
40pg 1897.8 ± 13
40pg 1876.1 ± 130
80pg 3078.9 ± 56
80pg 3543.2 ±81
incorporation 
(E2 : X)
X
228 0 ± 20 8 .3 :1
206.8 ± 3 7  9 .1 :1
409.0 ± 20 7.6 : 1
468.6 ± 16 7.6 : 1
Figure 5.2.1.3.1b Detailed results of 14C-Incorporatlon of E2 and X of  
bovine heart PDC employing lmM [2-14C] pyruvate
An example of the levels of 14C-acetylation of the E2 and X components 
following treatment with lmM [2-l4C] pyruvate as outlined in Fig. 5.2.1.3.1a, is 
presented here as mean values of triplicate results from which averaged 
background counts were subtracted giving net values (± error) in cpm. 
Corresponding (E2:X) acetylation ratios are presented, for each loading of PDC. 
Mean background counts for loadings of 40 and 80pg PDC, were 108 and 
119cpm for E2 and, 90 and 93cpm for protein X -  accounting for 3-6% and 15- 
30% of the incorporation into E2 and X, respectively.
9.8-13.7% of that observed for E2 in bovine kidney PDC. In addition, under 
equivalent conditions but employing 20p.M [ l- 14C]acetyl CoA (150jiCi.nmol_1), 
similar protein X incorporations of 9.7-9.9% were obtained. Furthermore, 
maximum acetylation with [2-14C]pyruvate yielded 100-120 acetyl groups/mol of 
bovine kidney PDC of which, approx. 10 were accounted for by protein X 
incorporation.
Through densitometer scanning of silver stained gel samples of purified 
protein X and bovine kidney PDC, and in accordance with the above evidence, Jilka 
et al. (1986), argued for the presence of 5-6mol protein X/mol PDC, with two sites 
of acetylation per protein X molecule. However, following confirmation in 
mammalian PDC, of the presence of one lipoyl domain/protein X molecule and of 
two lipoyl domains/E2 molecule (De Marcucci et al., 1986; Hodgson et al.y 1988; 
Neagle et al., 1989; Thekkumkara et al., 1988), such an explanation would only 
hold true if S^,S8-diacetylation were limited to the single lipoyl moieties of protein 
X. Yet, in intact complex, diacetylation of protein X has only been demonstrated in 
the presence of equivalent E2 diacetylation (Hodgson et al., 1986) and in this 
respect, the maximum acetylation recorded by Jilka et al. (1986), falls far short of a 
theoretical incorporation of 264 acetyl groups/PDC molecule. Indeed, as the slow, 
secondary acetylation of S6 ,S8-diacetylation was only observed by Hodgson et al. 
(1986) over extended incubation (i.e., 5-60min), it is unlikely that diacetylation 
would occur with the relatively short incubations of Jilka et al. (1986), and hence, a 
protein X incorporation of approx. 10 acetyl groups would therefore support the 
estimate of 12mol protein X/mol PDC proposed herein.
The marginally higher protein X incorporation demonstrated here may 
reflect: differences in incubation length and temperature; concentrations and specific 
activities of the radioactive substrates; the corresponding concentration of TPP; or,
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the method of isolation and quantification of the 14C-acetylation of E2 and X. 
Notably, Jilka et al. (1986), demonstrated increasing inhibition of pyruvate-linked 
acetylation and increasing deacetylation of acetyl CoA-linked acetylation with both 
increasing incubation and TPP concentration, caused by the accumulation of side 
products and, the formation of 1-hydroxyethylidene-pyrophosphate on E l, 
respectively. Accordingly, levels of TPP were maintained at equivalent or reduced 
levels to that of substrate which here, were set above the optimum Km values. 
Slight inhibition of acetyl CoA-linked acetylation may also have resulted from the 
accumulation of CoA which may be overcome by the inclusion of residual OGDC 
activity (Cate & Roche, 1979).
In contrast, De Marcucci & Lindsay (1985), employing [2-14C]pyruvate 
(10.4mCi.mmoH), achieved a protein X incorporation of 16% that measured for E2 
however, this may simply reflect incomplete acetylation owing to problems 
associated with the relative abundance of TPP (0.2mM), in relation to pyruvate (0- 
5pM) — see Cate & Roche (1979). Nevertheless, it should be noted that (in the 
apparent absence of diacetylation), the maximum incorporation recorded by Jilka et 
al. (1986), still falls short of the potential acetylation of 132 lipoyl domains, and 
may therefore reflect a reduction in the number of functional lipoyl groups. 
Alternatively, this could reflect a problem of geometry where, as increasing numbers 
of lipoyl domains become irreversibly acetylated, accessibility of the remaining 
unlipoylated moieties to E l decreases. In apparent agreement, incomplete 
acetylation of the three lipoyl domains of E2 from E. coli PDC, has been repeatedly 
reported as an incorporation of 1.7-2 acetyl groups/E2 chain (see Graham et al., 
1986, for overview), although this was later disputed in the recent review of Perham 
(1991), which cited the observation of three fully lipoylated lipoyl domains in E2 
from E. coli PDC (Packman et al.y 1991) as an indication of previously incorrect 
determinations of reductive acetylation.
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Thus in conclusion, the work presented here, in conjunction with the 
quantification of protein X detailed in sections 5.2.1.1-2, appears to support the 
proposed presence of 12mol protein X/mol bovine heart complex.
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5.2.2 Organisational studies of protein X from bovine 
heart PDC
5.2.2.1 Organisational studies of protein X employing covalent 
N,N' 1,2-phenylene-dimaleimide (PDM) crosslinking of NADH- 
reduced lipoyl domains
Following the quantification of protein X from bovine heart PDC outlined in 
sections 5.2.1.1-3, an examination of the structural organisation of this component, 
within the E2 core of native complex, was carried out employing NADH-induced 
N,N'-l,2-phenylene-|dimaleimide (PDM) covalent crosslinking of the lipoyl 
domains of protein X in the absence of the equivalent domain on E2. This required 
pre-treatment with non-radioactive N-ethylmaleimide (NEM) which, by the direct 
modification of reduced thiols present on E l and E3, precluded substrate- 
independent crosslinking between these components and the lipoyl domains on 
protein X. The lipoyl domains of E2 were then removed by proteolysis with 10% 
(w/v) collagenase. NADH-induced PDM crosslinking of the remaining protein X- 
derived lipoyl domains was then carried out following the method of Hodgson et al. 
(1988), but with the modifications listed in section 2.2.12. In addition, control 
NADH and substrate-induced crosslinking of OGDC were included to reveal 
potential differences between single lipoyl domain crosslinking: where both S6 ,S8- 
thiols are reduced (NADH-induced); or, where the one thiol is acylated and the 
second remains reduced and therefore, available for modification by PDM 
(substrate-induced). Details of both PDC and OGDC crosslinking are given in 
section 2 .2 .1 2 .
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Figs. 5.2.2.1.1a-d illustrate the results of NADH-induced PDM crosslinking 
of the lipoyl domains of protein X in bovine heart PDC. In agreement with the 
findings of Rahmatullah et al. (1990), and of Chapter 4 (section 4.3.2.1), Fig. 
5.3.1.1a illustrates the gradual loss in complex activity which reached a plateau at a 
residual 20% and accompanied cleavage of the E2 component into an inner catalytic 
and subunit binding domain fragment of Mr 33000 and a released lipoyl and linker 
region of Mr 39000 (E2Lin Fig. 5.2.2.1.1b), following treatment with 10% (w/v) 
collagenase over 60min at 33°C. In the absence of intact E2 (see Fig. 5.2.2.1.2b), 
residual complex activity is presumably protein X lipoyl domain-mediated and this is 
discussed further in Chapter 4. Thus, further inhibition of the residual complex 
activity upon treatment at 30°C with a range of PDM concentrations (7.4-9.2pM), 
employed in the presence of 0.2mM NADH, for the determination of optimum 
NADH-induced crosslinking (Fig. 5.2.2.1.1c), resulted from modification and 
therefore, inactivation of the remaining protein X-derived lipoyl domains. Control 
crosslinking was also examined with 9.2pM PDM in the presence of NAD+, the 
results of which are illustrated in Fig. 5.2.2.1.1c.
Following resolution of the above samples by 8 % (w/v) SDS-PAGE and 
Western analysis, initial exposures of protein X crosslinking revealed a smear of 
immunoreactivity ranging from a Mr value of 100000 to 200000 (Fig. 5.2.2.1. Id; 
panel A, lane I5). Subsequent dilution of the specific activity of the 1.5pCi of 125I- 
labelled protein A used, by the addition of lOpg non-radioactive protein A, improved 
the signal/noise ratio and revealed the pattern of discrete bands shown in panel B 
(lanes I5, 2io, 330). A cluster of 4-5 bands of Mr 126000, 110000, 97-95000 and 
92000 were repeatedly visible upon PDM treatment of various collagenase 
preparations of PDC. In addition, two further, occasionally less visible, protein X 
species of Mr 82000 and >200000 were also noted. Whilst anti-E3 screening 
suggested the absence of crosslinked aggregates involving E3 (panel C, lane I5), El
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Figure 5.2.2.1.1a Loss in PDC activity following collagenase treatment
NEM pretreatment of a 2m g.m H  purified bovine heart PDC sample was 
carried out as described in 2.2.12 and all traces of unbound NEM  removed. 
Following 10% (w/v) collagenase treatment at 30°C, during which time digestion 
was m onitored by the rem oval o f aliquots for assaying and im m unological 
analysis, the sample was split into 4 x 100pg aliquots for subsequent NADH- 
induced crosslinking as described in section 2 .2 . 1 2 c.
(0 - -O) control; (•— •) 1 0 % (w/v) collagenase.
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Figure 5.2.2.1.1b W estern analysis of collagenase treated bovine  
heart PDC.
l|ig  samples of 10% (w/v) collagenase treated PDC were removed at the 
tim es shown and analysed by 8% (w/v) SDS-PAGE before im m unological 
screening with anti-E2 specific serum. W here, M represents low Mr m arker 
proteins; C60, control undigested complex incubated for 60min; and E 2 l ,  the 
released lipoyl and linker regions.
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Figure 5.2.2.1.1c L oss  in PDC activity following treatment with varying 
concentrations of PDM
Crosslinking of collagenase-treated PDC (see Fig.5.2.2.1.1a) was 
initiated by the addition of PDM at the following concentrations : 1, (□--□) 9.2pM
PDM; 2, (A-A) 8.5tiM PDM; 3, (■--■) 7.4pM PDM; 4, (A--A) 9.2pM PDM; in 
the presence of 0.2mM NADH (1-3) or, 0.2mM NAD+ (4) as described in 
section 2.2.12. Crosslinking was monitored by direct assay at 340nm (see 
2 .2 .10), and once < 1 0% of the original complex activity remained, was arrested 
by addition of 20mM 2-ME on ice.
Figure 5 .2 .2 . l . ld  Im m unological a n a ly s is  of NADH-induced PDM 
crosslinking in co llagen ase  treated PDC
PDM treated complex (4pg), previously modified with NEM and 
collagenase (see Fig. 5.2.2.l.la-b), was diluted in 20mM 2-ME and Laemmli 
sample buffer, and resolved by 8 % (w/v) SDS-PAGE. Formation of crosslinked 
products was analysed with anti-protein X serum (panels A & B), anti-E3 serum 
(panel C), anti-El serum (panel D) and anti-E2 serum (panel E). In panel A, 
immune complexes were detected with 125Iodinated protein A (1.5pCi), whereas, 
in panels B-E its specific activity was reduced by addition of lOpg of non­
radioactive protein A. Lanes denoted 1, 2, 3 represent crosslinking in the 
presence of 0.2mM NADH and 9.2pM, 8.5pM, 7.4pM PDM, respectively; and 
lane 4 represents control crosslinking with 0.2mM NAD+ and 9.2pM PDM. 
Varying incubation lengths (indicated by subcripts) reflect the time taken for 
>90% activity loss, and X0 denotes sample prior to addition of PDM. Lane M, 
low Mr marker proteins; OGDC, 05 pg of purified complex.
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specific antiserum detected a faint but similar banding pattern to that of protein X 
(panel D, lane I5). However, in contrast to the NADH-dependent appearance of 
crosslinked species in panel B, equivalent E l banding occurred in the presence of 
either NADH or NAD+, suggestive of incomplete modificationj by NEM resulting in 
the low level NADH-independent formation of crosslinks between the individual 
subunits of E l components.
Whilst the existence of PDM-crosslinked El/X species remains a possibility, 
this is not favoured by the absence of crosslinked protein X species in the presence 
of NAD+ (panel B, lane 4 2 5 ), under which conditions, the S6 ,S8-thiols would 
remain oxidised and therefore, unavailable for PDM modification. Finally, anti-E2 
screening revealed both the absence of intact E2, and any apparent involvement in 
protein X crosslinking (panel E, lane I 5). Notably, a strongly immunogenic 42000- 
Mr species, observed only in the presence of PDM and NADH, was thought to 
represent the released lipoyl domain of E2 modified by PDM and therefore 
exhibiting marginally slower mobility to that of the unmodified domain.
Although, Hodgson et ah (1988), cite the singular appearance upon substrate 
or NADH-induced crosslinking, of a 105000-Mr protein X dimer, the results 
presented here suggest the possible formation of 3-4 conformationally different 
protein X dimers of correspondingly altered mobilities (Mr 110000-92000), 
postulated in Fig. 5.2.2.1.2, to result from 2-3 different lipoyl-lipoyl, and/or one or 
more lipoyl-thiol cross reactions. Further support was gained through the 
appearance of a single crosslinked species of Mr 100000, upon resolution by the low 
resistance continuous phosphate-buffered gel electrophoresis system of Weber & 
Osborne (results not shown). However, the appearance of conformationally distinct 
X/X dimers may simply reflect increased interaction between the individual lipoyl 
domains of protein X in the absence of the equivalent E2 lipoyl domains, and thus,
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Figure 5.2.2.1.2 Schematic representation of proposed protein X
dimer conformations
Shown are schem atic representations o f various perm utations o f the 
proposed protein X dim er conform ation crosslinked by specific lipoyl/lipoyl 
interactions (num bered 1-3), or by non-specific lipoyl/th io l in teractions 
(numbered 4-5). Protein X is represented as in Fig. 3.2.2.5.1b, where the lipoyl 
domain is represented by hatched box; the essential lysine by L; the dithiolane 
ring of the attached lipoic acid moiety by Y; the E3 binding domain by a boxed 
E3; the C-terminal domain by an open box; and the flexible interdomain linkers by 
zig-zag lines.
may provide an explanation for minor discrepancies with respect to Hodgson et al.
(1988), in intact PDC.
In addition, it should be noted that the 110000-Mr species present in both 
anti-X and E2 blots in the absence of PDM was identified through direct comparison 
with purified OGDC (panel E), to be the E l component of this latter complex, 
known to exhibit minor crossreactivity with both aforementioned sera following the 
discovery of N-terminal lipoyl-like sequences (Rice et al., 1992). Upon addition of 
PDM, this band appeared more immunoreactive with protein X, but not E2 specific 
anti-sera suggestive of an X/X species of identical mobility.
Furthermore, whilst the evidence of panel E suggests the absence of E2/X 
crosslinking as expected, the minor 126000 and >200000-Mr species detected with 
anti-X serum, closely resemble a dimer and unspecified aggregate of E2 and X 
identified through immunological and Mr analysis by Hodgson et al. (1988). 
Alternatively, the high Mr species of 200000 could represent an aggregate of protein 
X (possibly of two protein X dimers), although this would require the involvement 
of both S6 and S8 thiols in the crosslinking of adjacent molecules (see later, Fig. 
5.2.2.1.3).
Lastly, the identity of the minor 82000-Mr species remains unclear, although 
this could represent a protein X dimer of particularly compact conformation and 
therefore, enhanced mobility or, protein X crosslinked to the released E2 lipoyl 
domains. However, in light of the strong immunoreactivity of this latter domain, the 
corresponding absence of a 82000-Mr species in panel E is not supportive.
Initial studies of both substrate and NADH induced PDM crosslinking of the 
single-lipoyl domain containing E2 components of OGDC were then performed to
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verify the observation of Hodgson et al. (1988) of a single E2 dimer of Mr 100000. 
As before, pretreatment with NEM was followed by incubation with PDM (5-15jiM) 
at 30°C in the presence of 2mM 2-oxoglutarate or, 0.2mM NADH, until less than 
10% of the original activity remained (results not shown). At this point, 
crosslinking was terminated by the addition of 20mM 2-ME, and samples resolved 
by 8 % (w/v) SDS-PAGE for subsequent screening with component specific 
antisera. Whilst the conditions used here differ from those of Hodgson et al. 
(1988), where a constant 7.5pM PDM concentration was employed at 21°C, under 
N2 , and crosslinlting initiated by addition of substrate, and not PDM; it is clear from 
the results presented (Fig. 5.2.2.1.3; panel A), that an increase in immunoreactivity 
at Mr 100000 followed either substrate or, NADH-induced crosslinking (compare 
lanes lo & 1 io and, 2q & 2io, respectively). Dilution of the 1.5p.Ci used, into lOjig 
of non-radiolabelled protein A improved the signal/noise ratio and crossreactivity of 
the E2 serum to the E l and E3 components (due to the presence of lipoyl-like 
sequences on the 96000-Mr E l component, minor crossreactivity remains), and 
revealed the presence of a discrete band at 100000-Mr (compare lanes lio  & 2io of 
panels A & B), not apparent in the presence of NAD+ (lane 32o)- Immunological 
analysis with sera specific for E l (panel C), and E3 (panel D) indicated no 
involvement in crosslinking although, PDM modification of E l appeared to result in 
increased immunoreactivity.
In addition to the findings of Hodgson et al. (1988), a faint doublet of 
approx. Mr 200000 was also detected upon anti-E2 screening of NADH-induced 
PDM crosslinked OGDC (panel E, lane 4is). Whilst the presence of an E2 dimer 
necessitates the crosslinking of either the S6 or S8-thiol on adjacent E2 components 
following substrate and NADH-induced crosslinking, the possibility of E2 trimers, 
tetramers etc., requires the involvement of both S6 and S8-thiols within individual 
lipoyl moieties. Indeed, in view of the growing evidence for trimeric E2
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Figure 5.2 .2 .1 .3  Immunological e v id en ce  for the production of 2-
oxoglutarate and NADH-induced PDM crosslinking in E2 of bovine heart 
OGDC
Purified OGDC (0.5mg.ml_1) previously modified with NEM, was treated 
to NADH or substrate-induced PDM crosslinking at 30°C, pH 7.5, as decribed in 
sections 2.2.12a-c, and 4pg samples removed to 20mM 2-ME in Laemmli sample 
buffer for resolution by 8 % (w/v) SDS-PAGE and subsequent immunological 
analysis with subunit-specific antisera. Formation of crosslinked products was 
analysed with anti-E2 serum (panels A, B & E), anti-El serum (panel C) and anti- 
E3 serum (panel D). In panel A, immune complexes were detected with 
125Iodinated protein A (1.5|iCi), whereas, in panels B-E its specific activity was 
reduced by addition of lOpg of non-radioactive protein A. Lanes denoted 1 
represent crosslinking in the presence of 2mM 2-oxoglutarate and 0.2mM NAD+, 
with 15p.M PDM. Lanes labelled 2 and 4 represent crosslinking in the presence 
of 0.2mM NADH and 15jiM or 7pM PDM, respectively. Lane 3 represents a 
control crosslinking with 0.2mM NAD+ and 15pM PDM. Varying incubation 
lengths (indicated by subcripts) reflect the time taken for >90% activity loss, and 
X0 denotes sample prior to addition of PDM. Lane M, low Mr marker proteins.
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organisation within the octahedral and icosahedral cores of A. vinelandii and 
S. cerevisiae PDC, respectively (Mattevi et al., 1992; Stoops et al., 1992), the 
formation of trimeric species would not be unexpected for NADH-induced 
crosslinking in OGDC. However, the low levels of these higher Mr species of E2 in 
OGDC, and of X in PDC, may simply result from the inflexibility of the crosslinked 
dimers and/or the steric arrangement of the adjacent sulphydryl groups which could 
preclude modification by two molecules of PDM. Nevertheless, in OGDC, the 
formation of E2 dimers with substrate-induced PDM-crosslinking clearly indicates 
sufficient space for both succinyl and PDM modification within a single lipoic acid 
moiety. Furthermore, previous studies have demonstrated both diacetylation, and 
acetylation with accompanying NEM-modification, in the E2 and X components of 
bovine heart PDC (De Marcucci et al., 1986; Hodgson et al., 1986).
Thus in conclusion, in PDC the predominance of X/X dimers may indeed 
indicate pairwise symmetry for this component within the E2/X core. However, at 
this stage, it is unclear whether the minor formation of a larger aggregate points to 
limitations in inter-dimeric interactions involving both S6 ,S8-thiols within individual 
lipoyl moieties on X.
5.2 .2 .2 Structural analysis of protein X  employing Arg C 
treatment
The results of section 5.2.2.1 implied the presence of dimeric protein X 
organisation within collagenase-treated E2 core, in agreement with the findings of 
Hodgson et al. (1988) in intact complex, for both NADH and substrate-induced 
PDM crosslinking. Furthermore, previous observations of the incomplete cleavage
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of protein X, by Arg C, in intact complex (see Chapter 3; Gopalakrishnan et al., 
1989 and Rahmatullah et al., 1989b), hinted at a population of less accessible, 
presumably E3-protected protein X molecules. Hence, in addition to the proteolytic 
studies listed in Chapter 3, further investigations employing Arg C in the presence of 
mildly dissociating conditions such as, 1M NaCl or 0.25M MgCl2 , pH 7.6, were 
carried out here.
From the plot of intact complex activity over 135min at 33°C presented in 
Fig. 5.2.2.2.1, it is clear that activity loss in the presence of 1M NaCl proceeded at a 
faster rate than in its absence (i.e., almost a 2 -fold difference), following addition of 
3+3+3% (w/v) Arg C at 0, 45 and 90min. By 135min only 10% of the original 
complex activity remained in the presence of 1M NaCl, and was associated with the 
complete removal of intact protein X (see Fig. 5.2.2.2.2a). A similar result was 
obtained with 0.25M MgCl2 , pH 7.6, indicating a general effect of ionic strength, 
rather than a specific metal ion activation of Arg C. In regard to the recognised E3 
binding role of protein X, and the observed protection offered by E3 (Rahmatullah et 
al., 1989b), high ionic strength will presumably give rise to mild E3 dissociation 
and therefore, increased accessibility to protein X. As the pattern of degradation 
remained unchanged, new cleavage sites did not appear to be rendered, and in 
agreement with the observations of Chapter 3, immunological evidence suggested 
only minor E l (Fig 5.2.2.2.2b) and E2 (not shown) degradation. In contrast, in the 
absence of salt, a more gradual decline to a residual 30% complex activity was 
accompanied by incomplete protein X removal (Fig. 5.2.2.2.2a). Similar results 
were also obtained in sections 3.2.3.1-2.
As recent research points to flexible, and therefore, apparently variable 
tethering of this latter component to the E2/X core (Wagenknecht et al., 1991), one 
or both monomers of an X/X dimer could derive protection via E3 binding
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Figure 5.2.2.2.1 Affect of Arg C treatment on overall PDC activity in 
the presence and ab sen ce  of high salt
A final concentration of 1M NaCl was added to 2 of 3 identical samples of 
freshly purified PDC. diluted in Soln A to lmg.mH, one labelled as a control 
and all three preincubated at 33°C prior to the addition of 3% (w/v) Arg C to the 
remaining two samples. Complex activity was monitored over the I35min 
incubation (by the removal of 20/d aliquots to 4mM benzamidine at 4°C prior to 
assay), during which two further additions of 3% (w/v) ArgC were made at 45 
and 90min (indicated by arrows). Activity was then expressed as a % of the 
original at to.
( □ - - □ )  control + lM NaCl; (■—■) Arg C; ( •—•) Arg C + lM NaCl.
Figure 5 .2 .2 .2 .2  Immunological an a ly s is  of protein X degradation  
during Arg C treatment of PDC in the presence of 1M NaCl
Following removal to 4mM benzamidine on ice and dilution in Laemmli 
sample buffer, the samples described in Fig. 5.2.2.2.1 were resolved by 10% 
(w/v) SDS-PAGE, transferred to nitrocellulose and screened with protein X or 
El-specific anti-sera Fig. 5.2.2.2.2 a & b, respectively. Lane M, denotes the 
position of low Mr marker proteins; lanes 0-135, samples removed for analysis 
(3.5pg/track); lanes C0-C135, controls; PANEL A, in the absence of 1M NaCl; 
PANEL B, in the presence of 1M NaCl.
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interactions. Thus, any heterogeneity in the proteolytic sensitivity of a population of 
protein X molecules could reflect both transitory and variable E3 positioning. 
Alternatively, more protection may be offered to one subunit of each pair, which 
would necessarily indicate a differential E3 binding involvement (overcome in 
conditions of mild dissociation), within each dimer.
I
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5.3 DISCUSSION
In contrast to the estimated 5mol protein X/mol PDC proposed by Jilka et al. 
(1986), similar densitometric scanning experiments presented here indicated 
13.4±0.4mol X/mol PDC, with a 95% probability of the true value lying within two 
standard errors (i.e., ± 0.8). This value is slightly higher than the 12moles 
expected, and may reflect incomplete occupancy of E l and E3 binding sites in the 
PDH complex leading to overestimations of protein X stoichiometry. Notably, 
equivalent determinations of the degree of protein X acetylation obtained by Jilka et 
al. (1986), by the precise measurement of the incorporation of radiolabelled 
substrates, were achieved here. Hence, both the estimated acylation of protein X of 
approx. 10% that of E2 (Jilka et al., 1986), and the estimated incorporation ratio of 
8-9:1 (E2:X) presented here, apparently support the proposed molar ratio of 12:1 
(X:PDC), deduced herein from the quantification of purified protein X and PDC 
samples.
As the latter method of quantification is based on the pivotal assumption that 
all bovine heart PDC preparations contain a constant component ratio of E2:X and 
furthermore, that all lipoyl domains of E2 and X exhibit equivalent acetylation 
potentials, the resultant 1 0-2 0 % error noted may therefore reflect deviations from the 
above. Indeed, whilst E2 of E. coli possesses three apparently functionally 
equivalent lipoyl domains, numerous reports of maximum acetylation point to an 
incorporation of 1.7-2 acetyl groups/E2 chain (see Graham et al., 1986 for review). 
In addition, previous publications cite the existence of heterogenous populations of 
purified pig heart PDC ranging from a Mr of 1-8 x 106, and raise questions over the 
true size and composition in situ (Sumegi et al., 1987). Though not an isolated 
report, the significance of this latter finding is unclear, and although variable
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acetylation may exist within populations of E2 from both mammalian and bacterial 
PDC, the maximum acetylation of bovine heart PDC reported by Jilka et al. (1986), 
is 75-90% that expected for the total number of lipoyl domains, in comparison to 57- 
67% for E. coli PDC. Furthermore, in a recent review Perham (1991) disputed the 
accuracy of previous maximum acetylation determinations, following the discovery 
of the full lipoylation of the three lipoyl domains of E2p of E. coli by Packman et al. 
(1991).
The estimate of 12 molecules of protein X per molecule of complex becomes 
more intriguing when viewed in light of the suggested dimeric organisation of 
protein X within the E2 core, presented here. The formation of X/X dimers 
employing NADH-induced PDM crosslinking mirrored the results of similar 
substrate and NADH-linked crosslinking in intact PDC (Hodgson e ta l ., 1988), and 
suggested that even in the absence of E2 lipoyl domains, protein X interactions are 
limited and indicative of pairwise symmetry. In addition, and in contrast to the easy 
removal of protein X from isolated core (see Chapter 3), complete degradation of 
protein X, by Arg C, in intact PDC appeared dependent upon the presence of mild 
dissociating conditions (i.e., 1M NaCl or 0.25M MgCl2), which hinted at a 
population of less accessible molecules. Indeed, initial reports of an E3-mediated 
protection of protein X in bovine heart PDC (Rahmatullah et al., 1989b) were 
substantiated by further reports by Powers-Greenwood et al. (1989); and 
Gopalakrishan et al. (1989), and later consolidated by the confirmation of an E3 
binding role for protein X in S. cerevisiae (Lawson et al., 1991a).
In line with the 1:1 (E3:E1) binding relationship in bovine heart OGDC, 
where recent evidence indicated a role in E3 binding for the N-terminal lipoyl-like 
sequences of E l (Rice et al., 1992), and where both components exhibit dimeric 
organisation about an octahedral E2 core (Reed & Yeaman, 1987), a model of six E3
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dimers bound to the E2 core by six protein X dimers is suggested. Whilst it is 
difficult to reconcile the integration of these molecules of protein X into a core of 
icosahedral (532) symmetry without an accompanying disarray, post-assembly 
binding appears a more plausible explanation. Support comes from the 
demonstration of apparently native E2 core self-assembly in S. cerevisiae (Niu et 
al., 1990; Lawson et al., 1991a), and from preparations of active E2 core bovine 
heart PDC (Powers-Greenwood et al., 1989) — all in the absence of protein X. Yet, 
it is clear from the tight association of protein X for the E2 core, and the necessary 
employment of denaturing conditions in its removal, that such external binding must 
involve closer interactions to those of the peripherally bound E l and E3 
components, and of the kinase molecules which also exhibit high core affinity (Li et 
al., 1992).
Although, the integration of protein X during core assembly is not yet 
discounted, the recent elucidation through electron microscopy of the S. cerevisiae 
E2 core as 60 E2 molecules arranged along 20 vertices as cone-shaped trimers 
(Stoops et al., 1992), in agreement with the similar trimeric symmetries of 
A. vinelandii PDC, and of chloramphenicol acetyltransferases (Mattevi et al., 1992; 
DeRosier, 1992), would necessitate either quasi-icosahdral symmetry or the 
substitution of E2 by protein X molecules. Importantly, the latter suggestion is not 
supported by the determination of a 95% probability of the true number of E2 
molecules falling within two standard errors (i.e., ± 5.0) of a mean value of 61.8 
(Tom Aitchson, Dept, of Statistics, University of Glasgow). In addition, a study of 
protein X distribution within bovine kidney PDC, through the relative positioning of 
E3, revealed a wide yet variable distribution, thought to reflect the postulated flexible 
tethering of E3 to the E2/X core (Wagenknecht et al., 1991). Whilst it remains 
unclear which component contributes to such tethering (Schulze et al., 1993), this 
new information raises questions over the face-centred model of E3 binding
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originally proposed by Reed & Hackert (1990), and demonstrates the need for 
further structural and component interaction analysis. Furthermore, in view of the 
proposed flexible E3 tethering, variable and transitory E3 positioning relative to the 
E2/X core could explain variations in the proteolytic sensitivity of some protein X 
molecules which was not apparent in the absence of E3 in isolated core.
CHAPTER 6 :
DISCUSSION AND FUTURE DIRECTIONS
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6.0 DISCUSSION AND FUTURE DIRECTIONS
6.1 An E3 binding function for protein X in bovine heart 
PDC
The work presented in Chapter 3 confirmed and extended previous 
observations in S. cerevisiae PDC of an E3 binding function for the subunit binding 
domain of protein X (Lawson et al., 1991a).
Selective proteolysis of the lipoyl-bearing region of X from reconstituted or 
intact bovine heart PDC, employing Arg C, resulted in the loss of both E3 binding 
potential and complex activity but had litde affect on E l binding, in agreement with 
the findings of similar work carried out in bovine kidney PDC (Rahmatullah et al., 
1989a; Powers-Greenwood et al., 1989; Gopalakrishnan et al., 1989). These 
results pointed to a role in E3 binding for the lipoyl domain of X. In contrast, 
removal of this domain from X in intact bovine heart PDC, via selective proteolysis 
with Arg C (Neagle & Lindsay, 1991); or, via gene deletion experiments in 
S. cerevisiae PDC (Lawson et al., 1991a), had been shown previously to have little 
overall effect on complex catalysis or E3 binding.
N-terminal amino acid sequencing of the truncated protein X here, revealed 
significant homology to the highly conserved E3 binding domain motif of E2 
components from various species and of X from S. cerevisiae PDC. Thus, the close 
proximity of the Arg C cleavage site to the boundary of the E3 domain suggests that 
both lipoyl and linker regions are released by selective proteolysis. From these 
observations, it was proposed that loss of E3 binding follows disruption or
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destabilisation of the adjacent subunit binding domain and/or a specific E3 binding 
site within. However, attempts to investigate the possibility of a temperature- 
sensitive destabilisation were unsuccessful (results not shown) and hence, were in 
agreement with the previous findings of Rahmatullah et al. (1989a).
Direct or indirect participation, possibly through the stabilisation of the 
subunit binding domain, should not be ruled out for the lipoyl and linker regions of 
protein X. Indeed, minor losses in both E3 binding and PDC activity accompanied 
the removal of the lipoyl domain of X in S. cerevisiae (Lawson et al., 1991a). 
Furthermore, enhanced peripheral subunit binding in E2 from B. stearothermophilus 
and A. vinelandii PDC have been linked to additional binding sites in the linker 
regions separating the subunit binding and lipoyl domains (Hipps et al., 1994; 
Schulze et al., 1991b). This possibility is given more weight following the 
discovery of E3 binding properties ascribed to a lipoyl-like sequence at the N- 
terminus of E l from bovine heart OGDC (Rice et al., 1992). Although smaller than 
a lipoyl domain (i.e., 10000-Mr), and lacking a functional lipoamide group, this 
region of E l exhibits many characteristics associated with lipoyl domains. In 
addition, while OGDC lacks a separate protein X species, the presence of the lipoyl- 
like sequence on E l appears to confer X-like properties such as, E3 binding and 
tight core affinity — both of which are lost, together with overall complex (but not 
E l) activity, upon its removal from E l. The authors cite this as a clear case of 
“domain shuffling” and, in the absence of a subunit binding domain motif in the 
related E2 from rat OGDC (Nakano et al., 1991), it is not altogether surprising that 
both El and E3 binding affinities are affected by this removal.
As protein X has only been identified as an independent species in yeast and 
mammalian PDC, in all other 2-oxoacid dehydrogenase complexes characterised to 
date, peripheral subunit binding is the sole responsibility of the E2 component —
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necessitating in some cases, both subunit binding and inner catalytic domains. 
Clearly then, the evolutionary emergence of an additional subunit binding 
component in S. cerevisiae and mammalian PDC has led to differentiation, where 
E3 binds to X, and E l to E2 (Lawson et al., 1991a,b; Gopalakrishnan e ta l ., 1989). 
Although participation in E3 binding may not have provided the selective pressure 
necessary for the maintenance of X (see section 6.2), it is of interest to note that in 
the absence of X or X-like sequences in bovine kidney BCOADC, E3 affinity for the 
E2 core appears less than that observed in PDC and OGDC from the same source, 
and leads to significant dissociation during purification from mitochondria (Clarkson 
& Lindsay, 1991).
Physiological evidence, together with work presented in Chapter 3, suggest 
however, that E2 may maintain a low binding affinity for E3. In the former case, 
reports of lactic acidemia sufferers exhibiting residual (i.e., 10-20%) PDC activity in 
the apparent absence of protein X, have provided direct support (Robinson et al., 
1990; Marsac et al., 1993). In the latter, following increasing protein X degradation 
in isolated E2/X core, employing Arg C, successively higher levels of recovery were 
achieved upon reconstitution with E1/E3 in the presence of excess porcine E3, 
suggestive of a second independent binding site — presumably on E2. Full recovery 
of reconstitution was not achieved and may indicate the low specificity of this 
second E3 binding site. Alternatively, this may be a reflection of the incompatibility 
of porcine E3 in the reconstitution of bovine complexes.
This possibility has recently come to light following preliminary findings 
from current research in this laboratory. Competition assays involving 
reconstitution of bovine heart OGDC from constituent E l, E2 and E3 components in 
the presence of increasing concentrations of E3 from various sources, indicates 
significant differences in the catalytic and/or binding requirements of the otherwise
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highly conserved E3 components, across species (S. Khan, University of Glasgow, 
personal communication). One area of future research will, therefore, involve the 
extension of such competition binding assays to reconstituted bovine heart PDC. 
Since it is now clear that Arg C cleaves not only the lipoyl but also the linker regions 
of X, with the resultant disruption of the subunit binding domain, it would be of 
great advantage to identify a protease specific for the removal of only the lipoyl 
domain of X. In the absence of subunit binding domain instability, elucidation of 
the precise nature of the involvement of the lipoyl domain in E3 binding would be 
made posssible. An alternative approach, employing transfection studies in protein 
X-deficient cell lines (C. Marsac, INSERM U75 Institute, Paris, personal 
communication) has also been proposed and could provide fresh insight into the E3 
binding functions of both E2 and X.
6.2 The role of protein X in complex catalysis
In agreement with previous observations of a residual X lipoyl domain- 
mediated complex activity following removal of the lipoyl domains of E2, in 
S. cerevisiae PDC via genetic manipulation (Lawson et al., 1991b) or, in bovine 
kidney PDC after treatment with protease, collagenase (Rahmatullah et al., 1990); 
proteolytic cleavage of the lipoyl domains of either X or E2 in reconstituted or intact 
PDC resulted here, in a residual 10-15% complex activity.
Subsequent [2,3-14C]NEM labelling of the treated complexes, in the 
presence of various substrates and products, confirmed the ability of either 
component to substitute for the lipoyl domains of the other and furthermore, to 
undergo normal diacetylation. The results suggested a non-essential but clearly,
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rate-limiting involvement of either component in complex catalysis. This supported 
previous observations of low level PDC activity and, presumably E2/E3 binding, in 
the absence of intact X presented in Chapter 3, and the discovery of residual 10-20% 
PDC activity in X-deficient lactic acidemia sufferers (Robinson et al., 1990; Marsac 
et al., 1993). Whilst X l- mutants in S. cerevisiae exhibited approximately 70% 
wild type activity (Lawson et al., 1991a), the considerably lower E2-lipoyl domain 
mediated activity noted here, in bovine heart PDC following Arg C treatment, is 
accounted for by the loss in high affinity E3 binding to X. In contrast, a residual 
10-15% protein X lipoyl domain-mediated activity was observed both in 
S. cerevisiae and mammalian PDC, reflecting limitations in the number and 
(possibly) efficiency of X.
As the majority of publications dispute the existence of an acetyltransferase 
active site on X (Behai et al., 1989; Lawson et al., 1991b; Rahmatullah et al., 
1987), and attempts to isolate and sequence the C-terminal portion of X and thereby, 
confirm previous observations of an active site-like “His Xaa Xaa Xaa Ser Gly” 
sequence on X from human PDC (J.C. Neagle, University of Glasgow, 
unpublished results), remain in the initial stages; it is still unclear whether, and 
perhaps somewhat unlikely that, X functions as an isoenzyme of E2. Although, the 
close structural identity between E2 and X, and maintenance of a multi-domain 
conformation suggest the potential for more than just an E3 binding role, 
overwhelming evidence for an external core positioning (discussed in Chapter 5), is 
not supportive of an intimate participation in catalysis. In contrast, in servicing the 
active site on E2, protein X may function in the downstream channelling of reducing 
equivalents from E2 to E3 as initially proposed by Gopalakrishnan et al. (1989), in 
view of the E3 binding role.
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The ability of X to undergo the various acetylation reactions of E2 could 
therefore, exist as a vestigial function — secondary to that of E3 binding. A similar 
situation arises in E. coli PDC, where all three lipoyl domains on E2 remain fully 
functional yet, only one (presumably the outermost) is necessary for catalysis, with 
the inner domains thought to provide increased length and flexibility facilitating 
enhanced active site coupling by the extended “superarm” (Turner et al., 1993). 
Indeed, it is of interest to note that while the lipoyl domain-like sequence at the N- 
terminus of El from bovine heart OGDC exhibits characteristics common to protein 
X (such as, E3 binding and tight core associations), and of its lipoyl domain, 
suggestive of domain shuffling, no evidence exists for an involvement in catalysis 
(Rice et al., 1992).
The answer to the maintenance of the acetylation function on X may lie in the 
unique diacetylation properties of E2 and X from mammalian PDC. During 
conditions of excessive lipid metabolism such as, mild starvation or diabetes, high 
levels of products, NADH and acetyl CoA, are removed from the cytosol via E3- 
directed acetylation of the lipoyls of E2 and X. Following stabilisation of the 
[NADH]:[NAD+] ratio, acetyls are channelled to the TCA cycle to produce energy. 
The ability of both S6,S8-thiols of the lipoic acid moiety dithiolane ring to undergo 
acetylation, and the additional presence of X, increases the storage potential more 
than 2-fold to 264mol of acetyl groups/mol PDC. The apparent absence of X and 
diacetylation in OGDC and BCOADC presumably reflects differing positions in 
metabolism, and of diacetylation in PDH complexes from species such as plants and 
yeast, possibly the additional presence of acetyl CoA-utilising pathways like the 
glyoxylate cycle. One discrepancy still persists however, in that whilst El-directed 
acetylation does not require acetyltransferase activity, acetylation from precursors, 
acetyl CoA and NADH, does and, in the absence of such activity on X, the lipoyl 
domains of this latter component must therefore, service the active site on E2. If
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diacetylation is one of the selective pressures for the emergence and maintenance of a 
functional lipoyl domain on X, it seems odd that acetyltransferase activity is not 
similarily maintained. However, it should be noted that as the precise mechanism 
for diacetylation remains to be elucidated, an additional acetylation activity may be 
involved, which could quite plausibly reside on X.
In consideration of this fact, re-assessment of the active site-like motif 
observed in a partial cDNA clone of the human protein X gene (J.C. Neagle, 
University of Glasgow, unpublished results), is currently underway. Involving re­
sequencing of the nucleotide code (J.E. Rice, University of Glasgow), together with 
amino acid sequence analysis of the C-terminal tryptic peptides of X, obtained 
through anhydrotrypsin column purification (see Chapter 4), these results may 
provide new insight into the precise role of protein X in complex catalysis. In 
addition, if good correlation exists between both sequences, the partial cDNA clone, 
fluorescently or radioactively labelled, could then provide a powerful tool for the 
isolation of the entire protein X gene from a XgtlO library, and localisation on a 
specific chromosome.
6.3 Quantification and organisation of protein X within 
bovine heart PDC
In Chapter 5, densitometric scan analysis and 14C-acetylation of the lipoic 
acid moieties on E2 and X yielded an estimate of 12-13mol X/mol PDC. This result 
was in contrast to previous determinations of 5mol X/mol PDC in bovine kidney 
PDC, employing similar methods but, based on the incorrect assumption of there 
being only one lipoyl domain on E2 (Jilka et al., 1986). Statistical analysis of the
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data obtained here from densitometer scans of E2 and X, indicated a 95% probability 
of the true number of either component lying within two standard errors of the 
calculated mean values of 61.8 ± 2.5mol E2/mol PDC and 13.4 ± 0.4mol X/mol 
PDC, respectively (Tom Aitchson, Dept, of Statistics, University of Glasgow). 
This gave a slightly higher range for X of 12.6-14.2 molecules per complex than 
expected, and may arise from variable E l and E3 occupancy leading to 
overestimations of protein X stoichiometry. Nevertheless, the small standard error 
suggested close agreement between individual determinations -- supported further, 
by a good internal control value of 61.8 molecules of E2 per complex.
Organisational studies, employing covalent NADH-induced PDM 
crosslinking of the lipoyl domains of X in E2-lipoyl domain-depleted complex, 
revealed protein X interactions indicative of dimeric organisation and similar to that 
observed previously, in intact PDC, with substrate or NADH-induced crosslinking 
(Hodgson et al., 1988). In regard to the E3 binding function of X, and the dimeric 
nature of E3, a model of 6 homodimers of E3 bound via 6 dimers of X was 
proposed.
In support, additional findings in Chapter 3, pointed to an initial lag in E3 
release, compared to PDC activity loss, following cleavage of the lipoyl and linker 
regions of protein X in intact PDC, by Arg C. Clearly, this situation could arise if 
each E3 dimer were bound to more than one X molecule, necessitating disruption of 
the subunit binding domain on both monomers of each X dimer. Alternatively, if 
one monomer of each pair were engaged in core associations and the other in E3 
binding, accessibility of the latter subunit to Arg C could be partially obstructed by 
the presence of E3. Indeed, reports of E3-mediated protection in intact complex 
exist both here, where complete protein X degradation required use of mild 
dissociating conditions (see Chapter 5) and, elsewhere (Rahmatullah et al., 1989;
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Powers-Greenwood et al., 1989; Gopalakrishnan et al., 1989). However, it should 
be noted that the lag in E3 release may simply reflect a time-dependent 
conformational change and gradual lowering or loss of E3 affinity, following 
destabilisation of the subunit binding domain. Nevertheless, a 1:1 (E1:E3) binding 
relationship also exists in bovine heart OGDC where, both components arrange with 
dimeric symmetry and, where similarities have been drawn between the N-terminal 
portion of El (responsible for E3 binding) and the lipoyls of X (Rice et al., 1992). 
Furthermore, preliminary results suggest that both subunits of the E l dimer must be 
cleaved by trypsin, prior to E3 release (J.E. Rice, University of Glasgow, 
unpublished observations).
The unusually close core interactions and structural identity between E2 and 
X prompted proposals of an internal, integral positioning for X — again recently 
suggested by Li & coworkers (1992). However, it is difficult to reconcile the 
integration of 12 molecules of X into a core of icosahedral symmetry unless X 
substitutes for E2. This possibility is disputed by the successful isolation of native 
E2 core, devoid of protein X, from S. cerevisiae (Niu et al., 1990) and, bovine 
kidney PDC (Powers-Greenwood et al., 1989). In addition, the statistical analysis 
of E2 quantification shown here, in bovine heart PDC, gave a 95% probability of the 
true number of E2 lying in the range of 57-67mol E2/mol PDC, discounting the 
possibility of an icosahedral core comprising 12X and 48E2 molecules (Tom 
Aitchson, Statistical Dept., University of Glasgow). Indeed, in light of the 
proposed dimeric protein X organisation illustrated here, and the growing evidence 
for trimeric symmetry in both cubic (A. vinelandii -- Mattevi et al.9 1992) and 
icosahedral E2 cores (S. cerevisiae -- Stoops et al.y 1992), neither organisation 
appears compatible with the other, adding to the mounting evidence in favour of an 
external positioning for X.
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Following establishment of the number and organisation of X in bovine heart 
PDC, future objectives in this area will probably involve completion of E3 binding 
studies in OGDC and, extension of previous research into component interactions 
(concentrating specifically on E2/X and E3/X binding), during import of the nuclear 
encoded precursors into the mitochondrion, and subsequent complex assembly (De 
Marcucci et al.> 1988).
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